,broad_id,pert_iname,InChIKey14,moa,target,broad_date,clinical_phase,alternative_moa,alternative_target
0,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
1,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
2,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
3,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
4,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
5,BRD-A25234499,aminoglutethimide,ROBVIMPUHSLWNV,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,broad_id_20170327,Launched,,
6,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
7,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
8,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
9,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
10,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
11,BRD-A26032986,zaldaride,HTGCJAAPDHZCHL,calmodulin antagonist,CALM1,broad_id_20170327,Phase 3,,
12,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
13,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
14,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
15,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
16,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
17,BRD-A26095496,clobetasol-propionate,CBGUOGMQLZIXBE,glucocorticoid receptor agonist,NR3C1|PLA2G1B,broad_id_20170327,Launched,,
18,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
19,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
20,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
21,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
22,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
23,BRD-A26334849,propafenone,JWHAUXFOSRPERK,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,broad_id_20170327,Launched,,
24,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
25,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
26,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
27,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
28,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
29,BRD-A26690767,saquinavir,QWAXKHKRTORLEM,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
30,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
31,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
32,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
33,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
34,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
35,BRD-A26711594,nicardipine,ZBBHBTPTTSWHBA,calcium channel blocker,ADORA3,broad_id_20170327,Launched,,
36,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
37,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
38,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
39,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
40,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
41,BRD-A27376179,lestaurtinib,UIARLYUEJFELEN,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,broad_id_20170327,Phase 3,,
42,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
43,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
44,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
45,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
46,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
47,BRD-A27732521,tolperisone,FSKFPVLPFLJRQB,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,broad_id_20170327,Launched,,
48,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
49,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
50,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
51,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
52,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
53,BRD-A28467416,PKI-179,WXUUCRLKXQMWRY,mTOR inhibitor|PI3K inhibitor,MTOR,broad_id_20170327,Phase 1,,
54,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
55,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
56,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
57,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
58,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
59,BRD-A28545468,selegiline,MEZLKOACVSPNER,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
60,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
61,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
62,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
63,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
64,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
65,BRD-A28787076,inosine,UGQMRVRMYYASKQ,neurotrophic agent,PARP1|PNP,broad_id_20170327,Launched,,
66,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
67,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
68,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
69,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
70,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
71,BRD-A29260609,acebutolol,GOEMGAFJFRBGGG,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
72,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
73,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
74,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
75,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
76,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
77,BRD-A29289453,PCA-4248,DHCNAWNKZMNTIS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 1,,
78,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
79,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
80,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
81,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
82,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
83,BRD-A29322418,potassium-canrenoate,PBKZPPIHUVSDNM,mineralocorticoid receptor antagonist,NR3C2,broad_id_20170327,Launched,,
84,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
85,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
86,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
87,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
88,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
89,BRD-A29623586,anisodamine,WTQYWNWRJNXDEG,lipid peroxidase inhibitor,ADRA1A,broad_id_20170327,Phase 3,,
90,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
91,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
92,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
93,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
94,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
95,BRD-A29731977,17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,broad_id_20170327,Launched,,
96,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
97,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
98,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
99,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
100,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
101,BRD-A29734509,disopyramide,UVTNFZQICZKOEM,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,broad_id_20170327,Launched,,
102,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
103,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
104,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
105,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
106,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
107,BRD-A30051119,amikacin,LKCWBDHBTVXHDL,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
108,BRD-K03842655,,,,,,,,
109,BRD-K03842655,,,,,,,,
110,BRD-K03842655,,,,,,,,
111,BRD-K03842655,,,,,,,,
112,BRD-K03842655,,,,,,,,
113,BRD-K03842655,,,,,,,,
114,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
115,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
116,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
117,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
118,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
119,BRD-K25114078,aminoguanidine,HAMNKKUPIHEESI,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,broad_id_20170327,Phase 3,,
120,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
121,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
122,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
123,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
124,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
125,BRD-K25140590,CX-516,BXBNADAPIHHXJQ,glutamate receptor modulator,,broad_id_20170327,Phase 2/Phase 3,,
126,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
127,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
128,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
129,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
130,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
131,BRD-K25204779,pritelivir,IVZKZONQVYTCKC,helicase primase inhibitor,,broad_id_20170327,Phase 2,,
132,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
133,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
134,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
135,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
136,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
137,BRD-K25361343,batimastat,XFILPEOLDIKJHX,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,broad_id_20170327,Phase 3,,
138,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
139,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
140,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
141,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
142,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
143,BRD-K25394294,oxaprozin,OFPXSFXSNFPTHF,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
144,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
145,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
146,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
147,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
148,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
149,BRD-K25650355,physostigmine,PIJVFDBKTWXHHD,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
150,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
151,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
152,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
153,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
154,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
155,BRD-K25837718,,UKNSBNVKSFTZOJ,,,broad_id_20170327,,,
156,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
157,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
158,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
159,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
160,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
161,BRD-K25943794,blonanserin,XVGOZDAJGBALKS,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
162,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
163,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
164,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
165,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
166,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
167,BRD-K26011976,licochalcone-A,KAZSKMJFUPEHHW,topoisomerase inhibitor,PTPN1,broad_id_20170327,Phase 3,,
168,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
169,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
170,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
171,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
172,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
173,BRD-K26603252,PD-153035,LSPANGZZENHZNJ,EGFR inhibitor,EGFR|KDR,broad_id_20170327,Phase 1,,
174,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
175,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
176,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
177,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
178,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
179,BRD-K26619122,thiocolchicoside,LEQAKWQJCITZNK,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,broad_id_20170327,Launched,,
180,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
181,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
182,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
183,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
184,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
185,BRD-K26657438,imiquimod,DOUYETYNHWVLEO,interferon inducer|toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Launched,,
186,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
187,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
188,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
189,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
190,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
191,BRD-K26701552,tegobuvir,XBEQSQDCBSKCHJ,HCV inhibitor|protease inhibitor,,broad_id_20170327,Phase 3,,
192,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
193,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
194,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
195,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
196,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
197,BRD-K26712974,VX-765,SJDDOCKBXFJEJB,caspase inhibitor,CASP1,broad_id_20170327,Phase 2,,
198,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
199,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
200,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
201,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
202,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
203,BRD-K27938825,ASA-404,XGOYIMQSIKSOBS,angiogenesis inhibitor,,broad_id_20170327,Phase 3,,
204,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
205,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
206,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
207,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
208,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
209,BRD-K27955832,lomeguatrib,JUJPKFNFCWJBCX,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 2,,
210,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
211,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
212,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
213,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
214,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
215,BRD-K28143534,cyproheptadine,JJCFRYNCJDLXIK,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
216,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
217,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
218,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
219,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
220,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
221,BRD-K28183345,proguanil,SSOLNOMRVKKSON,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
222,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
223,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
224,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
225,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
226,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
227,BRD-K28217197,ganaxolone,PGTVWKLGGCQMBR,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 3,,
228,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
229,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
230,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
231,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
232,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
233,BRD-K28542495,benzydamine,CNBGNNVCVSKAQZ,prostanoid receptor antagonist,,broad_id_20170327,Launched,,
234,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
235,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
236,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
237,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
238,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
239,BRD-K28667793,pyrazinamide,IPEHBUMCGVEMRF,fatty acid synthase inhibitor,FASN,broad_id_20170327,Launched,,
240,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
241,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
242,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
243,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
244,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
245,BRD-K28731095,calcitriol,GMRQFYUYWCNGIN,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
246,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
247,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
248,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
249,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
250,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
251,BRD-K28761891,ramelteon,YLXDSYKOBKBWJQ,melatonin receptor agonist,MTNR1A|MTNR1B,broad_id_20170327,Launched,,
252,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
253,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
254,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
255,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
256,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
257,BRD-K28971625,ZD-7114,RVMBDLSFFNKKLG,adrenergic receptor agonist,ADRB3,broad_id_20170327,Phase 1,,
258,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
259,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
260,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
261,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
262,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
263,BRD-K28984613,dutasteride,JWJOTENAMICLJG,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,broad_id_20170327,Launched,,
264,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
265,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
266,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
267,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
268,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
269,BRD-K29322660,edoxaban,HGVDHZBSSITLCT,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
270,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
271,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
272,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
273,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
274,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
275,BRD-K29359156,ebselen,DYEFUKCXAQOFHX,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,broad_id_20170327,Phase 2/Phase 3,,
276,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
277,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
278,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
279,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
280,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
281,BRD-K29582115,ziprasidone,MVWVFYHBGMAFLY,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
282,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
283,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
284,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
285,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
286,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
287,BRD-K29653726,topiramate,KJADKKWYZYXHBB,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
288,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
289,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
290,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
291,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
292,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
293,BRD-K29656036,MK-8245,UJEAABFSXKCSGI,stearoyl-CoA desaturase inhibitor,SCD,broad_id_20170327,Phase 2,,
294,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
295,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
296,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
297,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
298,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
299,BRD-K29673530,hypericin,BTXNYTINYBABQR,tyrosine kinase inhibitor,,broad_id_20170327,Phase 3,,
300,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
301,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
302,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
303,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
304,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
305,BRD-K29735307,ostarine,JNGVJMBLXIUVRD,androgen receptor modulator,AR,broad_id_20170327,Phase 3,,
306,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
307,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
308,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
309,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
310,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
311,BRD-K30126819,dimesna,BYUKOOOZTSTOOH,tubulin polymerization inhibitor,,broad_id_20170327,Phase 3,,
312,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
313,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
314,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
315,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
316,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
317,BRD-K30331124,ASC-J9,ZMGUKFHHNQMKJI,androgen receptor enhancer,AR,broad_id_20200324,Phase 2,,
318,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
319,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
320,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
321,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
322,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
323,BRD-K30421593,timolol,BLJRIMJGRPQVNF,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
324,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
325,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
326,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
327,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
328,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
329,BRD-K30466858,ellagic-acid,AFSDNFLWKVMVRB,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,broad_id_20170327,Phase 2,,
330,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
331,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
332,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
333,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
334,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
335,BRD-K30480208,torasemide,NGBFQHCMQULJNZ,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,broad_id_20170327,Launched,,
336,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
337,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
338,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
339,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
340,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
341,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
342,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
343,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
344,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
345,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
346,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
347,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
348,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
349,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
350,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
351,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
352,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
353,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
354,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
355,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
356,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
357,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
358,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
359,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
360,,,,,,,,,
361,,,,,,,,,
362,,,,,,,,,
363,,,,,,,,,
364,,,,,,,,,
365,,,,,,,,,
366,,,,,,,,,
367,,,,,,,,,
368,,,,,,,,,
369,,,,,,,,,
370,,,,,,,,,
371,,,,,,,,,
372,,,,,,,,,
373,,,,,,,,,
374,,,,,,,,,
375,,,,,,,,,
376,,,,,,,,,
377,,,,,,,,,
378,,,,,,,,,
379,,,,,,,,,
380,,,,,,,,,
381,,,,,,,,,
382,,,,,,,,,
383,,,,,,,,,
384,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
385,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
386,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
387,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
388,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
389,BRD-A15909516,rebamipide,ALLWOAVDORUJLA,free radical scavenger,FPR1,broad_id_20170327,Launched,,
390,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
391,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
392,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
393,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
394,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
395,BRD-A16296925,indobufen,AYDXAULLCROVIT,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
396,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
397,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
398,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
399,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
400,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
401,BRD-A16347691,thioctic-acid,AGBQKNBQESQNJD,reducing agent,ACHE|PTGS2,broad_id_20170327,Launched,,
402,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
403,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
404,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
405,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
406,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
407,BRD-A16665823,butoconazole,SWLMUYACZKCSHZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
408,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
409,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
410,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
411,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
412,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
413,BRD-A16997652,protirelin,XNSAINXGIQZQOO,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
414,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
415,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
416,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
417,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
418,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
419,BRD-A17411484,carprofen,PUXBGTOOZJQSKH,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
420,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
421,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
422,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
423,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
424,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
425,BRD-A17462676,bambuterol,ANZXOIAKUNOVQU,adrenergic receptor agonist,ADRB2|BCHE,broad_id_20170327,Launched,,
426,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
427,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
428,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
429,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
430,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
431,BRD-A17655518,ibuprofen,HEFNNWSXXWATRW,cyclooxygenase inhibitor,,broad_id_20170327,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8
432,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
433,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
434,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
435,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
436,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
437,BRD-A17883755,lenalidomide,GOTYRUGSSMKFNF,anticancer agent,TNF,broad_id_20170327,Launched,,
438,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
439,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
440,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
441,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
442,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
443,BRD-A18043272,phensuximide,WLWFNJKHKGIJNW,succinimide antiepileptic,,broad_id_20170327,Launched,,
444,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
445,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
446,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
447,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
448,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
449,BRD-A18620900,estriol,PROQIPRRNZUXQM,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
450,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
451,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
452,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
453,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
454,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
455,BRD-K12184916,NVP-BEZ235,JOGKUKXHTYWRGZ,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 3,,
456,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
457,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
458,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
459,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
460,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
461,BRD-K15502390,nevirapine,NQDJXKOVJZTUJA,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,broad_id_20170327,Launched,,
462,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
463,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
464,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
465,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
466,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
467,BRD-K15507868,tesaglitazar,CXGTZJYQWSUFET,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,broad_id_20170327,Phase 3,,
468,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
469,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
470,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
471,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
472,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
473,BRD-K15567136,papaverine,XQYZDYMELSJDRZ,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,broad_id_20170327,Launched,,
474,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
475,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
476,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
477,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
478,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
479,BRD-K15766189,cefdinir,RTXOFQZKPXMALH,bacterial cell wall synthesis inhibitor,MPO,broad_id_20170327,Launched,,
480,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
481,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
482,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
483,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
484,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
485,BRD-K15916496,clotrimazole,VNFPBHJOKIVQEB,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,broad_id_20170327,Launched,,
486,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
487,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
488,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
489,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
490,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
491,BRD-K15933101,ropinirole,UHSKFQJFRQCDBE,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
492,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
493,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
494,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
495,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
496,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
497,BRD-K15976406,telbivudine,IQFYYKKMVGJFEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
498,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
499,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
500,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
501,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
502,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
503,BRD-K16037980,Z160,VCPMZDWBEWTGNW,N-type calcium channel blocker,CACNA2D1,broad_id_20170327,Phase 2,,
504,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
505,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
506,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
507,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
508,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
509,BRD-K16077845,fentiazac,JIEKMACRVQTPRC,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
510,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
511,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
512,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
513,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
514,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
515,BRD-K16133773,abiraterone-acetate,UVIQSJCZCSLXRZ,androgen biosynthesis inhibitor,CYP17A1,broad_id_20170327,Launched,,
516,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
517,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
518,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
519,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
520,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
521,BRD-K16195444,oxymetazoline,WYWIFABBXFUGLM,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,broad_id_20170327,Launched,,
522,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
523,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
524,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
525,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
526,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
527,BRD-K16295392,atrasentan,MOTJMGVDPWRKOC,endothelin receptor antagonist,EDNRA,broad_id_20170327,Phase 3,,
528,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
529,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
530,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
531,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
532,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
533,BRD-K16444452,ibudilast,ZJVFLBOZORBYFE,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
534,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
535,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
536,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
537,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
538,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
539,BRD-K16508793,,AAOVKJBEBIDNHE,,,broad_id_20170327,,,
540,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
541,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
542,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
543,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
544,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
545,BRD-K16542329,zaprinast,REZGGXNDEMKIQB,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,broad_id_20170327,Phase 2,,
546,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
547,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
548,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
549,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
550,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
551,BRD-K16730910,regorafenib,FNHKPVJBJVTLMP,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,broad_id_20170327,Launched,,
552,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
553,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
554,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
555,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
556,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
557,BRD-K16732600,MK-0893,DNTVJEMGHBIUMW,glucagon receptor antagonist,GCGR,broad_id_20170327,Phase 2,,
558,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
559,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
560,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
561,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
562,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
563,BRD-K16757695,PRX-08066,IENZFHBNCRQMNP,serotonin receptor antagonist,HTR2B,broad_id_20170327,Phase 2,,
564,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
565,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
566,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
567,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
568,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
569,BRD-K16761703,sotrastaurin,OAVGBZOFDPFGPJ,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,broad_id_20170327,Phase 2,,
570,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
571,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
572,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
573,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
574,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
575,BRD-K16762525,clarithromycin,AGOYDEPGAOXOCK,bacterial 50S ribosomal subunit inhibitor,CYP3A4,broad_id_20170327,Launched,,
576,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
577,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
578,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
579,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
580,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
581,BRD-K16803204,filgotinib,RIJLVEAXPNLDTC,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Phase 3,,
582,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
583,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
584,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
585,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
586,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
587,BRD-K16898998,bevirimat-dimeglumine,YJEJKUQEXFSVCJ,HIV capsid assembly inhibitor,,broad_id_20170327,Phase 2,,
588,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
589,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
590,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
591,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
592,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
593,BRD-K17026858,pibenzimol,INAAIJLSXJJHOZ,DNA inhibitor,,broad_id_20170327,Phase 2,,
594,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
595,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
596,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
597,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
598,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
599,BRD-K17068645,bendamustine,YTKUWDBFDASYHO,DNA inhibitor,,broad_id_20170327,Launched,,
600,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
601,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
602,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
603,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
604,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
605,BRD-K17075857,chloroxine,WDFKMLRRRCGAKS,opioid receptor antagonist,OPRK1,broad_id_20170327,Launched,,
606,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
607,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
608,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
609,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
610,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
611,BRD-K17203476,LY2874455,GKJCVYLDJWTWQU,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,broad_id_20170327,Phase 1,,
612,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
613,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
614,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
615,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
616,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
617,BRD-K17498618,atracurium,YXSLJKQTIDHPOT,acetylcholine receptor antagonist,,broad_id_20170327,Launched,acetylcholine receptor antagonist,CHRNA2
618,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
619,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
620,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
621,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
622,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
623,BRD-K17500877,bropirimine,CIUUIPMOFZIWIZ,interferon inducer,,broad_id_20170327,Phase 3,,
624,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
625,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
626,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
627,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
628,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
629,BRD-K17513304,firategrast,YLFZHHDVRSYTKT,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
630,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
631,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
632,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
633,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
634,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
635,BRD-K17555800,talmapimod,ZMELOYOKMZBMRB,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,broad_id_20170327,Phase 2,,
636,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
637,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
638,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
639,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
640,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
641,BRD-K17561142,amiodarone,IYIKLHRQXLHMJQ,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,broad_id_20170327,Launched,,
642,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
643,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
644,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
645,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
646,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
647,BRD-K17705806,JTC-801,VTGBZWHPJFMTKS,opioid receptor antagonist,OPRL1,broad_id_20170327,Phase 2,,
648,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
649,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
650,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
651,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
652,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
653,BRD-K17743125,belinostat,NCNRHFGMJRPRSK,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
654,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
655,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
656,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
657,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
658,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
659,BRD-K17849083,tranilast,NZHGWWWHIYHZNX,angiogenesis inhibitor,HPGDS|HRH1,broad_id_20170327,Launched,,
660,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
661,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
662,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
663,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
664,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
665,BRD-K17894950,indirubin,CRDNMYFJWFXOCH,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,broad_id_20170327,Phase 2/Phase 3,,
666,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
667,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
668,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
669,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
670,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
671,BRD-K17930269,retapamulin,STZYTFJPGGDRJD,protein synthesis inhibitor,,broad_id_20170327,Launched,,
672,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
673,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
674,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
675,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
676,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
677,BRD-K17944737,artesunate,FIHJKUPKCHIPAT,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
678,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
679,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
680,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
681,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
682,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
683,BRD-K17953908,LY2886721,NIDRNVHMMDAAIK,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1/Phase 2,,
684,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
685,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
686,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
687,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
688,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
689,BRD-K18157228,fdcyd,IDYKCXHJJGMAEV,DNA methyltransferase inhibitor,,broad_id_20170327,Phase 2,,
690,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
691,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
692,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
693,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
694,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
695,BRD-K18194590,mephentermine,RXQCGGRTAILOIN,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
696,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
697,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
698,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
699,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
700,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
701,BRD-K18324993,budipine,QIHLUZAFSSMXHQ,glutamate receptor antagonist,GRIN1,broad_id_20170327,Launched,,
702,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
703,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
704,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
705,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
706,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
707,BRD-K18673820,folic-acid,OVBPIULPVIDEAO,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,broad_id_20170327,Launched,,
708,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
709,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
710,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
711,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
712,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
713,BRD-K18678457,ZD-7288,JABSKGQQWUDVRU,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,broad_id_20170327,Phase 2,,
714,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
715,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
716,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
717,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
718,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
719,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
720,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
721,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
722,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
723,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
724,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
725,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
726,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
727,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
728,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
729,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
730,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
731,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
732,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
733,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
734,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
735,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
736,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
737,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
738,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
739,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
740,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
741,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
742,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
743,BRD-K99964838,bosutinib,UBPYILGKFZZVDX,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,broad_id_20170327,Launched,,
744,,,,,,,,,
745,,,,,,,,,
746,,,,,,,,,
747,,,,,,,,,
748,,,,,,,,,
749,,,,,,,,,
750,,,,,,,,,
751,,,,,,,,,
752,,,,,,,,,
753,,,,,,,,,
754,,,,,,,,,
755,,,,,,,,,
756,,,,,,,,,
757,,,,,,,,,
758,,,,,,,,,
759,,,,,,,,,
760,,,,,,,,,
761,,,,,,,,,
762,,,,,,,,,
763,,,,,,,,,
764,,,,,,,,,
765,,,,,,,,,
766,,,,,,,,,
767,,,,,,,,,
768,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
769,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
770,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
771,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
772,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
773,BRD-A31159102,fluoxetine,RTHCYVBBDHJXIQ,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,broad_id_20170327,Launched,,
774,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
775,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
776,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
777,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
778,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
779,BRD-A31521121,methocarbamol,GNXFOGHNGIVQEH,muscle relaxant,CA1,broad_id_20170327,Launched,,
780,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
781,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
782,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
783,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
784,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
785,BRD-A31811760,miltefosine,PQLXHQMOHUQAKB,membrane integrity inhibitor,PLA2G1B,broad_id_20170327,Launched,,
786,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
787,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
788,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
789,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
790,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
791,BRD-A32269193,VGX-1027,MUFJHYRCIHHATF,tumor necrosis factor receptor antagonist,TLR4,broad_id_20170327,Phase 1,,
792,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
793,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
794,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
795,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
796,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
797,BRD-A33168282,sotalol,ZBMZVLHSJCTVON,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,broad_id_20170327,Launched,,
798,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
799,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
800,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
801,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
802,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
803,BRD-A33447119,oxfendazole,BEZZFPOZAYTVHN,anthelmintic agent,,broad_id_20170327,Launched,,
804,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
805,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
806,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
807,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
808,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
809,BRD-A33711280,metixene,MJFJKKXQDNNUJF,acetylcholine receptor antagonist,CHRM5,broad_id_20170327,Launched,,
810,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
811,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
812,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
813,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
814,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
815,BRD-A34006693,suprofen,MDKGKXOCJGEUJW,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
816,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
817,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
818,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
819,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
820,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
821,BRD-A34513497,lacitol,VQHSOMBJVWLPSR,laxative,,broad_id_20170327,Launched,,
822,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
823,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
824,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
825,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
826,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
827,BRD-A36331462,oprozomib,SWZXEVABPLUDIO,proteasome inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
828,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
829,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
830,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
831,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
832,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
833,BRD-K23499943,alvespimycin,KUFRQPKVAWMTJO,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
834,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
835,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
836,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
837,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
838,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
839,BRD-K31111078,dimethyl-fumarate,LDCRTTXIJACKKU,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,broad_id_20170327,Launched,,
840,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
841,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
842,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
843,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
844,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
845,BRD-K31135544,IB-MECA,HUJXGQILHAUCCV,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
846,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
847,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
848,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
849,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
850,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
851,BRD-K31309378,lucitanib,CUDVHEFYRIWYQD,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 2,,
852,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
853,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
854,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
855,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
856,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
857,BRD-K31385749,ivabradine,ACRHBAYQBXXRTO,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,broad_id_20170327,Launched,,
858,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
859,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
860,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
861,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
862,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
863,BRD-K31627533,rimexolone,QTTRZHGPGKRAFB,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
864,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
865,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
866,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
867,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
868,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
869,BRD-K31731454,pemirolast,HIANJWSAHKJQTH,mediator release inhibitor,HRH1,broad_id_20170327,Launched,,
870,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
871,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
872,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
873,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
874,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
875,BRD-K31812033,levobunolol,IXHBTMCLRNMKHZ,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,adrenergic receptor antagonist,
876,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
877,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
878,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
879,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
880,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
881,BRD-K31841515,oxypurinol,HXNFUBHNUDHIGC,xanthine oxidase inhibitor,XDH,broad_id_20170327,Phase 2/Phase 3,,
882,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
883,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
884,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
885,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
886,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
887,BRD-K32101625,LX1031,XNMUICFMGGQSMZ,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Phase 2,,
888,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
889,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
890,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
891,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
892,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
893,BRD-K32247306,primidone,DQMZLTXERSFNPB,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
894,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
895,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
896,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
897,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
898,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
899,BRD-K32285926,AMG-208,HEAIZQNMNCHNFD,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
900,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
901,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
902,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
903,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
904,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
905,BRD-K32405725,etomoxir,DZLOHEOHWICNIL,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Phase 2,,
906,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
907,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
908,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
909,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
910,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
911,BRD-K32501161,vanoxerine,NAUWTFJOPJWYOT,dopamine reuptake inhibitor,SLC6A3,broad_id_20170327,Phase 3,,
912,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
913,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
914,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
915,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
916,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
917,BRD-K32744045,disulfiram,AUZONCFQVSMFAP,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,broad_id_20170327,Launched,,
918,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
919,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
920,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
921,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
922,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
923,BRD-K32821942,azathioprine,LMEKQMALGUDUQG,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,broad_id_20170327,Launched,,
924,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
925,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
926,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
927,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
928,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
929,BRD-K33141550,L-NAME,KCWZGJVSDFYRIX,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 2/Phase 3,,
930,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
931,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
932,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
933,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
934,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
935,BRD-K33211335,dextromethorphan,MKXZASYAUGDDCJ,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
936,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
937,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
938,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
939,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
940,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
941,BRD-K33226500,indinavir,CBVCZFGXHXORBI,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
942,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
943,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
944,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
945,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
946,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
947,BRD-K33379087,tivantinib,UCEQXRCJXIVODC,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 3,,
948,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
949,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
950,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
951,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
952,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
953,BRD-K33453211,levocabastine,ZCGOMHNNNFPNMX,histamine receptor antagonist,HRH1|NTSR2,broad_id_20170327,Launched,,
954,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
955,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
956,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
957,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
958,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
959,BRD-K33732501,methylnaltrexone,JVLBPIPGETUEET,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
960,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
961,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
962,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
963,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
964,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
965,BRD-K33852358,arofylline,GVTLDPJNRVMCAL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 3,,
966,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
967,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
968,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
969,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
970,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
971,BRD-K33882852,ZK-93423,ALBKMJDFBZVHAK,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 3,,
972,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
973,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
974,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
975,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
976,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
977,BRD-K34022604,clofarabine,WDDPHFBMKLOVOX,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
978,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
979,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
980,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
981,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
982,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
983,BRD-K34154330,tracazolate,PCTRYMLLRKWXGF,GABA receptor modulator,GABRA1,broad_id_20170327,Phase 2,,
984,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
985,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
986,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
987,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
988,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
989,BRD-K34341643,glasdegib,SFNSLLSYNZWZQG,hedgehog pathway inhibitor,SMO,broad_id_20170327,Launched,,
990,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
991,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
992,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
993,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
994,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
995,BRD-K34469523,albuterol,NDAUXUAQIAJITI,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
996,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
997,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
998,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
999,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
1000,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
1001,BRD-K34713073,PD-123319,YSTVFDAKLDMYCR,angiotensin antagonist,AGTR2,broad_id_20170327,Phase 1,,
1002,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1003,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1004,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1005,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1006,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1007,BRD-K34776109,glimepiride,WIGIZIANZCJQQY,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,broad_id_20170327,Launched,,
1008,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1009,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1010,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1011,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1012,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1013,BRD-K34870043,adoprazine,IUVSEUFHPNITEQ,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Phase 2,,
1014,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1015,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1016,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1017,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1018,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1019,BRD-K35245662,ciclesonide,LUKZNWIVRBCLON,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
1020,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1021,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1022,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1023,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1024,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1025,BRD-K35520305,dacarbazine,FDKXTQMXEQVLRF,DNA alkylating agent,PGD|POLA2,broad_id_20170327,Launched,,
1026,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1027,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1028,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1029,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1030,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1031,BRD-K35586044,rauwolscine,BLGXFZZNTVWLAY,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
1032,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1033,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1034,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1035,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1036,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1037,BRD-K35589454,danegaptide,BIZKIHUJGMSVFD,gap junction modulator,,broad_id_20170327,Phase 2,,
1038,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1039,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1040,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1041,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1042,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1043,BRD-K35629949,SR-27897,ILNRQFBVVQUOLP,CCK receptor antagonist,CCKAR,broad_id_20170327,Phase 2,,
1044,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1045,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1046,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1047,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1048,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1049,BRD-K35687421,gimeracil,ZPLQIPFOCGIIHV,dihydropyrimidine dehydrogenase inhibitor,DPYD,broad_id_20170327,Launched,,
1050,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1051,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1052,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1053,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1054,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1055,BRD-K35719256,rotundine,AEQDJSLRWYMAQI,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,broad_id_20170327,Launched,,
1056,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1057,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1058,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1059,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1060,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1061,BRD-K35775715,liranaftate,VPHPQNGOVQYUMG,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
1062,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1063,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1064,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1065,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1066,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1067,BRD-K36280065,tofacitinib,UJLAWZDWDVHWOW,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Launched,,
1068,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1069,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1070,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1071,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1072,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1073,BRD-K36386086,dolutegravir,RHWKPHLQXYSBKR,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,broad_id_20170327,Launched,,
1074,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1075,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1076,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1077,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1078,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1079,BRD-K36467523,bindarit,MTHORRSSURHQPZ,NFkB pathway inhibitor,CCL2|CCL7|CCL8,broad_id_20170327,Phase 2,,
1080,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1081,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1082,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1083,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1084,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1085,BRD-K36627727,tamibarotene,MUTNCGKQJGXKEM,retinoid receptor agonist,RARA|RARB,broad_id_20170327,Launched,,
1086,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1087,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1088,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1089,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1090,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1091,BRD-K36680103,omecamtiv-mecarbil,RFUBTTPMWSKEIW,cardiac myosin activator,MYBPC3,broad_id_20170327,Phase 3,,
1092,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1093,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1094,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1095,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1096,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1097,BRD-K36732695,setiptiline,GVPIXRLYKVFFMK,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,broad_id_20170327,Launched,,
1098,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1099,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1100,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1101,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1102,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1103,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1104,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1105,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1106,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1107,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1108,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1109,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1110,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1111,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1112,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1113,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1114,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1115,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1116,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1117,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1118,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1119,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1120,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1121,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1122,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1123,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1124,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1125,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1126,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1127,BRD-K96550715,linagliptin,LTXREWYXXSTFRX,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
1128,,,,,,,,,
1129,,,,,,,,,
1130,,,,,,,,,
1131,,,,,,,,,
1132,,,,,,,,,
1133,,,,,,,,,
1134,,,,,,,,,
1135,,,,,,,,,
1136,,,,,,,,,
1137,,,,,,,,,
1138,,,,,,,,,
1139,,,,,,,,,
1140,,,,,,,,,
1141,,,,,,,,,
1142,,,,,,,,,
1143,,,,,,,,,
1144,,,,,,,,,
1145,,,,,,,,,
1146,,,,,,,,,
1147,,,,,,,,,
1148,,,,,,,,,
1149,,,,,,,,,
1150,,,,,,,,,
1151,,,,,,,,,
1152,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1153,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1154,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1155,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1156,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1157,BRD-A02006392,nitrendipine,PVHUJELLJLJGLN,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,broad_id_20170327,Launched,,
1158,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1159,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1160,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1161,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1162,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1163,BRD-A18611368,tazobactam,LPQZKKCYTLCDGQ,beta lactamase inhibitor,,broad_id_20170327,Launched,,
1164,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1165,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1166,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1167,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1168,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1169,BRD-A19195498,trimipramine,ZSCDBOWYZJWBIY,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1170,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1171,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1172,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1173,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1174,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1175,BRD-A19633847,perhexiline,CYXKNKQEMFBLER,carnitine palmitoyltransferase inhibitor,CPT1A,broad_id_20170327,Launched,,
1176,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1177,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1178,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1179,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1180,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1181,BRD-A19661776,mianserin,UEQUQVLFIPOEMF,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
1182,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1183,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1184,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1185,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1186,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1187,BRD-A19736161,ondansetron,FELGMEQIXOGIFQ,serotonin receptor antagonist,HTR3A|HTR3B,broad_id_20170327,Launched,,
1188,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1189,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1190,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1191,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1192,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1193,BRD-A20119038,mecamylamine,IMYZQPCYWPFTAG,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,broad_id_20170327,Launched,,
1194,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1195,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1196,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1197,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1198,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1199,BRD-A20126139,medrysone,GZENKSODFLBBHQ,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
1200,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1201,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1202,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1203,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1204,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1205,BRD-A22032524,amlodipine,HTIQEAQVCYTUBX,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,broad_id_20170327,Launched,calcium channel blocker,
1206,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1207,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1208,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1209,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1210,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1211,BRD-A22769835,homochlorcyclizine,WEUCDJCFJHYFRL,antihistamine,HRH1,broad_id_20170327,Launched,,
1212,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1213,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1214,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1215,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1216,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1217,BRD-A24228527,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1218,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1219,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1220,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1221,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1222,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1223,BRD-A25619068,fadrozole,CLPFFLWZZBQMAO,aromatase inhibitor,CYP11B1|CYP19A1,broad_id_20170327,Launched,,
1224,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1225,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1226,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1227,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1228,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1229,BRD-A26384407,chlorthalidone,JIVPVXMEBJLZRO,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,broad_id_20170327,Launched,,
1230,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1231,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1232,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1233,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1234,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1235,BRD-A26423207,sparfloxacin,DZZWHBIBMUVIIW,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
1236,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1237,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1238,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1239,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1240,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1241,BRD-A26503646,formestane,ZMEULISFKSVRLQ,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
1242,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1243,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1244,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1245,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1246,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1247,BRD-K18779551,bifemelane,QSQQPMHPCBLLGX,acetylcholine release enhancer,MAOA|MAOB,broad_id_20170327,Launched,,
1248,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1249,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1250,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1251,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1252,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1253,BRD-K18850819,MK-0752,XCGJIFAKUZNNOR,gamma secretase inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
1254,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1255,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1256,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1257,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1258,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1259,BRD-K19284129,salvinorin-A,OBSYBRPAKCASQB,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Phase 1,,
1260,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1261,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1262,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1263,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1264,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1265,BRD-K19352500,prochlorperazine,WIKYUJGCLQQFNW,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,broad_id_20170327,Launched,,
1266,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1267,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1268,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1269,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1270,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1271,BRD-K19388745,colforsin-daproate,RSOZZQTUMVBTMR,adenylyl cyclase activator,,broad_id_20170327,Launched,,
1272,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1273,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1274,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1275,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1276,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1277,BRD-K19540840,saracatinib,OUKYUETWWIPKQR,SRC inhibitor,ABL1|LCK|SRC|YES1,broad_id_20170327,Phase 2/Phase 3,,
1278,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1279,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1280,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1281,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1282,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1283,BRD-K19687926,lapatinib,BCFGMOOMADDAQU,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Launched,,
1284,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1285,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1286,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1287,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1288,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1289,BRD-K19939891,TIC10,RSAQARAFWMUYLL,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,broad_id_20170327,Phase 2,,
1290,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1291,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1292,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1293,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1294,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1295,BRD-K20141153,atomoxetine,VHGCDTVCOLNTBX,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
1296,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1297,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1298,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1299,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1300,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1301,BRD-K20285085,R406,NHHQJBCNYHBUSI,SYK inhibitor,RET|SYK,broad_id_20170327,Phase 1,,
1302,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1303,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1304,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1305,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1306,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1307,BRD-K20920669,cromoglicic-acid,IMZMKUWMOSJXDT,immunosuppressant,KCNMA1|S100P,broad_id_20170327,Launched,,
1308,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1309,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1310,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1311,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1312,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1313,BRD-K21295289,senicapoc,SCTZUZTYRMOMKT,intermediate conductance potassium channel blocker,KCNN4,broad_id_20170327,Phase 3,,
1314,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1315,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1316,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1317,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1318,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1319,BRD-K21361524,selinexor,DEVSOMFAQLZNKR,exportin antagonist,XPO1,broad_id_20170327,Launched,,
1320,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1321,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1322,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1323,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1324,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1325,BRD-K21396683,marimastat,OCSMOTCMPXTDND,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,broad_id_20170327,Phase 3,,
1326,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1327,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1328,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1329,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1330,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1331,BRD-K21450440,benzthiazide,MQMCZGVMQZPYQA,carbonic anhydrase inhibitor,CA2,broad_id_20200324,Launched,,
1332,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1333,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1334,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1335,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1336,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1337,BRD-K21718444,KW-2449,YYLKKYCXAOBSRM,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,broad_id_20170327,Phase 1,,
1338,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1339,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1340,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1341,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1342,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1343,BRD-K21908111,AZD1208,MCUJKPPARUPFJM,Pim kinase inhibitor,PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
1344,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1345,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1346,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1347,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1348,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1349,BRD-K22024824,RG4733,OJPLJFIFUQPSJR,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
1350,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1351,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1352,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1353,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1354,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1355,BRD-K22031190,diflunisal,HUPFGZXOMWLGNK,prostanoid receptor antagonist,PTGS1|PTGS2,broad_id_20170327,Launched,,
1356,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1357,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1358,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1359,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1360,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1361,BRD-K22134346,simvastatin,RYMZZMVNJRMUDD,HMGCR inhibitor,HMGCR|ITGB2,broad_id_20170327,Launched,,
1362,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1363,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1364,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1365,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1366,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1367,BRD-K22749967,ABT-239,KFHYZKCRXNRKRC,histamine receptor antagonist,HRH1|HRH2|HRH3,broad_id_20170327,Phase 1,,
1368,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1369,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1370,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1371,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1372,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1373,BRD-K22822991,odanacatib,FWIVDMJALNEADT,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 3,,
1374,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1375,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1376,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1377,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1378,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1379,BRD-K22848513,bardoxolone-methyl,WPTTVJLTNAWYAO,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,broad_id_20170327,Phase 3,,
1380,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1381,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1382,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1383,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1384,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1385,BRD-K23248433,camicinal,RZKDEGZIFSJVNA,motilin receptor agonist,MLNR,broad_id_20170327,Phase 2,,
1386,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1387,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1388,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1389,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1390,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1391,BRD-K23363278,CYT-997,MTJHLONVHHPNSI,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
1392,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1393,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1394,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1395,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1396,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1397,BRD-K23672206,BCI-540,PSPGQHXMUKWNDI,glutamate receptor agonist,,broad_id_20170327,Phase 2,,
1398,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1399,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1400,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1401,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1402,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1403,BRD-K23677682,voreloxin,XZAFZXJXZHRNAQ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Phase 3,,
1404,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1405,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1406,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1407,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1408,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1409,BRD-K23728141,tafamidis-meglumine,TXEIIPDJKFWEEC,transthyretin amyloid inhibitor,TTR,broad_id_20170327,Launched,,
1410,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1411,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1412,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1413,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1414,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1415,BRD-K23976833,travoprost,MKPLKVHSHYCHOC,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1416,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1417,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1418,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1419,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1420,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1421,BRD-K24616672,procaine,MFDFERRIHVXMIY,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,broad_id_20170327,Launched,,
1422,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1423,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1424,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1425,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1426,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1427,BRD-K24723746,solifenacin-succinate,FBOUYBDGKBSUES,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
1428,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1429,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1430,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1431,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1432,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1433,BRD-K24844714,5-fluorouracil,GHASVSINZRGABV,thymidylate synthase inhibitor,DPYD|TYMS,broad_id_20170327,Launched,,
1434,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1435,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1436,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1437,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1438,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1439,BRD-K24943235,grazoprevir,OBMNJSNZOWALQB,HCV inhibitor,,broad_id_20170327,Launched,,
1440,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1441,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1442,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1443,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1444,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1445,BRD-K24968862,SB-683698,DRSJLVGDSNWQBI,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,broad_id_20170327,Phase 1,,
1446,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1447,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1448,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1449,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1450,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1451,BRD-K25433859,maprotiline,QSLMDECMDJKHMQ,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,broad_id_20170327,Launched,,
1452,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1453,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1454,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1455,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1456,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1457,BRD-K25630527,LY2784544,SQSZANZGUXWJEA,JAK inhibitor,JAK2|JAK3,broad_id_20170327,Phase 2,,
1458,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1459,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1460,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1461,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1462,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1463,BRD-K26341917,L-ergothioneine,SSISHJJTAXXQAX,free radical scavenger,,broad_id_20170327,Phase 3,,
1464,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1465,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1466,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1467,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1468,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1469,BRD-K27182532,metatinib,PDYXPCKITKHFOZ,Bcr-Abl kinase inhibitor,ABL1|BCR,broad_id_20170327,Phase 1,,
1470,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1471,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1472,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1473,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1474,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1475,BRD-K27184429,cetirizine,ZKLPARSLTMPFCP,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
1476,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1477,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1478,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1479,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1480,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1481,BRD-K27204852,balicatib,LLCRBOWRJOUJAE,cathepsin inhibitor,CTSK,broad_id_20170327,Phase 2,,
1482,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1483,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1484,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1485,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1486,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1487,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1488,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1489,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1490,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1491,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1492,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1493,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1494,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1495,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1496,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1497,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1498,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1499,BRD-K53097745,pterostilbene,VLEUZFDZJKSGMX,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,broad_id_20170327,Phase 2/Phase 3,,
1500,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1501,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1502,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1503,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1504,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1505,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1506,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1507,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1508,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1509,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1510,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1511,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1512,,,,,,,,,
1513,,,,,,,,,
1514,,,,,,,,,
1515,,,,,,,,,
1516,,,,,,,,,
1517,,,,,,,,,
1518,,,,,,,,,
1519,,,,,,,,,
1520,,,,,,,,,
1521,,,,,,,,,
1522,,,,,,,,,
1523,,,,,,,,,
1524,,,,,,,,,
1525,,,,,,,,,
1526,,,,,,,,,
1527,,,,,,,,,
1528,,,,,,,,,
1529,,,,,,,,,
1530,,,,,,,,,
1531,,,,,,,,,
1532,,,,,,,,,
1533,,,,,,,,,
1534,,,,,,,,,
1535,,,,,,,,,
1536,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1537,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1538,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1539,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1540,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1541,BRD-A07986123,galeterone,PAFKTGFSEFKSQG,androgen receptor modulator,AR|CYP17A1,broad_id_20170327,Phase 3,,
1542,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1543,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1544,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1545,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1546,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1547,BRD-A08187463,racecadotril,ODUOJXZPIYUATO,enkephalinase inhibitor,MME,broad_id_20170327,Launched,,
1548,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1549,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1550,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1551,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1552,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1553,BRD-A08545410,E-64,LTLYEAJONXGNFG,calpain inhibitor|cysteine protease inhibitor,CTSS,deprecated_broad_id_20180516,Preclinical,,
1554,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1555,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1556,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1557,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1558,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1559,BRD-A09349126,norethindrone-acetate,IMONTRJLAWHYGT,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
1560,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1561,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1562,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1563,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1564,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1565,BRD-A09472452,flecainide,DJBNUMBKLMJRSA,sodium channel blocker,KCNA5|KCNA7|SCN5A,broad_id_20170327,Launched,,
1566,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1567,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1568,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1569,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1570,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1571,BRD-A09533288,verapamil,SGTNSNPWRIOYBX,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,broad_id_20170327,Launched,,
1572,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1573,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1574,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1575,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1576,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1577,BRD-A10012892,argatroban,KXNPVXPOPUZYGB,thrombin inhibitor,F2,broad_id_20170327,Launched,,
1578,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1579,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1580,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1581,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1582,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1583,BRD-A10039652,tipranavir,MYXACKZCYFKMTE,HIV protease inhibitor,,broad_id_20170327,Launched,,
1584,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1585,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1586,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1587,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1588,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1589,BRD-A10070317,propranolol,AQHHHDLHHXJYJD,adrenergic receptor antagonist,ADRB1|ADRB2,broad_id_20170327,Launched,adrenergic receptor antagonist;adrenergic receptor antagonist,ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
1590,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1591,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1592,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1593,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1594,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1595,BRD-A10903566,imiloxan,UXABARREKCJULM,adrenergic receptor antagonist,ADRA2A|ADRA2B,broad_id_20170327,Phase 1,,
1596,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1597,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1598,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1599,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1600,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1601,BRD-A10967948,granisetron,MFWNKCLOYSRHCJ,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1602,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1603,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1604,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1605,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1606,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1607,BRD-A10977446,carvedilol,OGHNVEJMJSYVRP,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Launched,,
1608,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1609,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1610,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1611,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1612,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1613,BRD-A11319535,beclomethasone-dipropionate,KUVIULQEHSCUHY,glucocorticoid receptor agonist,GPR97|NR3C1,broad_id_20170327,Launched,,
1614,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1615,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1616,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1617,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1618,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1619,BRD-K07881437,danusertib,XKFTZKGMDDZMJI,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,broad_id_20170327,Phase 2,,
1620,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1621,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1622,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1623,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1624,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1625,BRD-K07954936,2-iminobiotin,WWVANQJRLPIHNS,nitric oxide synthase inhibitor,NOS1|NOS2,broad_id_20170327,Phase 2,,
1626,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1627,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1628,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1629,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1630,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1631,BRD-K08037784,arbutin,BJRNKVDFDLYUGJ,melanin inhibitor,TYR,broad_id_20170327,Phase 2/Phase 3,,
1632,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1633,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1634,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1635,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1636,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1637,BRD-K08109215,I-BET-762,AAAQFGUYHFJNHI,bromodomain inhibitor,BRD2|BRD3|BRD4,broad_id_20170327,Phase 2,,
1638,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1639,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1640,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1641,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1642,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1643,BRD-K08206212,entecavir,QDGZDCVAUDNJFG,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
1644,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1645,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1646,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1647,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1648,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1649,BRD-K08248804,LCL-161,UFPFGVNKHCLJJO,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
1650,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1651,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1652,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1653,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1654,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1655,BRD-K08252256,diclofenac,DCOPUUMXTXDBNB,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,broad_id_20170327,Launched,,
1656,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1657,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1658,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1659,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1660,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1661,BRD-K08547377,irinotecan,UWKQSNNFCGGAFS,topoisomerase inhibitor,TOP1|TOP1MT,broad_id_20170327,Launched,,
1662,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1663,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1664,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1665,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1666,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1667,BRD-K08586861,ramatroban,LDXDSHIEDAPSSA,prostanoid receptor antagonist,PTGDR2|TBXA2R,broad_id_20170327,Launched,,
1668,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1669,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1670,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1671,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1672,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1673,BRD-K08703257,3-amino-benzamide,GSCPDZHWVNUUFI,PARP inhibitor,PARP1,broad_id_20170327,Phase 2,,
1674,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1675,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1676,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1677,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1678,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1679,BRD-K08799216,pelitinib,WVUNYSQLFKLYNI,EGFR inhibitor,EGFR,broad_id_20170327,Phase 2,,
1680,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1681,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1682,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1683,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1684,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1685,BRD-K08832567,naringenin,FTVWIRXFELQLPI,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,broad_id_20170327,Phase 1,,
1686,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1687,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1688,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1689,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1690,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1691,BRD-K08859203,DU-728,NNRFRJQMBSBXGO,structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Phase 1,,
1692,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1693,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1694,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1695,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1696,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1697,BRD-K08924299,palonosetron,CPZBLNMUGSZIPR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
1698,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1699,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1700,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1701,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1702,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1703,BRD-K08976401,azelaic-acid,BDJRBEYXGGNYIS,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,broad_id_20170327,Launched,,
1704,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1705,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1706,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1707,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1708,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1709,BRD-K09078998,deforolimus,BUROJSBIWGDYCN,mTOR inhibitor,MTOR,broad_id_20170327,Phase 3,,
1710,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1711,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1712,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1713,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1714,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1715,BRD-K09090949,"CP-945,598",UNAZAADNBYXMIV,cannabinoid receptor antagonist,CNR1,broad_id_20170327,Phase 3,,
1716,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1717,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1718,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1719,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1720,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1721,BRD-K09132007,D-4476,DPDZHVCKYBCJHW,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,broad_id_20170327,Preclinical,,
1722,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1723,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1724,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1725,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1726,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1727,BRD-K09255212,clioquinol,QCDFBFJGMNKBDO,chelating agent,OPRK1,broad_id_20170327,Withdrawn,,
1728,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1729,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1730,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1731,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1732,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1733,BRD-K09372874,merimepodib,JBPUGFODGPKTDW,inosine monophosphate dehydrogenase inhibitor,IMPDH1,broad_id_20170327,Phase 2,,
1734,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1735,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1736,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1737,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1738,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1739,BRD-K09397065,SR-57227A,WPVVMKYQOMJPIN,serotonin receptor agonist,HTR3A,broad_id_20170327,Phase 2,,
1740,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1741,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1742,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1743,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1744,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1745,BRD-K09426783,TAS-103,ROWSTIYZUWEOMM,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
1746,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1747,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1748,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1749,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1750,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1751,BRD-K09471561,levofloxacin,GSDSWSVVBLHKDQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,bacterial DNA gyrase inhibitor,
1752,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1753,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1754,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1755,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1756,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1757,BRD-K09549677,mibefradil,HBNPJJILLOYFJU,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,broad_id_20170327,Withdrawn,,
1758,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1759,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1760,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1761,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1762,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1763,BRD-K09602097,colforsin,OHCQJHSOBUTRHG,adenylyl cyclase activator,ADCY2|ADCY5,broad_id_20170327,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
1764,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1765,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1766,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1767,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1768,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1769,BRD-K09711437,varespladib,BHLXTPHDSZUFHR,secretory phospholipase inhibitor,PLA2G2A,broad_id_20170327,Phase 3,,
1770,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1771,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1772,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1773,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1774,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1775,BRD-K09951645,dabrafenib,BFSMGDJOXZAERB,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,broad_id_20170327,Launched,,
1776,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1777,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1778,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1779,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1780,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1781,BRD-K10670311,sulfasalazine,NCEXYHBECQHGNR,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,broad_id_20170327,Launched,,
1782,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1783,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1784,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1785,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1786,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1787,BRD-K10843433,phenylbutazone,VYMDGNCVAMGZFE,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
1788,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1789,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1790,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1791,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1792,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1793,BRD-K10845183,tiludronate,DKJJVAGXPKPDRL,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,broad_id_20170327,Launched,,
1794,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1795,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1796,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1797,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1798,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1799,BRD-K10852020,tolcapone,MIQPIUSUKVNLNT,catechol O methyltransferase inhibitor,COMT,broad_id_20170327,Withdrawn,,
1800,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1801,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1802,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1803,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1804,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1805,BRD-K10859802,APD668,XTRUQJBVQBUKSQ,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 1,,
1806,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1807,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1808,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1809,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1810,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1811,BRD-K10961822,latanoprost,GGXICVAJURFBLW,prostanoid receptor agonist,PTGFR,broad_id_20170327,Launched,,
1812,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1813,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1814,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1815,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1816,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1817,BRD-K11071038,ICI-162846,ALCSGJCIESECFD,histamine receptor antagonist,HRH2,broad_id_20170327,Phase 1,,
1818,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1819,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1820,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1821,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1822,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1823,BRD-K11073688,CPI-1189,DJKNRCWSXSZACF,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 2,,
1824,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1825,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1826,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1827,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1828,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1829,BRD-K11129031,gemfibrozil,HEMJJKBWTPKOJG,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,broad_id_20170327,Launched,,
1830,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1831,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1832,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1833,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1834,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1835,BRD-K11153516,iniparib,MDOJTZQKHMAPBK,PARP inhibitor,PARP1,broad_id_20170327,Phase 3,,
1836,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1837,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1838,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1839,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1840,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1841,BRD-K11196887,norfloxacin,OGJPXUAPXNRGGI,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
1842,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1843,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1844,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1845,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1846,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1847,BRD-K11267252,alectinib,KDGFLJKFZUIJMX,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,,
1848,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1849,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1850,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1851,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1852,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1853,BRD-K11399644,phenformin,ICFJFFQQTFMIBG,AMPK activator,KCNJ8|PRKAA1,broad_id_20170327,Withdrawn,,
1854,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1855,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1856,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1857,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1858,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1859,BRD-K11433652,aspirin,BSYNRYMUTXBXSQ,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,broad_id_20170327,Launched,,
1860,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1861,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1862,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1863,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1864,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1865,BRD-K11717138,benzbromarone,WHQCHUCQKNIQEC,chloride channel blocker,ABCC1,broad_id_20170327,Launched,,
1866,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1867,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1868,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1869,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1870,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1871,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1872,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1873,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1874,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1875,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1876,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1877,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
1878,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1879,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1880,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1881,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1882,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1883,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1884,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1885,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1886,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1887,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1888,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1889,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
1890,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1891,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1892,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1893,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1894,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1895,BRD-K80738081,resveratrol,LUKBXSAWLPMMSZ,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,broad_id_20170327,Launched,,
1896,,,,,,,,,
1897,,,,,,,,,
1898,,,,,,,,,
1899,,,,,,,,,
1900,,,,,,,,,
1901,,,,,,,,,
1902,,,,,,,,,
1903,,,,,,,,,
1904,,,,,,,,,
1905,,,,,,,,,
1906,,,,,,,,,
1907,,,,,,,,,
1908,,,,,,,,,
1909,,,,,,,,,
1910,,,,,,,,,
1911,,,,,,,,,
1912,,,,,,,,,
1913,,,,,,,,,
1914,,,,,,,,,
1915,,,,,,,,,
1916,,,,,,,,,
1917,,,,,,,,,
1918,,,,,,,,,
1919,,,,,,,,,
1920,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1921,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1922,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1923,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1924,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1925,BRD-A02710418,meptazinol,JLICHNCFTLFZJN,opioid receptor agonist,BCHE,broad_id_20170327,Launched,,
1926,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1927,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1928,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1929,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1930,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1931,BRD-A18917088,estradiol,VOXZDWNPVJITMN,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,broad_id_20170327,Launched,,
1932,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1933,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1934,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1935,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1936,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1937,BRD-A19795905,atovaquone,UYFLKEIEOREOFC,mitochondrial electron transport inhibitor,,broad_id_20170327,Launched,,
1938,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1939,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1940,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1941,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1942,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1943,BRD-A19952358,closantel,JMPFSEBWVLAJKM,chitinase inhibitor|NFkB pathway inhibitor,,broad_id_20170327,Launched,,
1944,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1945,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1946,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1947,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1948,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1949,BRD-A21607826,dexmedetomidine,CUHVIMMYOGQXCV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
1950,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1951,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1952,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1953,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1954,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1955,BRD-A21858158,praziquantel,FSVJFNAIGNNGKK,anthelmintic agent,,broad_id_20170327,Launched,,
1956,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1957,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1958,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1959,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1960,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1961,BRD-A22081593,sulmazole,XMFCOYRWYYXZMY,adenosine receptor antagonist,,broad_id_20170327,Phase 1,,
1962,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1963,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1964,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1965,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1966,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1967,BRD-A22305049,benfluorex,CJAVTWRYCDNHSM,gluconeogenesis inhibitor,HMGCR,broad_id_20170327,Withdrawn,,
1968,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1969,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1970,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1971,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1972,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1973,BRD-A22380646,pantoprazole,IQPSEEYGBUAQFF,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,,
1974,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1975,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1976,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1977,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1978,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1979,BRD-A22642447,licarbazepine,BMPDWHIDQYTSHX,voltage-gated sodium channel blocker,SCN5A,broad_id_20170327,Phase 3,,
1980,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1981,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1982,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1983,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1984,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1985,BRD-A23067620,itraconazole,VHVPQPYKVGDNFY,cytochrome P450 inhibitor,,broad_id_20170327,Launched,,
1986,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1987,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1988,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1989,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1990,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1991,BRD-A24191444,ifenprodil,UYNVMODNBIQBMV,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,broad_id_20170327,Launched,,
1992,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1993,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1994,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1995,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1996,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1997,BRD-A24514565,warfarin,PJVWKTKQMONHTI,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
1998,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
1999,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
2000,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
2001,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
2002,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
2003,BRD-A24560335,efatutazone,JCYNMRJCUYVDBC,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
2004,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2005,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2006,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2007,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2008,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2009,BRD-K18895904,olanzapine,KVWDHTXUZHCGIO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
2010,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2011,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2012,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2013,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2014,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2015,BRD-K18922609,neostigmine,ALWKGYPQUAPLQC,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
2016,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2017,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2018,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2019,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2020,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2021,BRD-K18961567,LY2801653,QHADVLVFMKEIIP,MET inhibitor,MET,broad_id_20170327,Phase 2,,
2022,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2023,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2024,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2025,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2026,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2027,BRD-K19061412,mubritinib,ZTFBIUXIQYRUNT,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2028,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2029,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2030,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2031,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2032,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2033,BRD-K19085898,darapladib,WDPFJWLDPVQCAJ,phospholipase inhibitor,PLA2G7,broad_id_20170327,Phase 3,,
2034,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2035,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2036,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2037,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2038,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2039,BRD-K19412355,SB-242235,PDTYLGXVBIWRIM,p38 MAPK inhibitor,HSPB1|MAPK14,broad_id_20170327,Phase 1,,
2040,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2041,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2042,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2043,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2044,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2045,BRD-K19416115,sitagliptin,MFFMDFFZMYYVKS,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
2046,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2047,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2048,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2049,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2050,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2051,BRD-K19438463,CNQX,RPXVIAFEQBNEAX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 1,,
2052,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2053,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2054,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2055,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2056,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2057,BRD-K19456237,piracetam,GMZVRMREEHBGGF,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Launched,,
2058,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2059,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2060,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2061,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2062,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2063,BRD-K19462402,buflomedil,OWYLAEYXIQKAOL,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,broad_id_20170327,Launched,,
2064,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2065,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2066,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2067,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2068,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2069,BRD-K19477839,SGX523,BCZUAADEACICHN,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 1,,
2070,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2071,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2072,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2073,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2074,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2075,BRD-K19741547,vernakalant,VBHQKCBVWWUUKN,potassium channel blocker,KCNA5,broad_id_20170327,Launched,,
2076,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2077,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2078,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2079,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2080,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2081,BRD-K19761926,eplerenone,JUKPWJGBANNWMW,cytochrome P450 inhibitor,NR3C2,broad_id_20170327,Launched,,
2082,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2083,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2084,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2085,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2086,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2087,BRD-K20001883,apabetalone,NETXMUIMUZJUTB,apolipoprotein expression enhancer,BRD3,broad_id_20170327,Phase 3,,
2088,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2089,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2090,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2091,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2092,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2093,BRD-K20008181,LCQ908,GXALXAKNHIROPE,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 3,,
2094,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2095,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2096,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2097,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2098,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2099,BRD-K20079257,rufinamide,POGQSBRIGCQNEG,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
2100,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2101,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2102,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2103,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2104,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2105,BRD-K20722021,CEP-32496,DKNUPRMJNUQNHR,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Phase 1/Phase 2,,
2106,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2107,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2108,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2109,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2110,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2111,BRD-K20738689,dazmegrel,DEQLGSOHGTZKFB,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
2112,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2113,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2114,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2115,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2116,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2117,BRD-K20745393,olprinone,JPAWFIIYTJQOKW,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
2118,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2119,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2120,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2121,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2122,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2123,BRD-K20897876,castanospermine,JDVVGAQPNNXQDW,glucosidase inhibitor,GAA|GBA,broad_id_20170327,Phase 2,,
2124,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2125,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2126,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2127,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2128,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2129,BRD-K20958582,TH-302,UGJWRPJDTDGERK,DNA alkylating agent,,broad_id_20170327,Phase 3,,
2130,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2131,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2132,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2133,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2134,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2135,BRD-K21071223,VP-20629,GOLXRNDWAUTYKT,beta amyloid antagonist,PLA2G2E|SLC36A1,broad_id_20170327,Phase 1,,
2136,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2137,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2138,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2139,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2140,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2141,BRD-K21283037,riluzole,FTALBRSUTCGOEG,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,broad_id_20170327,Launched,,
2142,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2143,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2144,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2145,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2146,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2147,BRD-K21547160,,GGCSSNBKKAUURC,,,broad_id_20170327,,,
2148,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2149,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2150,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2151,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2152,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2153,BRD-K21548250,moracizine,FUBVWMNBEHXPSU,sodium channel blocker,SCN5A,broad_id_20170327,Withdrawn,,
2154,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2155,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2156,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2157,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2158,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2159,BRD-K21670884,cariporide,IWXNYAIICFKCTM,sodium/hydrogen exchanger inhibitor,SLC9A1,broad_id_20170327,Phase 3,,
2160,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2161,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2162,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2163,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2164,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2165,BRD-K21680192,mitoxantrone,KKZJGLLVHKMTCM,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
2166,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2167,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2168,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2169,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2170,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2171,BRD-K21884483,mizolastine,PVLJETXTTWAYEW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
2172,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2173,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2174,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2175,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2176,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2177,BRD-K22097830,OCO-1112,ODLDHXPJRGNTPC,cholesterol inhibitor,,broad_id_20170327,Phase 2,,
2178,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2179,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2180,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2181,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2182,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2183,BRD-K22482860,dalfampridine,NUKYPUAOHBNCPY,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,broad_id_20170327,Launched,,
2184,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2185,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2186,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2187,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2188,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2189,BRD-K22662435,ganciclovir,IRSCQMHQWWYFCW,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
2190,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2191,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2192,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2193,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2194,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2195,BRD-K22861715,chrysin,RTIXKCRFFJGDFG,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,broad_id_20170327,Phase 1,,
2196,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2197,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2198,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2199,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2200,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2201,BRD-K22936972,diphenylpyraline,OWQUZNMMYNAXSL,dopamine reuptake inhibitor,HRH1|SLC6A3,broad_id_20170327,Launched,,
2202,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2203,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2204,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2205,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2206,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2207,BRD-K22969690,chloramphenicol,WIIZWVCIJKGZOK,bacterial 50S ribosomal subunit inhibitor,CD55,broad_id_20170327,Launched,,
2208,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2209,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2210,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2211,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2212,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2213,BRD-K23082237,butaclamol,ZZJYIKPMDIWRSN,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,broad_id_20170327,Phase 2,,
2214,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2215,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2216,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2217,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2218,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2219,BRD-K23190681,AV-412,ZAJXXUDARPGGOC,protein tyrosine kinase inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
2220,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2221,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2222,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2223,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2224,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2225,BRD-K23204545,busulfan,COVZYZSDYWQREU,DNA inhibitor,,broad_id_20170327,Launched,,
2226,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2227,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2228,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2229,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2230,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2231,BRD-K23228615,GDC-0980,YOVVNQKCSKSHKT,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,broad_id_20170327,Phase 2,,
2232,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2233,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2234,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2235,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2236,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2237,BRD-K23984367,sorafenib,MLDQJTXFUGDVEO,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,broad_id_20170327,Launched,,
2238,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2239,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2240,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2241,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2242,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2243,BRD-K24219278,amineptine,ONNOFKFOZAJDHT,dopamine receptor agonist,SLC6A2|SLC6A4,broad_id_20170327,Withdrawn,,
2244,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2245,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2246,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2247,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2248,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2249,BRD-K24576554,AT-9283,LOLPPWBBNUVNQZ,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,broad_id_20170327,Phase 2,,
2250,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2251,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2252,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2253,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2254,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2255,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2256,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2257,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2258,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2259,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2260,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2261,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2262,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2263,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2264,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2265,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2266,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2267,BRD-K53972329,ruxolitinib,HFNKQEVNSGCOJV,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,broad_id_20170327,Launched,JAK inhibitor,JAK1|JAK2
2268,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2269,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2270,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2271,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2272,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2273,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2274,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2275,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2276,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2277,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2278,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2279,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2280,,,,,,,,,
2281,,,,,,,,,
2282,,,,,,,,,
2283,,,,,,,,,
2284,,,,,,,,,
2285,,,,,,,,,
2286,,,,,,,,,
2287,,,,,,,,,
2288,,,,,,,,,
2289,,,,,,,,,
2290,,,,,,,,,
2291,,,,,,,,,
2292,,,,,,,,,
2293,,,,,,,,,
2294,,,,,,,,,
2295,,,,,,,,,
2296,,,,,,,,,
2297,,,,,,,,,
2298,,,,,,,,,
2299,,,,,,,,,
2300,,,,,,,,,
2301,,,,,,,,,
2302,,,,,,,,,
2303,,,,,,,,,
2304,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2305,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2306,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2307,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2308,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2309,BRD-A37288617,,XXEPPPIWZFICOJ,,,broad_id_20170327,,,
2310,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2311,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2312,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2313,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2314,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2315,BRD-A38076815,glafenine,GWOFUCIGLDBNKM,DeltaF508-CFTR Correctors,CFTR,broad_id_20170327,Withdrawn,,
2316,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2317,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2318,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2319,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2320,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2321,BRD-A42699921,teriflunomide,NABQBYDEMLGCEO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Launched,,
2322,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2323,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2324,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2325,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2326,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2327,BRD-A42759514,ornidazole,IPWKIXLWTCNBKN,antiprotozoal agent,,broad_id_20170327,Launched,,
2328,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2329,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2330,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2331,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2332,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2333,BRD-A44448661,,WEXRUCMBJFQVBZ,,,broad_id_20170327,,,
2334,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2335,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2336,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2337,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2338,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2339,BRD-A51382177,fosinopril,BIDNLKIUORFRQP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
2340,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2341,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2342,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2343,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2344,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2345,BRD-A51964809,halofantrine,FOHHNHSLJDZUGQ,antimalarial agent,KCNN4,broad_id_20170327,Launched,,
2346,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2347,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2348,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2349,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2350,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2351,BRD-A52922642,gallopamil,XQLWNAFCTODIRK,L-type calcium channel blocker,ATP2A2,broad_id_20170327,Launched,,
2352,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2353,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2354,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2355,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2356,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2357,BRD-A55272860,levosulpiride,BGRJTUBHPOOWDU,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,broad_id_20170327,Launched,dopamine receptor antagonist,
2358,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2359,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2360,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2361,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2362,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2363,BRD-A56359832,zileuton,MWLSOWXNZPKENC,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
2364,BRD-A84045418,,,,,,,,
2365,BRD-A84045418,,,,,,,,
2366,BRD-A84045418,,,,,,,,
2367,BRD-A84045418,,,,,,,,
2368,BRD-A84045418,,,,,,,,
2369,BRD-A84045418,,,,,,,,
2370,BRD-K01192156,,,,,,,,
2371,BRD-K01192156,,,,,,,,
2372,BRD-K01192156,,,,,,,,
2373,BRD-K01192156,,,,,,,,
2374,BRD-K01192156,,,,,,,,
2375,BRD-K01192156,,,,,,,,
2376,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2377,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2378,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2379,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2380,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2381,BRD-K37111771,trientine,VILCJCGEZXAXTO,chelating agent,CA14,broad_id_20170327,Launched,,
2382,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2383,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2384,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2385,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2386,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2387,BRD-K38852836,ganetespib,RVAQIUULWULRNW,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 3,,
2388,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2389,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2390,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2391,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2392,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2393,BRD-K40175214,torin-1,AKCRNFFTGXBONI,mTOR inhibitor,MTOR,broad_id_20170327,Preclinical,,
2394,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2395,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2396,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2397,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2398,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2399,BRD-K40718343,AEE788,OONFNUWBHFSNBT,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,broad_id_20170327,Phase 1/Phase 2,,
2400,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2401,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2402,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2403,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2404,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2405,BRD-K41438959,,PRMWGUBFXWROHD,,,broad_id_20170327,,,
2406,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2407,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2408,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2409,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2410,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2411,BRD-K41772907,tolimidone,HJQILFPVRNHTIG,SRC activator,LYN|SRC,broad_id_20170327,Phase 2,,
2412,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2413,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2414,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2415,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2416,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2417,BRD-K42191735,buparlisib,CWHUFRVAEUJCEF,PI3K inhibitor,PIK3CA|PIK3CG,broad_id_20170327,Phase 3,,
2418,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2419,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2420,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2421,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2422,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2423,BRD-K42805893,osimertinib,DUYJMQONPNNFPI,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
2424,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2425,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2426,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2427,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2428,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2429,BRD-K42898655,temsirolimus,CBPNZQVSJQDFBE,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
2430,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2431,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2432,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2433,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2434,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2435,BRD-K43586850,lacidipine,GKQPCPXONLDCMU,calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
2436,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2437,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2438,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2439,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2440,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2441,BRD-K43723251,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
2442,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2443,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2444,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2445,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2446,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2447,BRD-K43797669,genistein,TZBJGXHYKVUXJN,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,broad_id_20170327,Phase 2/Phase 3,,
2448,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2449,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2450,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2451,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2452,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2453,BRD-K43802723,AMG-837,ZOPNBMMVVZRSGH,free fatty acid receptor agonist,FFAR1,broad_id_20170327,Phase 1,,
2454,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2455,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2456,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2457,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2458,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2459,BRD-K43806473,camostat-mesilate,XASIMHXSUQUHLV,protease inhibitor,PRSS1,broad_id_20170327,Launched,,
2460,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2461,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2462,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2463,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2464,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2465,BRD-K44366189,anacetrapib,MZZLGJHLQGUVPN,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
2466,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2467,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2468,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2469,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2470,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2471,BRD-K44408410,2-methoxyestradiol,CQOQDQWUFQDJMK,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,broad_id_20170327,Phase 2,,
2472,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2473,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2474,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2475,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2476,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2477,BRD-K44442813,pidotimod,UUTKICFRNVKFRG,interferon receptor agonist|interleukin receptor agonist,,broad_id_20170327,Launched,,
2478,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2479,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2480,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2481,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2482,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2483,BRD-K48168960,propylthiouracil,KNAHARQHSZJURB,thyroid peroxidase inhibitor,DIO1|TPO,broad_id_20170327,Launched,,
2484,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2485,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2486,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2487,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2488,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2489,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2490,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2491,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2492,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2493,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2494,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2495,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2496,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2497,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2498,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2499,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2500,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2501,BRD-K51033547,,TVYLLZQTGLZFBW,,,broad_id_20170327,,,
2502,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2503,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2504,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2505,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2506,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2507,BRD-K51040301,cobicistat,ZCIGNRJZKPOIKD,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2508,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2509,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2510,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2511,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2512,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2513,BRD-K51333959,siramesine,XWAONOGAGZNUSF,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Phase 2,,
2514,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2515,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2516,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2517,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2518,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2519,BRD-K51350053,toremifene,XFCLJVABOIYOMF,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,broad_id_20170327,Launched,,
2520,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2521,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2522,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2523,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2524,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2525,BRD-K51485625,ritonavir,NCDNCNXCDXHOMX,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,broad_id_20170327,Launched,,
2526,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2527,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2528,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2529,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2530,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2531,BRD-K52020312,metronidazole,VAOCPAMSLUNLGC,DNA inhibitor,CYP2C9|CYP3A4,broad_id_20170327,Launched,,
2532,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2533,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2534,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2535,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2536,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2537,BRD-K52080565,,NPAGDVCDWIYMMC,,,broad_id_20170327,,,
2538,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2539,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2540,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2541,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2542,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2543,BRD-K52172416,anastrozole,YBBLVLTVTVSKRW,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2544,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2545,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2546,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2547,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2548,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2549,BRD-K52183142,pregnenolone,ORNBQBCIOKFOEO,glutamate receptor modulator,SULT2B1,broad_id_20170327,Launched,,
2550,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2551,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2552,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2553,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2554,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2555,BRD-K52911425,GDC-0941,LHNIIDJUOCFXAP,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
2556,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2557,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2558,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2559,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2560,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2561,BRD-K52959329,mitiglinide,WPGGHFDDFPHPOB,insulin secretagogue,ABCC8|KCNJ10|PPARG,broad_id_20170327,Launched,,
2562,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2563,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2564,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2565,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2566,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2567,BRD-K52989797,clomipramine,GDLIGKIOYRNHDA,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
2568,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2569,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2570,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2571,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2572,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2573,BRD-K53581288,baricitinib,XUZMWHLSFXCVMG,JAK inhibitor,JAK1|JAK2,broad_id_20170327,Launched,,
2574,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2575,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2576,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2577,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2578,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2579,BRD-K53665955,MK-5108,LCVIRAZGMYMNNT,Aurora kinase inhibitor,AURKA|AURKB|AURKC,broad_id_20170327,Phase 1,,
2580,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2581,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2582,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2583,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2584,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2585,BRD-K53737926,amitriptyline,KRMDCWKBEZIMAB,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2586,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2587,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2588,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2589,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2590,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2591,BRD-K53765467,empagliflozin,OBWASQILIWPZMG,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
2592,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2593,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2594,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2595,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2596,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2597,BRD-K54472332,elvitegravir,JUZYLCPPVHEVSV,HIV integrase inhibitor,,broad_id_20170327,Launched,,
2598,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2599,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2600,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2601,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2602,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2603,BRD-K54520417,LXR-623,KYWWJENKIMRJBI,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,broad_id_20170327,Phase 1,,
2604,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2605,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2606,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2607,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2608,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2609,BRD-K54640016,WAY-362450,INASOKQDNHHMRE,FXR agonist,NR1H4,broad_id_20170327,Phase 1,,
2610,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2611,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2612,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2613,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2614,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2615,BRD-K54759182,dosulepin,PHTUQLWOUWZIMZ,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
2616,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2617,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2618,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2619,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2620,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2621,BRD-K55250441,sulfadoxine,PJSFRIWCGOHTNF,dihydropteroate synthase inhibitor,,broad_id_20170327,Launched,,
2622,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2623,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2624,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2625,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2626,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2627,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2628,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2629,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2630,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2631,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2632,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2633,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2634,BRD-K60623809,,,,,,,,
2635,BRD-K60623809,,,,,,,,
2636,BRD-K60623809,,,,,,,,
2637,BRD-K60623809,,,,,,,,
2638,BRD-K60623809,,,,,,,,
2639,BRD-K60623809,,,,,,,,
2640,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2641,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2642,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2643,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2644,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2645,BRD-K67868012,PI-103,TUVCWJQQGGETHL,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,broad_id_20170327,Preclinical,,
2646,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2647,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2648,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2649,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2650,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2651,BRD-K70792160,10-DEBC,GYBXAGDWMCJZJK,AKT inhibitor,PIM1,broad_id_20170327,Preclinical,,
2652,BRD-K73395020,,,,,,,,
2653,BRD-K73395020,,,,,,,,
2654,BRD-K73395020,,,,,,,,
2655,BRD-K73395020,,,,,,,,
2656,BRD-K73395020,,,,,,,,
2657,BRD-K73395020,,,,,,,,
2658,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2659,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2660,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2661,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2662,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2663,BRD-K89732114,trifluoperazine,ZEWQUBUPAILYHI,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,broad_id_20170327,Launched,,
2664,,,,,,,,,
2665,,,,,,,,,
2666,,,,,,,,,
2667,,,,,,,,,
2668,,,,,,,,,
2669,,,,,,,,,
2670,,,,,,,,,
2671,,,,,,,,,
2672,,,,,,,,,
2673,,,,,,,,,
2674,,,,,,,,,
2675,,,,,,,,,
2676,,,,,,,,,
2677,,,,,,,,,
2678,,,,,,,,,
2679,,,,,,,,,
2680,,,,,,,,,
2681,,,,,,,,,
2682,,,,,,,,,
2683,,,,,,,,,
2684,,,,,,,,,
2685,,,,,,,,,
2686,,,,,,,,,
2687,,,,,,,,,
2688,BRD-A20131130,,,,,,,,
2689,BRD-A20131130,,,,,,,,
2690,BRD-A20131130,,,,,,,,
2691,BRD-A20131130,,,,,,,,
2692,BRD-A20131130,,,,,,,,
2693,BRD-A20131130,,,,,,,,
2694,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2695,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2696,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2697,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2698,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2699,BRD-A36010170,amcinonide,ILKJAFIWWBXGDU,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
2700,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2701,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2702,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2703,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2704,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2705,BRD-A49838158,phenprocoumon,DQDAYGNAKTZFIW,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
2706,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2707,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2708,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2709,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2710,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2711,BRD-A50684349,fenoldopam,TVURRHSHRRELCG,dopamine receptor agonist,DRD1|DRD4,broad_id_20170327,Launched,,
2712,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2713,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2714,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2715,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2716,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2717,BRD-A68009927,daunorubicin,STQGQHZAVUOBTE,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Launched,,
2718,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2719,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2720,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2721,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2722,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2723,BRD-A87983072,benzotript,QJERBBQXOMUURJ,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
2724,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2725,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2726,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2727,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2728,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2729,BRD-A89585551,mefloquine,XEEQGYMUWCZPDN,adenosine receptor antagonist|hemoglobin antagonist,,broad_id_20170327,Launched,,
2730,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2731,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2732,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2733,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2734,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2735,BRD-K03353589,ecabet,IWCWQNVIUXZOMJ,gastrin inhibitor|urease inhibitor,NOXO1,broad_id_20170327,Launched,,
2736,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2737,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2738,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2739,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2740,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2741,BRD-K31339321,lirimilast,YPFLFUJKZDAXRA,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
2742,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2743,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2744,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2745,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2746,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2747,BRD-K31928526,barasertib,GBJVVSCPOBPEIT,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 2/Phase 3,,
2748,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2749,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2750,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2751,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2752,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2753,BRD-K32318651,acyclovir,MKUXAQIIEYXACX,DNA polymerase inhibitor,PNP,broad_id_20170327,Launched,,
2754,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2755,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2756,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2757,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2758,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2759,BRD-K33251802,miglustat,UQRORFVVSGFNRO,glycosyl transferase inhibitor,UGCG,broad_id_20170327,Launched,,
2760,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2761,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2762,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2763,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2764,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2765,BRD-K34008116,dolasetron,UKTAZPQNNNJVKR,serotonin receptor antagonist,HTR3A,broad_id_20170327,Launched,,
2766,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2767,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2768,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2769,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2770,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2771,BRD-K34415467,trimethobenzamide,FEZBIKUBAYAZIU,histamine receptor antagonist,DRD2,broad_id_20170327,Launched,,
2772,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2773,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2774,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2775,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2776,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2777,BRD-K35007173,enprofylline,SIQPXVQCUCHWDI,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,broad_id_20170327,Phase 3,,
2778,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2779,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2780,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2781,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2782,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2783,BRD-K35960502,niclosamide,RJMUSRYZPJIFPJ,DNA replication inhibitor|STAT inhibitor,STAT3,broad_id_20170327,Launched,,
2784,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2785,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2786,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2787,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2788,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2789,BRD-K36269323,asymmetrical-dimethylarginine,YDGMGEXADBMOMJ,nitric oxide synthase inhibitor,NOS2|NOS3,broad_id_20170327,Phase 1,,
2790,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2791,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2792,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2793,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2794,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2795,BRD-K36270037,esculin,XHCADAYNFIFUHF,antioxidant,,broad_id_20170327,Phase 1,,
2796,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2797,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2798,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2799,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2800,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2801,BRD-K36740062,GSK1070916,QTBWCSQGBMPECM,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,broad_id_20170327,Phase 1,,
2802,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2803,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2804,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2805,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2806,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2807,BRD-K36862742,hydroflumethiazide,DMDGGSIALPNSEE,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,broad_id_20170327,Launched,,
2808,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2809,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2810,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2811,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2812,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2813,BRD-K36927236,glyburide,ZNNLBTZKUZBEKO,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,broad_id_20170327,Launched,,
2814,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2815,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2816,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2817,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2818,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2819,BRD-K36970462,tonabersat,XLIIRNOPGJTBJD,gap junction modulator|nitric oxide production inhibitor,,broad_id_20170327,Phase 2,,
2820,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2821,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2822,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2823,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2824,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2825,BRD-K37516142,idebenone,JGPMMRGNQUBGND,calcium channel modulator,,broad_id_20170327,Launched,,
2826,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2827,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2828,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2829,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2830,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2831,BRD-K47539947,tetradecylthioacetic-acid,IPBCWPPBAWQYOO,lipid peroxidase inhibitor,,broad_id_20170327,Phase 2,,
2832,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2833,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2834,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2835,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2836,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2837,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2838,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2839,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2840,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2841,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2842,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2843,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
2844,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2845,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2846,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2847,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2848,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2849,BRD-K58550667,FK-866,KPBNHDGDUADAGP,niacinamide phosphoribosyltransferase inhibitor,NAMPT,broad_id_20170327,Phase 2,,
2850,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2851,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2852,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2853,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2854,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2855,BRD-K60038276,irbesartan,YOSHYTLCDANDAN,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,broad_id_20170327,Launched,,
2856,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2857,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2858,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2859,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2860,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2861,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2862,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2863,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2864,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2865,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2866,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2867,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
2868,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2869,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2870,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2871,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2872,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2873,BRD-K63712959,temoporfin,JGLSWAGTNWZKQU,radical formation stimulant,,broad_id_20200324,Launched,,
2874,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2875,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2876,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2877,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2878,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2879,BRD-K69688083,mestinon,RVOLLAQWKVFTGE,cholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
2880,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2881,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2882,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2883,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2884,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2885,BRD-K73691377,alprostadil,GMVPRGQOIOIIMI,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,broad_id_20170327,Launched,,
2886,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2887,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2888,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2889,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2890,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2891,BRD-K75024268,lesinurad,FGQFOYHRJSUHMR,uric acid diuretic,SLC22A12,broad_id_20170327,Launched,,
2892,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2893,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2894,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2895,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2896,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2897,BRD-K76703230,YM-155,OTSOOHRUMBRSHZ,survivin inhibitor,BIRC5,broad_id_20170327,Phase 2,,
2898,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2899,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2900,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2901,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2902,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2903,BRD-K77771411,moxonidine,WPNJAUFVNXKLIM,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
2904,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2905,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2906,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2907,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2908,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2909,BRD-K80535353,enoxolone,MPDGHEJMBKOTSU,gap junction modulator,HSD11B1,broad_id_20170327,Launched,,
2910,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2911,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2912,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2913,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2914,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2915,BRD-K82164249,andarine,YVXVTLGIDOACBJ,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
2916,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2917,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2918,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2919,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2920,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2921,BRD-K87202646,isoniazid,QRXWMOHMRWLFEY,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,broad_id_20170327,Launched,,
2922,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2923,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2924,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2925,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2926,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2927,BRD-K87278688,,YFGHCGITMMYXAQ,,,broad_id_20170327,,,
2928,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2929,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2930,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2931,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2932,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2933,BRD-K87990216,piretanide,UJEWTUDSLQGTOA,glucocorticoid receptor agonist,SLC12A1|SLC12A2,broad_id_20170327,Launched,,
2934,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2935,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2936,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2937,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2938,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2939,BRD-K88025533,fingolimod,KKGQTZUTZRNORY,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,broad_id_20170327,Launched,,
2940,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2941,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2942,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2943,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2944,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2945,BRD-K88052444,urea,XSQUKJJJFZCRTK,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,broad_id_20170327,Launched,,
2946,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2947,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2948,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2949,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2950,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2951,BRD-K88789588,letrozole,HPJKCIUCZWXJDR,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
2952,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2953,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2954,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2955,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2956,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2957,BRD-K88807631,elacridar,OSFCMRGOZNQUSW,P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 1,,
2958,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2959,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2960,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2961,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2962,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2963,BRD-K89014967,AS-703026,VIUAUNHCRHHYNE,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
2964,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2965,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2966,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2967,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2968,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2969,BRD-K89015388,GSK923295,WHMXDBPHBVLYRC,centromere associated protein inhibitor,CENPE,broad_id_20170327,Phase 1,,
2970,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2971,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2972,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2973,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2974,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2975,BRD-K89104321,gaboxadol,ZXRVKCBLGJOCEE,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,broad_id_20170327,Phase 3,,
2976,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2977,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2978,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2979,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2980,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2981,BRD-K89402695,L-655240,JLPYLHLUHJOPNL,thromboxane receptor antagonist,PTGES,broad_id_20170327,Phase 1,,
2982,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2983,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2984,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2985,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2986,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2987,BRD-K89561498,SN-38,FJHBVJOVLFPMQE,topoisomerase inhibitor,TOP1,broad_id_20170327,Launched,,
2988,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2989,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2990,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2991,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2992,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2993,BRD-K89704198,vincamine,RXPRRQLKFXBCSJ,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Withdrawn,,
2994,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
2995,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
2996,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
2997,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
2998,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
2999,BRD-K90239174,AMG-487,WQTKNBPCJKRYPA,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,CC chemokine receptor antagonist,CXCR3
3000,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3001,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3002,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3003,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3004,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3005,BRD-K90789829,nefazodone,VRBKIVRKKCLPHA,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
3006,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3007,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3008,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3009,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3010,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3011,BRD-K91290917,amodiaquine,OVCDSSHSILBFBN,histamine receptor agonist,HNMT,broad_id_20170327,Launched,,
3012,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3013,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3014,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3015,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3016,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3017,BRD-K92731339,perindopril,IPVQLZZIHOAWMC,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
3018,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3019,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3020,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3021,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3022,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3023,BRD-K96029467,alagebrium,LYLFQLCLUXOFOL,glycosylation inhibitor,,broad_id_20170327,Phase 2/Phase 3,,
3024,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3025,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3026,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3027,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3028,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3029,BRD-K97688263,benzamil,KXDROGADUISDGY,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,broad_id_20170327,Phase 2,,
3030,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3031,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3032,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3033,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3034,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3035,BRD-K98453471,salirasib,WUILNKCFCLNXOK,mTOR inhibitor,TRPA1,broad_id_20170327,Phase 2,,
3036,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3037,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3038,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3039,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3040,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3041,BRD-K99107520,felbamate,WKGXYQFOCVYPAC,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
3042,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3043,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3044,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3045,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3046,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3047,BRD-M98279124,,YMMKDPCCYMGDHD,,,broad_id_20170327,,,
3048,,,,,,,,,
3049,,,,,,,,,
3050,,,,,,,,,
3051,,,,,,,,,
3052,,,,,,,,,
3053,,,,,,,,,
3054,,,,,,,,,
3055,,,,,,,,,
3056,,,,,,,,,
3057,,,,,,,,,
3058,,,,,,,,,
3059,,,,,,,,,
3060,,,,,,,,,
3061,,,,,,,,,
3062,,,,,,,,,
3063,,,,,,,,,
3064,,,,,,,,,
3065,,,,,,,,,
3066,,,,,,,,,
3067,,,,,,,,,
3068,,,,,,,,,
3069,,,,,,,,,
3070,,,,,,,,,
3071,,,,,,,,,
3072,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3073,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3074,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3075,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3076,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3077,BRD-A28746609,paclitaxel,RCINICONZNJXQF,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3078,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3079,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3080,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3081,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3082,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3083,BRD-A29485665,bicalutamide,LKJPYSCBVHEWIU,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3084,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3085,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3086,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3087,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3088,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3089,BRD-A29520968,acifran,DFDGRKNOFOJBAJ,cholesterol inhibitor,HCAR2|HCAR3,broad_id_20170327,Phase 3,,
3090,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3091,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3092,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3093,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3094,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3095,BRD-A29844814,ABT-202,LVGMMVAWLISWJD,acetylcholine receptor agonist,,broad_id_20170327,Phase 1,,
3096,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3097,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3098,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3099,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3100,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3101,BRD-A29854054,lorglumide,IEKOTSCYBBDIJC,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Phase 1,,
3102,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3103,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3104,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3105,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3106,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3107,BRD-A30815329,felodipine,RZTAMFZIAATZDJ,calcium channel blocker,CFTR,broad_id_20170327,Launched,,
3108,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3109,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3110,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3111,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3112,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3113,BRD-A30984645,GDC-0834,CDOOFZZILLRUQH,Bruton's tyrosine kinase (BTK) inhibitor,BTK,broad_id_20170327,Phase 1,,
3114,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3115,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3116,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3117,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3118,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3119,BRD-A31095847,mozavaptan,WRNXUQJJCIZICJ,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,broad_id_20170327,Launched,,
3120,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3121,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3122,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3123,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3124,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3125,BRD-A32172948,methiopril,JHFOAISYWJRTIM,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Phase 2,,
3126,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3127,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3128,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3129,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3130,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3131,BRD-A33084557,tioconazole,QXHHHPZILQDDPS,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3132,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3133,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3134,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3135,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3136,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3137,BRD-A33692381,zidovudine,HBOMLICNUCNMMY,nucleoside reverse transcriptase inhibitor,TERT,broad_id_20170327,Launched,,
3138,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3139,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3140,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3141,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3142,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3143,BRD-A33697453,fenticonazole,ZCJYUTQZBAIHBS,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3144,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3145,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3146,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3147,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3148,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3149,BRD-A34255068,(R)-(-)-rolipram,HJORMJIFDVBMOB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Phase 1,phosphodiesterase inhibitor;phosphodiesterase inhibitor,PDE4B|PDE4D;nan
3150,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3151,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3152,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3153,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3154,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3155,BRD-K24771047,ampalex,ANDGGVOPIJEHOF,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
3156,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3157,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3158,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3159,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3160,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3161,BRD-K25412176,GSK2110183,AFJRDFWMXUECEW,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
3162,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3163,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3164,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3165,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3166,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3167,BRD-K26325692,API-001,DGPGXHRHNRYVDH,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 2,,
3168,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3169,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3170,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3171,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3172,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3173,BRD-K26667523,TAK-733,RCLQNICOARASSR,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
3174,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3175,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3176,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3177,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3178,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3179,BRD-K26823213,GW-842166,TWQYWUXBZHPIIV,cannabinoid receptor agonist,CNR2,broad_id_20170327,Phase 2,,
3180,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3181,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3182,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3183,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3184,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3185,BRD-K28115081,apafant,JGPJQFOROWSRRS,platelet activating factor receptor antagonist,PTAFR,broad_id_20170327,Phase 3,,
3186,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3187,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3188,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3189,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3190,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3191,BRD-K28307902,flutamide,MKXKFYHWDHIYRV,androgen receptor antagonist,AHR|AR,broad_id_20170327,Launched,,
3192,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3193,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3194,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3195,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3196,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3197,BRD-K28392481,AZD4547,VRQMAABPASPXMW,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,broad_id_20170327,Phase 2/Phase 3,,
3198,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3199,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3200,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3201,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3202,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3203,BRD-K28428262,brivanib,WCWUXEGQKLTGDX,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,broad_id_20170327,Phase 3,,
3204,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3205,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3206,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3207,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3208,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3209,BRD-K28456624,seocalcitol,LVLLALCJVJNGQQ,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 3,,
3210,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3211,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3212,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3213,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3214,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3215,BRD-K28470988,L-690330,JKOCAAWWDVHWKB,inositol monophosphatase inhibitor,IMPA1,broad_id_20170327,Preclinical,,
3216,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3217,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3218,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3219,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3220,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3221,BRD-K28822270,resminostat,FECGNJPYVFEKOD,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 2,,
3222,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3223,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3224,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3225,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3226,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3227,BRD-K28912512,nicotinamide,DFPAKSUCGFBDDF,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,broad_id_20170327,Launched,,
3228,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3229,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3230,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3231,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3232,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3233,BRD-K28936863,ketotifen,OVJRNFMIYGGLDL,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,broad_id_20200324,Launched,,
3234,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3235,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3236,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3237,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3238,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3239,BRD-K28965160,BVD-523,KSERXGMCDHOLSS,MAP kinase inhibitor,,broad_id_20170327,Phase 2,,
3240,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3241,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3242,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3243,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3244,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3245,BRD-K29133151,"ICI-185,282",ZWAVGFSZMACJHA,thromboxane receptor antagonist,,broad_id_20170327,Phase 1,,
3246,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3247,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3248,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3249,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3250,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3251,BRD-K29458283,chlorambucil,JCKYGMPEJWAADB,DNA inhibitor,,broad_id_20170327,Launched,,
3252,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3253,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3254,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3255,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3256,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3257,BRD-K29530284,amlexanox,SGRYPYWGNKJSDL,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,broad_id_20170327,Launched,,
3258,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3259,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3260,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3261,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3262,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3263,BRD-K29950728,clomifene,GKIRPKYJQBWNGO,estrogen receptor antagonist,ESR1,broad_id_20170327,Launched,,
3264,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3265,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3266,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3267,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3268,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3269,BRD-K29968218,KX2-391,HUNGUWOZPQBXGX,SRC inhibitor|tubulin polymerization inhibitor,SRC,broad_id_20170327,Phase 3,,
3270,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3271,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3272,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3273,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3274,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3275,BRD-K30020243,aliskiren-hemifumarate,UXOWGYHJODZGMF,renin inhibitor,REN,broad_id_20170327,Launched,,
3276,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3277,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3278,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3279,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3280,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3281,BRD-K30550578,PF-04620110,GEVVQZHMFVFGLN,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3282,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3283,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3284,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3285,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3286,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3287,BRD-K30563334,,AZFBLLCNOQPJGJ,,,broad_id_20170327,,,
3288,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3289,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3290,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3291,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3292,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3293,BRD-K30685142,levothyroxine,XUIIKFGFIJCVMT,thyroid hormone stimulant,THRA|THRB,broad_id_20170327,Launched,,
3294,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3295,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3296,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3297,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3298,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3299,BRD-K31092604,donitriptan,SOHCKWZVTCTQBG,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,broad_id_20170327,Phase 2,,
3300,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3301,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3302,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3303,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3304,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3305,BRD-K31342827,GF109203X,QMGUOJYZJKLOLH,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,broad_id_20170327,Preclinical,,
3306,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3307,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3308,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3309,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3310,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3311,BRD-K31447894,pravastatin,TUZYXOIXSAXUGO,HMGCR inhibitor,HMGCR|SLCO1B1,broad_id_20170327,Launched,,
3312,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3313,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3314,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3315,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3316,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3317,BRD-K31476763,AZD9668,QNQZWEGMKJBHEM,elastase inhibitor,ELANE,broad_id_20170327,Phase 2,,
3318,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3319,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3320,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3321,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3322,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3323,BRD-K31495718,AZD7687,YXFNPRHZMOGREC,diacylglycerol O acyltransferase inhibitor,DGAT1,broad_id_20170327,Phase 1,,
3324,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3325,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3326,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3327,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3328,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3329,BRD-K31519811,PF-02545920,AZEXWHKOMMASPA,phosphodiesterase inhibitor,PDE10A,broad_id_20170327,Phase 2,,
3330,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3331,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3332,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3333,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3334,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3335,BRD-K32107296,temozolomide,BPEGJWRSRHCHSN,DNA alkylating agent,MGMT,broad_id_20170327,Launched,,
3336,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3337,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3338,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3339,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3340,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3341,BRD-K32164935,tolazamide,OUDSBRTVNLOZBN,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,broad_id_20170327,Launched,,
3342,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3343,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3344,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3345,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3346,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3347,BRD-K32218650,MBX-2982,NFTMKHWBOINJGM,glucose dependent insulinotropic receptor agonist,GPR119,broad_id_20170327,Phase 2,,
3348,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3349,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3350,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3351,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3352,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3353,BRD-K32977963,eugenol,RRAFCDWBNXTKKO,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
3354,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3355,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3356,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3357,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3358,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3359,BRD-K33106058,cytarabine,UHDGCWIWMRVCDJ,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,broad_id_20170327,Launched,,
3360,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3361,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3362,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3363,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3364,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3365,BRD-K33127281,adapalene,LZCDAPDGXCYOEH,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
3366,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3367,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3368,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3369,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3370,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3371,BRD-K33483813,actarit,MROJXXOCABQVEF,interleukin receptor agonist,,broad_id_20170327,Launched,,
3372,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3373,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3374,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3375,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3376,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3377,BRD-K33610132,rociletinib,HUFOZJXAKZVRNJ,EGFR inhibitor,EGFR,broad_id_20170327,Phase 3,,
3378,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3379,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3380,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3381,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3382,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3383,BRD-K34157611,cimetidine,AQIXAKUUQRKLND,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,broad_id_20170327,Launched,,
3384,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3385,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3386,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3387,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3388,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3389,BRD-K34185671,AMG-517,YUTIXVXZQIQWGY,TRPV antagonist,TRPV1,broad_id_20170327,Phase 1,,
3390,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3391,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3392,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3393,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3394,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3395,BRD-K34313798,LY215490,ZXFRFPSZAKNPQQ,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,broad_id_20170327,Phase 1,,
3396,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3397,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3398,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3399,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3400,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3401,BRD-K34888156,theobromine,YAPQBXQYLJRXSA,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,broad_id_20170327,Launched,,
3402,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3403,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3404,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3405,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3406,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3407,BRD-K35169477,taranabant,QLYKJCMUNUWAGO,cannabinoid receptor inverse agonist,CNR1,broad_id_20170327,Phase 3,,
3408,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3409,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3410,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3411,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3412,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3413,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3414,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3415,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3416,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3417,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3418,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3419,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3420,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3421,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3422,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3423,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3424,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3425,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3426,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3427,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3428,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3429,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3430,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3431,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3432,,,,,,,,,
3433,,,,,,,,,
3434,,,,,,,,,
3435,,,,,,,,,
3436,,,,,,,,,
3437,,,,,,,,,
3438,,,,,,,,,
3439,,,,,,,,,
3440,,,,,,,,,
3441,,,,,,,,,
3442,,,,,,,,,
3443,,,,,,,,,
3444,,,,,,,,,
3445,,,,,,,,,
3446,,,,,,,,,
3447,,,,,,,,,
3448,,,,,,,,,
3449,,,,,,,,,
3450,,,,,,,,,
3451,,,,,,,,,
3452,,,,,,,,,
3453,,,,,,,,,
3454,,,,,,,,,
3455,,,,,,,,,
3456,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3457,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3458,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3459,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3460,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3461,BRD-A11990600,,DIWRORZWFLOCLC,,,broad_id_20170327,,,
3462,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3463,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3464,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3465,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3466,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3467,BRD-A12077521,cefepime,HVFLCNVBZFFHBT,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
3468,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3469,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3470,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3471,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3472,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3473,BRD-A12230535,nutlin-3,BDUHCSBCVGXTJM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Preclinical,,
3474,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3475,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3476,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3477,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3478,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3479,BRD-A12237696,L-citrulline,RHGKLRLOHDJJDR,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,broad_id_20170327,Launched,,
3480,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3481,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3482,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3483,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3484,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3485,BRD-A12896037,cisapride,DCSUBABJRXZOMT,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,broad_id_20170327,Withdrawn,,
3486,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3487,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3488,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3489,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3490,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3491,BRD-A12994259,pomalidomide,UVSMNLNDYGZFPF,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Launched,,
3492,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3493,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3494,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3495,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3496,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3497,BRD-A13084692,troglitazone,GXPHKUHSUJUWKP,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,broad_id_20170327,Withdrawn,,
3498,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3499,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3500,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3501,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3502,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3503,BRD-A13133631,fluorometholone,FAOZLTXFLGPHNG,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
3504,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3505,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3506,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3507,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3508,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3509,BRD-A13188892,doxazosin,RUZYUOTYCVRMRZ,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
3510,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3511,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3512,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3513,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3514,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3515,BRD-A14262390,guanadrel,HPBNRIOWIXYZFK,adrenergic inhibitor,,broad_id_20170327,Launched,,
3516,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3517,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3518,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3519,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3520,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3521,BRD-A14798026,mestranol,IMSSROKUHAOUJS,estrogen receptor agonist,ESR1,broad_id_20170327,Launched,,
3522,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3523,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3524,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3525,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3526,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3527,BRD-A14886633,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
3528,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3529,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3530,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3531,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3532,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3533,BRD-A14941520,dofequidar,KLWUUPVJTLHYIM,MRP inhibitor|P glycoprotein inhibitor,ABCB1,broad_id_20170327,Phase 3,,
3534,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3535,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3536,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3537,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3538,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3539,BRD-A14966924,alaproclate,FZSPJBYOKQPKCD,serotonin receptor antagonist,SLC6A4,broad_id_20170327,Phase 2,,
3540,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3541,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3542,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3543,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3544,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3545,BRD-A15202882,milnacipran,GJJFMKBJSRMPLA,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
3546,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3547,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3548,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3549,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3550,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3551,BRD-A15297126,fluocinonide,WJOHZNCJWYWUJD,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,broad_id_20170327,Launched,,
3552,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3553,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3554,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3555,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3556,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3557,BRD-A15435692,BMY-14802,ZXUYYZPJUGQHLQ,sigma receptor antagonist,HTR1A,broad_id_20170327,Phase 2,,
3558,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3559,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3560,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3561,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3562,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3563,BRD-K01638814,rilmenidine,CQXADFVORZEARL,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,broad_id_20170327,Launched,,
3564,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3565,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3566,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3567,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3568,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3569,BRD-K11973162,tipiracil,QQHMKNYGKVVGCZ,thymidine phosphorylase inhibitor,,broad_id_20170327,Launched,,
3570,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3571,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3572,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3573,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3574,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3575,BRD-K12219985,glipizide,ZJJXGWJIGJFDTL,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
3576,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3577,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3578,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3579,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3580,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3581,BRD-K12423485,griseofulvin,DDUHZTYCFQRHIY,tubulin polymerization inhibitor,KRT12,broad_id_20170327,Launched,,
3582,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3583,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3584,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3585,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3586,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3587,BRD-K12539416,sulbutiamine,CKHJPWQVLKHBIH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
3588,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3589,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3590,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3591,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3592,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3593,BRD-K12609457,exalamide,CKSJXOVLXUMMFF,membrane permeability inhibitor,,broad_id_20170327,Launched,,
3594,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3595,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3596,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3597,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3598,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3599,BRD-K12735121,TG-100801,JMGXJHWTVBGOKG,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,broad_id_20170327,Phase 2,,
3600,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3601,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3602,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3603,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3604,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3605,BRD-K12737986,veliparib,JNAHVYVRKWKWKQ,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Phase 3,,
3606,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3607,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3608,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3609,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3610,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3611,BRD-K12787259,CX-5461,XGPBJCHFROADCK,RNA polymerase inhibitor,,broad_id_20170327,Phase 1,,
3612,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3613,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3614,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3615,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3616,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3617,BRD-K12867552,PCI-24781,MAUCONCHVWBMHK,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,broad_id_20170327,Phase 3,,
3618,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3619,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3620,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3621,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3622,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3623,BRD-K12885236,dapivirine,ILAYIAGXTHKHNT,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,broad_id_20170327,Phase 3,,
3624,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3625,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3626,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3627,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3628,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3629,BRD-K12932420,YM-976,MNHXYNNKDDXKNP,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 1,,
3630,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3631,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3632,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3633,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3634,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3635,BRD-K12994359,valdecoxib,LNPDTQAFDNKSHK,cyclooxygenase inhibitor,CA12|PTGS2,broad_id_20170327,Withdrawn,,
3636,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3637,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3638,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3639,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3640,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3641,BRD-K13050541,acivicin,QAWIHIJWNYOLBE,gamma glutamyltransferase inhibitor,CTPS1,broad_id_20170327,Phase 2,,
3642,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3643,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3644,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3645,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3646,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3647,BRD-K13154216,everolimus,HKVAMNSJSFKALM,mTOR inhibitor,MTOR,broad_id_20170327,Launched,,
3648,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3649,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3650,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3651,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3652,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3653,BRD-K13183738,pentamidine,XDRYMKDFEDOLFX,anti-pneumocystis agent,TRDMT1,broad_id_20170327,Launched,,
3654,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3655,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3656,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3657,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3658,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3659,BRD-K13296708,rimonabant,JZCPYUJPEARBJL,cannabinoid receptor antagonist,CNR1|GPR55,broad_id_20170327,Withdrawn,,
3660,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3661,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3662,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3663,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3664,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3665,BRD-K13356952,methazolamide,FLOSMHQXBMRNHR,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
3666,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3667,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3668,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3669,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3670,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3671,BRD-K13390322,AT-7519,OVPNQJVDAFNBDN,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,broad_id_20170327,Phase 2,,
3672,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3673,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3674,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3675,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3676,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3677,BRD-K13646352,midostaurin,BMGQWWVMWDBQGC,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,broad_id_20170327,Launched,,
3678,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3679,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3680,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3681,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3682,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3683,BRD-K13662825,dinaciclib,PIMQWRZWLQKKBJ,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,broad_id_20170327,Phase 3,,
3684,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3685,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3686,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3687,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3688,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3689,BRD-K13756951,bitopertin,YUUGYIUSCYNSQR,glycine transporter inhibitor,SLC6A5|SLC6A9,broad_id_20170327,Phase 3,,
3690,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3691,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3692,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3693,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3694,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3695,BRD-K13819402,desoxypeganine,WUFQLZTXIWKION,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,broad_id_20170327,Phase 1,,
3696,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3697,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3698,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3699,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3700,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3701,BRD-K13926615,vardenafil,SECKRCOLJRRGGV,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,broad_id_20170327,Launched,,
3702,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3703,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3704,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3705,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3706,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3707,BRD-K14175878,MK-0812,MTMDXAIUENDNDL,CC chemokine receptor antagonist,CCR2,broad_id_20170327,Phase 2,,
3708,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3709,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3710,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3711,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3712,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3713,BRD-K14529030,meisoindigo,QNOCRUSVMMAKSC,STAT inhibitor,STAT3,broad_id_20170327,Phase 3,,
3714,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3715,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3716,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3717,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3718,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3719,BRD-K14619660,altrenogest,VWAUPFMBXBWEQY,progestogen hormone,PGR,broad_id_20170327,Launched,,
3720,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3721,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3722,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3723,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3724,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3725,BRD-K14653796,tasquinimod,ONDYALNGTUAJDX,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,broad_id_20170327,Phase 3,,
3726,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3727,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3728,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3729,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3730,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3731,BRD-K14704277,cinoxacin,VDUWPHTZYNWKRN,topoisomerase inhibitor,,broad_id_20170327,Launched,,
3732,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3733,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3734,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3735,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3736,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3737,BRD-K14796088,berberine,YBHILYKTIRIUTE,LDL receptor activator,LDLR,broad_id_20170327,Launched,,
3738,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3739,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3740,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3741,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3742,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3743,BRD-K14870255,R-428,KXMZDGSRSGHMMK,AXL kinase inhibitor,AXL,broad_id_20170327,Phase 2,,
3744,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3745,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3746,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3747,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3748,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3749,BRD-K14993104,bemegride,ORRZGUBHBVWWOP,chemoreceptor agonist,GABRA1,broad_id_20170327,Launched,,
3750,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3751,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3752,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3753,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3754,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3755,BRD-K15010214,emedastine,KBUZBQVCBVDWKX,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
3756,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3757,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3758,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3759,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3760,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3761,BRD-K15108141,gemcitabine,SDUQYLNIPVEERB,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,broad_id_20170327,Launched,,
3762,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3763,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3764,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3765,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3766,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3767,BRD-K15170068,swainsonine,FXUAIOOAOAVCGD,alpha mannosidase inhibitor,MAN2A1,broad_id_20170327,Phase 2,,
3768,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3769,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3770,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3771,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3772,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3773,BRD-K15179879,carfilzomib,BLMPQMFVWMYDKT,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,broad_id_20170327,Launched,,
3774,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3775,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3776,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3777,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3778,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3779,BRD-K15318383,ammonium-glycyrrhizinate,LPLVUJXQOOQHMX,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
3780,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3781,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3782,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3783,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3784,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3785,BRD-K15409150,penfluridol,MDLAAYDRRZXJIF,T-type calcium channel blocker,CACNA1G,broad_id_20170327,Launched,,
3786,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3787,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3788,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3789,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3790,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3791,BRD-K15426076,iguratimod,ANMATWQYLIFGOK,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,broad_id_20170327,Launched,,
3792,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3793,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3794,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3795,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3796,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3797,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3798,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3799,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3800,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3801,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3802,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3803,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
3804,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3805,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3806,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3807,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3808,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3809,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3810,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3811,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3812,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3813,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3814,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3815,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
3816,,,,,,,,,
3817,,,,,,,,,
3818,,,,,,,,,
3819,,,,,,,,,
3820,,,,,,,,,
3821,,,,,,,,,
3822,,,,,,,,,
3823,,,,,,,,,
3824,,,,,,,,,
3825,,,,,,,,,
3826,,,,,,,,,
3827,,,,,,,,,
3828,,,,,,,,,
3829,,,,,,,,,
3830,,,,,,,,,
3831,,,,,,,,,
3832,,,,,,,,,
3833,,,,,,,,,
3834,,,,,,,,,
3835,,,,,,,,,
3836,,,,,,,,,
3837,,,,,,,,,
3838,,,,,,,,,
3839,,,,,,,,,
3840,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3841,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3842,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3843,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3844,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3845,BRD-A00147595,balaglitazone,IETKPTYAGKZLKY,insulin sensitizer|PPAR receptor partial agonist,PPARG,broad_id_20170327,Phase 3,,
3846,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3847,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3848,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3849,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3850,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3851,BRD-A00218260,flutrimazole,QHMWCHQXCUNUAK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
3852,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3853,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3854,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3855,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3856,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3857,BRD-A00376169,KBG,FOLRUCXBTYDAQK,neprilysin inhibitor,MME,broad_id_20170327,Phase 2,,
3858,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3859,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3860,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3861,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3862,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3863,BRD-A00546892,biperiden,YSXKPIUOCJLQIE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
3864,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3865,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3866,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3867,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3868,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3869,BRD-A00938334,drospirenone,METQSPRSQINEEU,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,broad_id_20170327,Launched,,
3870,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3871,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3872,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3873,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3874,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3875,BRD-A01636364,bupivacaine,LEBVLXFERQHONN,sodium channel blocker,KCNA5|SCN10A,broad_id_20170327,Launched,,
3876,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3877,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3878,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3879,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3880,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3881,BRD-A01787639,naftopidil,HRRBJVNMSRJFHQ,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
3882,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3883,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3884,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3885,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3886,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3887,BRD-A02367930,ethinyl-estradiol,BFPYWIDHMRZLRN,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,broad_id_20170327,Launched,,
3888,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3889,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3890,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3891,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3892,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3893,BRD-A02990301,lofexidine,KSMAGQUYOIHWFS,adrenergic receptor agonist,,broad_id_20170327,Launched,,
3894,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3895,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3896,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3897,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3898,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3899,BRD-A03061970,alizapride,KSEYRUGYKHXGFW,dopamine receptor antagonist,,broad_id_20170327,Launched,,
3900,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3901,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3902,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3903,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3904,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3905,BRD-A03216249,mepivacaine,INWLQCZOYSRPNW,potassium channel blocker|sodium channel blocker,,broad_id_20170327,Launched,,
3906,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3907,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3908,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3909,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3910,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3911,BRD-A03249105,fulvestrant,VWUXBMIQPBEWFH,estrogen receptor antagonist,ESR1|ESR2|GPER1,broad_id_20170327,Launched,,
3912,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3913,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3914,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3915,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3916,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3917,BRD-K00077635,estramustine-phosphate,ADFOJJHRTBFFOF,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
3918,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3919,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3920,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3921,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3922,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3923,BRD-K00152668,adarotene,QAWBIEIZDDIEMW,retinoid receptor agonist,RARB|RARG,broad_id_20170327,Phase 1,,
3924,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3925,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3926,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3927,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3928,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3929,BRD-K00259736,colchicine,IAKHMKGGTNLKSZ,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,broad_id_20170327,Launched,,
3930,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3931,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3932,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3933,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3934,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3935,BRD-K00494077,trovafloxacin,WVPSKSLAZQPAKQ,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Withdrawn,,
3936,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3937,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3938,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3939,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3940,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3941,BRD-K00521308,ATN-161,MMHDBUJXLOFTLC,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,broad_id_20170327,Phase 2,,
3942,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3943,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3944,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3945,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3946,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3947,BRD-K00603606,ticlopidine,PHWBOXQYWZNQIN,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
3948,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3949,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3950,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3951,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3952,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3953,BRD-K00610438,altanserin,SMYALUSCZJXWHG,serotonin receptor antagonist,HTR2A,broad_id_20170327,Phase 2,,
3954,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3955,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3956,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3957,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3958,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3959,BRD-K00662280,CL-218872,GUOQUXNJZHGPQF,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,broad_id_20170327,Phase 1,,
3960,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3961,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3962,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3963,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3964,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3965,BRD-K00673382,famotidine,XUFQPHANEAPEMJ,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
3966,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3967,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3968,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3969,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3970,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3971,BRD-K00674894,orteronel,OZPFIJIOIVJZMN,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 3,,
3972,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3973,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3974,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3975,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3976,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3977,BRD-K00911143,brexpiprazole,ZKIAIYBUSXZPLP,dopamine receptor partial agonist,DRD2,broad_id_20170327,Launched,,
3978,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3979,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3980,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3981,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3982,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3983,BRD-K01029106,chromium-picolinate,CBDQOLKNTOMMTL,insulin sensitizer,,broad_id_20170327,Launched,,
3984,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3985,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3986,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3987,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3988,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3989,BRD-K01039503,sofalcone,GFWRVVCDTLRWPK,mucus protecting agent,CBR1,broad_id_20170327,Launched,,
3990,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3991,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3992,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3993,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3994,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3995,BRD-K01174345,anamorelin,VQPFSIRUEPQQPP,growth hormone secretagogue receptor agonist,GHSR,broad_id_20170327,Phase 3,,
3996,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
3997,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
3998,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
3999,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
4000,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
4001,BRD-K01292756,pimozide,YVUQSNJEYSNKRX,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,broad_id_20170327,Launched,,
4002,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4003,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4004,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4005,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4006,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4007,BRD-K01577834,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
4008,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4009,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4010,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4011,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4012,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4013,BRD-K01621533,acarbose,XUFXOAAUWZOOIT,glucosidase inhibitor,AMY2A|MGAM,broad_id_20170327,Launched,,
4014,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4015,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4016,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4017,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4018,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4019,BRD-K01663662,diphenidol,OGAKLTJNUQRZJU,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4020,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4021,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4022,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4023,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4024,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4025,BRD-K01674964,histamine,NTYJJOPFIAHURM,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,broad_id_20170327,Launched,,
4026,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4027,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4028,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4029,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4030,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4031,BRD-K01815685,indole-3-carbinol,IVYPNXXAYMYVSP,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,broad_id_20170327,Phase 2/Phase 3,,
4032,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4033,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4034,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4035,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4036,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4037,BRD-K01824921,DPCPX,FFBDFADSZUINTG,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 1,,
4038,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4039,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4040,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4041,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4042,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4043,BRD-K02079473,oxatomide,BAINIUMDFURPJM,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
4044,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4045,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4046,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4047,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4048,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4049,BRD-K02113016,olaparib,FDLYAMZZIXQODN,PARP inhibitor,PARP1|PARP2,broad_id_20170327,Launched,,
4050,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4051,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4052,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4053,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4054,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4055,BRD-K02123250,JNJ-38877605,JRWCBEOAFGHNNU,tyrosine kinase inhibitor,MET,broad_id_20170327,Phase 1,,
4056,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4057,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4058,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4059,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4060,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4061,BRD-K02265150,amoxapine,QWGDMFLQWFTERH,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4062,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4063,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4064,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4065,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4066,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4067,BRD-K02292852,cefoperazone,GCFBRXLSHGKWDP,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4068,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4069,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4070,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4071,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4072,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4073,BRD-K02314383,epitiostanol,OBMLHUPNRURLOK,androgen receptor agonist,AR,broad_id_20170327,Launched,,
4074,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4075,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4076,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4077,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4078,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4079,BRD-K02389548,RG2833,VOPDXHFYDJAYNS,HDAC inhibitor,HDAC1|HDAC3,broad_id_20170327,Phase 1,,
4080,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4081,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4082,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4083,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4084,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4085,BRD-K02404261,caffeine,RYYVLZVUVIJVGH,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,broad_id_20170327,Launched,,
4086,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4087,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4088,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4089,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4090,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4091,BRD-K02501528,S18986,MNTIJYGEITVWHU,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,broad_id_20170327,Phase 2,,
4092,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4093,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4094,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4095,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4096,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4097,BRD-K02637541,celecoxib,RZEKVGVHFLEQIL,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,broad_id_20170327,Launched,,
4098,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4099,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4100,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4101,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4102,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4103,BRD-K02867583,minaprine,LDMWSLGGVTVJPG,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,broad_id_20170327,Withdrawn,,
4104,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4105,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4106,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4107,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4108,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4109,BRD-K02900412,clofoctol,HQVZOORKDNCGCK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
4110,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4111,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4112,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4113,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4114,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4115,BRD-K02943813,dasabuvir,NBRBXGKOEOGLOI,HCV inhibitor,,broad_id_20170327,Launched,,
4116,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4117,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4118,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4119,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4120,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4121,BRD-K02950022,BMS-299897,IZAOBRWCUGOKNH,gamma secretase inhibitor,,broad_id_20170327,Phase 1,,
4122,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4123,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4124,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4125,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4126,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4127,BRD-K02992638,lamivudine,JTEGQNOMFQHVDC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
4128,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4129,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4130,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4131,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4132,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4133,BRD-K03095347,levosimendan,WHXMKTBCFHIYNQ,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,broad_id_20170327,Launched,,
4134,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4135,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4136,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4137,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4138,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4139,BRD-K03194791,roflumilast,MNDBXUUTURYVHR,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
4140,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4141,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4142,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4143,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4144,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4145,BRD-K03289534,lersivirine,MCPUZZJBAHRIPO,non-nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 2,,
4146,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4147,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4148,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4149,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4150,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4151,BRD-K03384561,roquinimex,SGOOQMRIPALTEL,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,broad_id_20170327,Phase 3,,
4152,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4153,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4154,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4155,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4156,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4157,BRD-K03390685,cobimetinib,BSMCAPRUBJMWDF,MEK inhibitor,MAP2K1,broad_id_20170327,Launched,,
4158,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4159,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4160,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4161,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4162,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4163,BRD-K03449891,foretinib,CXQHYVUVSFXTMY,VEGFR inhibitor,FLT1|FLT4|KDR|MET,broad_id_20170327,Phase 2,,
4164,BRD-K03816923,,,,,,,,
4165,BRD-K03816923,,,,,,,,
4166,BRD-K03816923,,,,,,,,
4167,BRD-K03816923,,,,,,,,
4168,BRD-K03816923,,,,,,,,
4169,BRD-K03816923,,,,,,,,
4170,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4171,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4172,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4173,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4174,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4175,BRD-K05658747,raltegravir,CZFFBEXEKNGXKS,HIV integrase inhibitor,,broad_id_20170327,Launched,,
4176,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4177,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4178,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4179,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4180,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4181,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4182,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4183,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4184,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4185,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4186,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4187,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4188,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4189,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4190,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4191,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4192,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4193,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4194,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4195,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4196,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4197,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4198,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4199,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4200,,,,,,,,,
4201,,,,,,,,,
4202,,,,,,,,,
4203,,,,,,,,,
4204,,,,,,,,,
4205,,,,,,,,,
4206,,,,,,,,,
4207,,,,,,,,,
4208,,,,,,,,,
4209,,,,,,,,,
4210,,,,,,,,,
4211,,,,,,,,,
4212,,,,,,,,,
4213,,,,,,,,,
4214,,,,,,,,,
4215,,,,,,,,,
4216,,,,,,,,,
4217,,,,,,,,,
4218,,,,,,,,,
4219,,,,,,,,,
4220,,,,,,,,,
4221,,,,,,,,,
4222,,,,,,,,,
4223,,,,,,,,,
4224,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4225,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4226,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4227,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4228,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4229,BRD-A37780065,triamcinolone,GFNANZIMVAIWHM,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
4230,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4231,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4232,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4233,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4234,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4235,BRD-A37959677,estrone,DNXHEGUUPJUMQT,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,broad_id_20170327,Launched,,
4236,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4237,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4238,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4239,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4240,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4241,BRD-A40084411,CGP-12177,UMQUQWCJKFOUGV,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,broad_id_20170327,Phase 1,,
4242,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4243,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4244,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4245,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4246,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4247,BRD-A40639672,ketorolac,OZWKMVRBQXNZKK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4248,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4249,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4250,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4251,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4252,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4253,BRD-A40787240,gemifloxacin,ZRCVYEYHRGVLOC,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
4254,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4255,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4256,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4257,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4258,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4259,BRD-A41451487,PK-11195,RAVIZVQZGXBOQO,benzodiazepine receptor antagonist,TSPO,broad_id_20170327,Phase 1,,
4260,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4261,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4262,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4263,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4264,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4265,BRD-A43082555,loxoprofen,YMBXTVYHTMGZDW,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,broad_id_20170327,Launched,,
4266,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4267,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4268,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4269,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4270,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4271,BRD-A43882281,pinacidil,IVVNZDGDKPTYHK,ATP channel activator|potassium channel activator,ABCC8|ABCC9,broad_id_20170327,Launched,,
4272,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4273,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4274,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4275,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4276,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4277,BRD-A44090213,indoprofen,RJMIEHBSYVWVIN,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,broad_id_20170327,Withdrawn,,
4278,BRD-A67373739,,,,,,,,
4279,BRD-A67373739,,,,,,,,
4280,BRD-A67373739,,,,,,,,
4281,BRD-A67373739,,,,,,,,
4282,BRD-A67373739,,,,,,,,
4283,BRD-A67373739,,,,,,,,
4284,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4285,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4286,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4287,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4288,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4289,BRD-K37289225,clozapine,QZUDBNBUXVUHMW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
4290,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4291,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4292,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4293,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4294,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4295,BRD-K37355418,efaproxiral,BNFRJXLZYUTIII,hemoglobin oxygen release stimulant,HBA1|HBB,broad_id_20170327,Phase 3,,
4296,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4297,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4298,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4299,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4300,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4301,BRD-K37385792,conivaptan,IKENVDNFQMCRTR,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
4302,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4303,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4304,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4305,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4306,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4307,BRD-K37561857,zardaverine,HJMQDJPMQIHLPB,phosphodiesterase inhibitor,PDE4D,broad_id_20170327,Phase 2,,
4308,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4309,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4310,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4311,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4312,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4313,BRD-K37590257,GSK256066,JFHROPTYMMSOLG,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Phase 2,,
4314,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4315,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4316,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4317,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4318,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4319,BRD-K37846922,"3,3'-diindolylmethane",VFTRKSBEFQDZKX,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,broad_id_20170327,Phase 3,,
4320,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4321,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4322,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4323,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4324,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4325,BRD-K37872686,tirofiban,COKMIXFXJJXBQG,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,broad_id_20170327,Launched,,
4326,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4327,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4328,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4329,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4330,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4331,BRD-K37890730,camptothecin,VSJKWCGYPAHWDS,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 3,,
4332,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4333,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4334,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4335,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4336,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4337,BRD-K37991163,paroxetine,AHOUBRCZNHFOSL,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4338,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4339,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4340,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4341,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4342,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4343,BRD-K38183498,,DGBIGWXXNGSACT,,,broad_id_20170327,,,
4344,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4345,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4346,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4347,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4348,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4349,BRD-K38436528,imipramine,BCGWQEUPMDMJNV,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4350,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4351,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4352,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4353,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4354,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4355,BRD-K38473998,cilomilast,CFBUZOUXXHZCFB,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,broad_id_20170327,Phase 3,,
4356,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4357,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4358,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4359,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4360,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4361,BRD-K38744518,betulinic-acid,QGJZLNKBHJESQX,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,broad_id_20170327,Phase 1/Phase 2,,
4362,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4363,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4364,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4365,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4366,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4367,BRD-K38868394,MK-0773,GBEUKTWTUSPHEE,androgen receptor modulator,AR,broad_id_20170327,Phase 2,,
4368,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4369,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4370,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4371,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4372,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4373,BRD-K39252998,atipamezole,HSWPZIDYAHLZDD,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
4374,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4375,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4376,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4377,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4378,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4379,BRD-K39339537,epirizole,RHAXSHUQNIEUEY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4380,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4381,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4382,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4383,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4384,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4385,BRD-K39974922,lenvatinib,WOSKHXYHFSIKNG,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,broad_id_20170327,Launched,,
4386,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4387,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4388,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4389,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4390,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4391,BRD-K40227168,vinburnine,WYJAPUKIYAZSEM,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,broad_id_20170327,Launched,,
4392,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4393,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4394,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4395,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4396,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4397,BRD-K40738845,BMS-777607,VNBRGSXVFBYQNN,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,broad_id_20170327,Phase 1/Phase 2,,
4398,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4399,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4400,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4401,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4402,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4403,BRD-K40758068,efavirenz,XPOQHMRABVBWPR,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,broad_id_20170327,Launched,,
4404,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4405,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4406,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4407,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4408,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4409,BRD-K41185545,ambrisentan,OUJTZYPIHDYQMC,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
4410,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4411,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4412,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4413,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4414,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4415,BRD-K41213548,KW-2478,VFUXSYAXEKYYMB,HSP inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4416,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4417,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4418,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4419,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4420,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4421,BRD-K41260949,valproic-acid,NIJJYAXOARWZEE,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
4422,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4423,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4424,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4425,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4426,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4427,BRD-K41410256,balsalazide,IPOKCKJONYRRHP,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,broad_id_20170327,Launched,,
4428,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4429,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4430,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4431,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4432,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4433,BRD-K41434598,ORG-9768,JOLKQWPKJFRPOU,adrenergic receptor antagonist,ADRA2A,broad_id_20170327,Phase 1,,
4434,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4435,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4436,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4437,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4438,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4439,BRD-K41524689,paracetamol,RZVAJINKPMORJF,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,broad_id_20170327,Launched,,
4440,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4441,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4442,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4443,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4444,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4445,BRD-K41783120,STA-5326,HSKAZIJJKRAJAV,interleukin synthesis inhibitor,IL12A,broad_id_20170327,Phase 2,,
4446,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4447,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4448,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4449,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4450,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4451,BRD-K42098891,protriptyline,BWPIARFWQZKAIA,tricyclic antidepressant,SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4452,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4453,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4454,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4455,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4456,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4457,BRD-K42348709,cyclobenzaprine,JURKNVYFZMSNLP,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,broad_id_20170327,Launched,,
4458,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4459,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4460,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4461,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4462,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4463,BRD-K42352790,anandamide,LGEQQWMQCRIYKG,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,broad_id_20170327,Phase 2,,
4464,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4465,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4466,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4467,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4468,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4469,BRD-K42417338,,IFKLAQQSCNILHL,,,broad_id_20170327,,,
4470,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4471,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4472,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4473,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4474,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4475,BRD-K42495768,tasisulam,WWONFUQGBVOKOF,apoptosis stimulant,,broad_id_20170327,Phase 3,,
4476,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4477,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4478,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4479,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4480,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4481,BRD-K42679050,Y-27152,RHFUXPCCELGMFC,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
4482,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4483,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4484,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4485,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4486,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4487,BRD-K42948882,AMD11070,WVLHHLRVNDMIAR,CC chemokine receptor antagonist,CCR5|CXCR4,broad_id_20170327,Phase 3,,
4488,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4489,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4490,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4491,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4492,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4493,BRD-K42981054,mibampator,ULRDYYKSPCRXAJ,glutamate receptor modulator,GRIA1,broad_id_20170327,Phase 2,,
4494,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4495,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4496,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4497,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4498,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4499,BRD-K43002771,SR-33805,GCVFQRRBTCHIPK,calcium channel blocker,,broad_id_20170327,Phase 1,,
4500,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4501,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4502,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4503,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4504,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4505,BRD-K43164539,cholic-acid,BHQCQFFYRZLCQQ,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,broad_id_20170327,Launched,,
4506,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4507,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4508,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4509,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4510,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4511,BRD-K43410529,MLN2480,VWMJHAFYPMOMGF,RAF inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
4512,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4513,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4514,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4515,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4516,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4517,BRD-K43457670,acetazolamide,BZKPWHYZMXOIDC,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,broad_id_20170327,Launched,,
4518,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4519,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4520,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4521,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4522,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4523,BRD-K43578482,defactinib,FWLMVFUGMHIOAA,focal adhesion kinase inhibitor,PTK2,broad_id_20170327,Phase 2,,
4524,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4525,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4526,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4527,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4528,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4529,BRD-K43887077,dopamine,VYFYYTLLBUKUHU,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
4530,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4531,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4532,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4533,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4534,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4535,BRD-K43966364,penicillin-v-potassium,BPLBGHOLXOTWMN,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
4536,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4537,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4538,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4539,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4540,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4541,BRD-K44273375,tolnaftate,FUSNMLFNXJSCDI,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
4542,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4543,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4544,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4545,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4546,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4547,BRD-K44309363,dexniguldipine,SVJMLYUFVDMUHP,calmodulin antagonist,ADORA3,broad_id_20170327,Phase 2,adrenergic receptor antagonist,ADRA1A
4548,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4549,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4550,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4551,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4552,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4553,BRD-K44353683,nateglinide,OELFLUMRDSZNSF,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,broad_id_20170327,Launched,,
4554,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4555,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4556,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4557,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4558,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4559,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4560,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4561,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4562,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4563,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4564,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4565,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4566,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4567,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4568,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4569,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4570,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4571,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4572,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4573,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4574,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4575,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4576,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4577,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4578,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4579,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4580,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4581,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4582,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4583,BRD-M39350793,,XGSCYTRLSDKRRZ,,,broad_id_20170327,,,
4584,,,,,,,,,
4585,,,,,,,,,
4586,,,,,,,,,
4587,,,,,,,,,
4588,,,,,,,,,
4589,,,,,,,,,
4590,,,,,,,,,
4591,,,,,,,,,
4592,,,,,,,,,
4593,,,,,,,,,
4594,,,,,,,,,
4595,,,,,,,,,
4596,,,,,,,,,
4597,,,,,,,,,
4598,,,,,,,,,
4599,,,,,,,,,
4600,,,,,,,,,
4601,,,,,,,,,
4602,,,,,,,,,
4603,,,,,,,,,
4604,,,,,,,,,
4605,,,,,,,,,
4606,,,,,,,,,
4607,,,,,,,,,
4608,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4609,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4610,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4611,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4612,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4613,BRD-A38218502,metenkephalin,YFGBQHOOROIVKG,immunostimulant,OPRD1,broad_id_20170327,Phase 2,,
4614,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4615,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4616,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4617,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4618,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4619,BRD-A38350138,ketoconazole,XMAYWYJOQHXEEK,sterol demethylase inhibitor,KCNA10,broad_id_20170327,Launched,,
4620,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4621,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4622,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4623,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4624,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4625,BRD-A39390670,rabeprazole,YREYEVIYCVEVJK,ATPase inhibitor|gastrin inhibitor,ATP4A,broad_id_20170327,Launched,,
4626,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4627,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4628,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4629,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4630,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4631,BRD-A39415247,norethindrone,VIKNJXKGJWUCNN,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
4632,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4633,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4634,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4635,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4636,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4637,BRD-A39935389,teroxirone,OUPZKGBUJRBPGC,DNA inhibitor,,broad_id_20170327,Phase 1,,
4638,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4639,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4640,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4641,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4642,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4643,BRD-A55393291,,MUMGGOZAMZWBJJ,,,broad_id_20170327,,,
4644,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4645,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4646,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4647,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4648,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4649,BRD-A55962179,esomeprazole,SUBDBMMJDZJVOS,ATPase inhibitor,ATP4A,broad_id_20170327,Launched,ATPase inhibitor,ATP4A|CLCN2
4650,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4651,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4652,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4653,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4654,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4655,BRD-A56085258,encorafenib,CMJCXYNUCSMDBY,RAF inhibitor,BRAF,broad_id_20170327,Launched,,
4656,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4657,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4658,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4659,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4660,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4661,BRD-A56371469,AGI-5198,FNYGWXSATBUBER,isocitrate dehydrogenase inhibitor,IDH1,broad_id_20170327,Preclinical,,
4662,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4663,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4664,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4665,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4666,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4667,BRD-A56592690,PX-12,BPBPYQWMFCTCNG,thioredoxin inhibitor,CNR1|TXN,broad_id_20170327,Phase 2,,
4668,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4669,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4670,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4671,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4672,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4673,BRD-A57382968,,MNSCVRXKDINXEY,,,broad_id_20170327,,,
4674,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4675,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4676,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4677,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4678,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4679,BRD-A58955223,sulforaphane,SUVMJBTUFCVSAD,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,broad_id_20170327,Phase 2,,
4680,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4681,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4682,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4683,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4684,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4685,BRD-A59174698,ritodrine,IOVGROKTTNBUGK,adrenergic receptor agonist,,broad_id_20170327,Withdrawn,,
4686,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4687,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4688,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4689,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4690,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4691,BRD-A61676498,climbazole,OWEGWHBOCFMBLP,enzyme inducer,,broad_id_20170327,Launched,,
4692,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4693,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4694,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4695,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4696,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4697,BRD-K37687095,AZD8330,RWEVIPRMPFNTLO,MEK inhibitor,MAP3K1,broad_id_20170327,Phase 1,,
4698,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4699,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4700,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4701,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4702,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4703,BRD-K37694030,doxepin,ODQWQRRAPPTVAG,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
4704,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4705,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4706,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4707,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4708,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4709,BRD-K37714784,ABT-724,FRPJGTNLZNXQEX,dopamine receptor agonist,DRD4,broad_id_20170327,Phase 2,,
4710,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4711,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4712,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4713,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4714,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4715,BRD-K37764012,PF-03758309,AYCPARAPKDAOEN,p21 activated kinase inhibitor,PAK4,broad_id_20170327,Phase 1,,
4716,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4717,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4718,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4719,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4720,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4721,BRD-K38197229,bumetanide,MAEIEVLCKWDQJH,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,broad_id_20170327,Launched,,
4722,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4723,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4724,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4725,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4726,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4727,BRD-K38287497,narlaprevir,RICZEKWVNZFTNZ,HCV inhibitor,,broad_id_20170327,Phase 3,,
4728,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4729,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4730,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4731,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4732,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4733,BRD-K39503511,quiflapon,NZOONKHCNQFYCI,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,broad_id_20170327,Phase 2,,
4734,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4735,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4736,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4737,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4738,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4739,BRD-K40797222,SC-12267,XPRDUGXOWVXZLL,dihydroorotate dehydrogenase inhibitor,IL17A,broad_id_20170327,Phase 2,,
4740,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4741,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4742,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4743,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4744,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4745,BRD-K40870905,CT-7758,KYHVWHYLKOHLKA,integrin antagonist,ITGA4,broad_id_20170327,Phase 2,,
4746,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4747,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4748,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4749,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4750,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4751,BRD-K41160163,fenobam,DWPQODZAOSWNHB,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
4752,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4753,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4754,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4755,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4756,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4757,BRD-K41170226,deoxycholic-acid,KXGVEGMKQFWNSR,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,broad_id_20170327,Launched,,
4758,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4759,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4760,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4761,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4762,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4763,BRD-K41599323,lonafarnib,DHMTURDWPRKSOA,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,broad_id_20170327,Phase 3,,
4764,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4765,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4766,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4767,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4768,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4769,BRD-K41708980,triamcinolone-acetonide,YNDXUCZADRHECN,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,broad_id_20170327,Launched,,
4770,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4771,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4772,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4773,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4774,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4775,BRD-K41731458,triclosan,XEFQLINVKFYRCS,antibacterial agent,DNMT1,broad_id_20170327,Launched,,
4776,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4777,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4778,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4779,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4780,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4781,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4782,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4783,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4784,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4785,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4786,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4787,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
4788,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4789,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4790,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4791,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4792,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4793,BRD-K55512740,MK-8033,VMJFTOSOFDEKTM,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
4794,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4795,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4796,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4797,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4798,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4799,BRD-K55966568,orantinib,NHFDRBXTEDBWCZ,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
4800,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4801,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4802,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4803,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4804,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4805,BRD-K56032964,AP26113,OVDSPTSBIQCAIN,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,broad_id_20170327,Phase 2,,
4806,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4807,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4808,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4809,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4810,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4811,BRD-K56558538,ambroxol,JBDGDEWWOUBZPM,sodium channel blocker,CYP3A4,broad_id_20170327,Launched,,
4812,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4813,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4814,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4815,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4816,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4817,BRD-K56614220,clofazimine,WDQPAMHFFCXSNU,GK0582 inhibitor,,broad_id_20170327,Launched,,
4818,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4819,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4820,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4821,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4822,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4823,BRD-K56751279,Y-39983,JTVBXQAYBIJXRP,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Phase 2,,
4824,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4825,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4826,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4827,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4828,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4829,BRD-K56851771,enzalutamide,WXCXUHSOUPDCQV,androgen receptor antagonist,AR,broad_id_20170327,Launched,,
4830,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4831,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4832,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4833,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4834,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4835,BRD-K57222227,indomethacin,CGIGDMFJXJATDK,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,broad_id_20170327,Launched,,
4836,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4837,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4838,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4839,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4840,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4841,BRD-K57252450,cilengitide,AMLYAMJWYAIXIA,integrin antagonist,ITGAV|ITGB3,broad_id_20170327,Phase 3,,
4842,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4843,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4844,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4845,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4846,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4847,BRD-K57371763,fidaxomicin,ZVGNESXIJDCBKN,RNA polymerase inhibitor,,broad_id_20170327,Launched,,
4848,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4849,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4850,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4851,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4852,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4853,BRD-K57764956,cariprazine,KPWSJANDNDDRMB,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
4854,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4855,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4856,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4857,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4858,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4859,BRD-K58211978,roxithromycin,RXZBMPWDPOLZGW,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
4860,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4861,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4862,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4863,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4864,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4865,BRD-K58435339,AT13387,IFRGXKKQHBVPCQ,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
4866,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4867,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4868,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4869,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4870,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4871,BRD-K58486055,reparixin,KQDRVXQXKZXMHP,CC chemokine receptor antagonist,CXCR1|CXCR2,broad_id_20170327,Phase 3,,
4872,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4873,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4874,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4875,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4876,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4877,BRD-K58501140,TAK-875,BZCALJIHZVNMGJ,insulin secretagogue,FFAR1,broad_id_20170327,Phase 3,,
4878,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4879,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4880,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4881,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4882,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4883,BRD-K59058766,chlorprothixene,WSPOMRSOLSGNFJ,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,broad_id_20170327,Launched,,
4884,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4885,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4886,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4887,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4888,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4889,BRD-K59197931,naproxen,CMWTZPSULFXXJA,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
4890,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4891,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4892,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4893,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4894,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4895,BRD-K59227464,LY2228820,XPPBBJCBDOEXDN,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
4896,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4897,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4898,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4899,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4900,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4901,BRD-K59325863,delanzomib,SJFBTAPEPRWNKH,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,broad_id_20170327,Phase 1/Phase 2,,
4902,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4903,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4904,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4905,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4906,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4907,BRD-K59506194,targinine,NTNWOCRCBQPEKQ,nitric oxide synthase inhibitor,NOS3,broad_id_20170327,Phase 3,,
4908,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4909,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4910,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4911,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4912,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4913,BRD-K59524082,maribavir,KJFBVJALEQWJBS,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,broad_id_20170327,Phase 3,,
4914,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4915,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4916,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4917,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4918,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4919,BRD-K59573506,cyproterone-acetate,UWFYSQMTEOIJJG,androgen receptor antagonist,ADORA1|AR,broad_id_20170327,Launched,,
4920,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4921,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4922,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4923,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4924,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4925,BRD-K59574735,ubenimex,VGGGPCQERPFHOB,leukotriene synthesis inhibitor,LTA4H|RNPEP,broad_id_20170327,Launched,,
4926,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4927,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4928,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4929,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4930,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4931,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4932,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4933,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4934,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4935,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4936,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4937,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
4938,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4939,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4940,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4941,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4942,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4943,BRD-K60341624,GSK1292263,AYJRTVVIBJSSKN,glucose dependent insulinotropic receptor agonist,GRPR,broad_id_20170327,Phase 2,,
4944,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4945,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4946,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4947,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4948,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4949,BRD-K60585088,paricalcitol,BPKAHTKRCLCHEA,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
4950,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4951,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4952,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4953,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4954,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4955,BRD-K60866521,idelalisib,IFSDAJWBUCMOAH,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Launched,,
4956,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4957,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4958,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4959,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4960,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4961,BRD-K60997853,PHA-848125,RXZMYLDMFYNEIM,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,broad_id_20170327,Phase 2,,
4962,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4963,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4964,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4965,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4966,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4967,BRD-K61036791,rucinol,CSHZYWUPJWVTMQ,tyrosinase inhibitor,TYR,broad_id_20170327,Phase 1,,
4968,,,,,,,,,
4969,,,,,,,,,
4970,,,,,,,,,
4971,,,,,,,,,
4972,,,,,,,,,
4973,,,,,,,,,
4974,,,,,,,,,
4975,,,,,,,,,
4976,,,,,,,,,
4977,,,,,,,,,
4978,,,,,,,,,
4979,,,,,,,,,
4980,,,,,,,,,
4981,,,,,,,,,
4982,,,,,,,,,
4983,,,,,,,,,
4984,,,,,,,,,
4985,,,,,,,,,
4986,,,,,,,,,
4987,,,,,,,,,
4988,,,,,,,,,
4989,,,,,,,,,
4990,,,,,,,,,
4991,,,,,,,,,
4992,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4993,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4994,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4995,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4996,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4997,BRD-A51078674,diclofensine,ZJDCGVDEEHWEIG,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,broad_id_20170327,Phase 3,,
4998,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
4999,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
5000,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
5001,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
5002,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
5003,BRD-A55579717,cytisine,ANJTVLIZGCUXLD,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,broad_id_20170327,Launched,,
5004,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5005,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5006,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5007,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5008,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5009,BRD-A55913614,primaquine,INDBQLZJXZLFIT,antimalarial agent|DNA inhibitor,,broad_id_20170327,Launched,acetylcholine receptor antagonist,
5010,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5011,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5012,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5013,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5014,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5015,BRD-A58048407,nimodipine,UIAGMCDKSXEBJQ,calcium channel blocker,CFTR|NR3C2,broad_id_20170327,Launched,,
5016,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5017,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5018,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5019,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5020,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5021,BRD-A58564983,selamectin,AFJYYKSVHJGXSN,nematocide,,broad_id_20170327,Launched,,
5022,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5023,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5024,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5025,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5026,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5027,BRD-A61154809,gliclazide,BOVGTQGAOIONJV,ATP channel blocker|insulin secretagogue,,broad_id_20170327,Launched,,
5028,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5029,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5030,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5031,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5032,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5033,BRD-A61221616,medroxyprogesterone-acetate,PSGAAPLEWMOORI,progesterone receptor agonist,ESR1|PGR,broad_id_20170327,Launched,,
5034,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5035,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5036,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5037,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5038,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5039,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5040,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5041,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5042,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5043,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5044,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5045,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5046,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5047,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5048,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5049,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5050,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5051,BRD-K55748775,SCH-28080,PYKJFEPAUKAXNN,ATPase inhibitor,ATP4A,broad_id_20170327,Phase 1,,
5052,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5053,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5054,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5055,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5056,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5057,BRD-K55781385,rimegepant,KRNAOFGYEFKHPB,calcitonin antagonist,CALCA,broad_id_20170327,Launched,,
5058,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5059,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5060,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5061,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5062,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5063,BRD-K55847762,lobenzarit,UGDPYGKWIHHBMB,immunosuppressant,,broad_id_20170327,Launched,,
5064,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5065,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5066,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5067,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5068,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5069,BRD-K55930204,phenytoin,CXOFVDLJLONNDW,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
5070,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5071,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5072,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5073,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5074,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5075,BRD-K56104152,oxiconazole,QRJJEGAJXVEBNE,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
5076,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5077,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5078,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5079,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5080,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5081,BRD-K56195681,losmapimod,KKYABQBFGDZVNQ,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 3,,
5082,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5083,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5084,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5085,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5086,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5087,BRD-K56291712,voxtalisib,RGHYDLZMTYDBDT,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,broad_id_20170327,Phase 2,,
5088,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5089,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5090,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5091,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5092,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5093,BRD-K56301217,ABT-737,HPLNQCPCUACXLM,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 1/Phase 2,,
5094,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5095,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5096,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5097,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5098,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5099,BRD-K56334280,amonafide,UPALIKSFLSVKIS,topoisomerase inhibitor,TOP2A|TOP2B,broad_id_20170327,Phase 3,,
5100,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5101,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5102,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5103,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5104,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5105,BRD-K56343971,vemurafenib,GPXBXXGIAQBQNI,RAF inhibitor,BRAF|RAF1,broad_id_20170327,Launched,,
5106,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5107,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5108,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5109,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5110,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5111,BRD-K56405753,MK-2461,JGEBLDKNWBUGRZ,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,broad_id_20170327,Phase 1/Phase 2,,
5112,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5113,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5114,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5115,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5116,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5117,BRD-K56800335,guanaben-acetate,WDZVGELJXXEGPV,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
5118,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5119,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5120,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5121,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5122,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5123,BRD-K56810756,fomepizole,RIKMMFOAQPJVMX,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,broad_id_20170327,Launched,,
5124,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5125,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5126,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5127,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5128,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5129,BRD-K56844688,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
5130,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5131,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5132,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5133,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5134,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5135,BRD-K56957086,dacinostat,BWDQBBCUWLSASG,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Phase 1,,
5136,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5137,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5138,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5139,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5140,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5141,BRD-K57041787,dabigatran-etexilate,KSGXQBZTULBEEQ,thrombin inhibitor,F2,broad_id_20170327,Launched,,
5142,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5143,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5144,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5145,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5146,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5147,BRD-K57080016,selumetinib,CYOHGALHFOKKQC,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 3,,
5148,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5149,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5150,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5151,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5152,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5153,BRD-K57169635,dacomitinib,LVXJQMNHJWSHET,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
5154,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5155,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5156,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5157,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5158,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5159,BRD-K57432881,tiapride,JTVPZMFULRWINT,dopamine receptor antagonist,DRD2|DRD3,broad_id_20170327,Launched,,
5160,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5161,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5162,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5163,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5164,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5165,BRD-K57545991,enalapril,GBXSMTUPTTWBMN,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
5166,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5167,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5168,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5169,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5170,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5171,BRD-K57569181,pentoxifylline,BYPFEZZEUUWMEJ,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,broad_id_20170327,Launched,,
5172,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5173,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5174,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5175,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5176,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5177,BRD-K57631554,5-aminolevulinic-acid,ZGXJTSGNIOSYLO,oxidizing agent,ALAD,broad_id_20170327,Launched,,
5178,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5179,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5180,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5181,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5182,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5183,BRD-K58010567,vilazodone,SGEGOXDYSFKCPT,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,broad_id_20170327,Launched,,
5184,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5185,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5186,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5187,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5188,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5189,BRD-K58114536,rasagiline,RUOKEQAAGRXIBM,monoamine oxidase inhibitor,BCL2|MAOB,broad_id_20170327,Launched,,
5190,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5191,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5192,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5193,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5194,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5195,BRD-K58626373,,DBGIVFWFUFKIQN,,,broad_id_20170327,,,
5196,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5197,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5198,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5199,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5200,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5201,BRD-K58736316,cianidanol,PFTAWBLQPZVEMU,fatty acid synthase inhibitor,PTGS1,broad_id_20170327,Withdrawn,,
5202,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5203,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5204,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5205,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5206,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5207,BRD-K58951486,rocuronium,YXRDKMPIGHSVRX,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,broad_id_20170327,Launched,,
5208,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5209,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5210,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5211,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5212,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5213,BRD-K59013864,AM-24,VAPDZNUFNKUROY,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
5214,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5215,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5216,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5217,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5218,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5219,BRD-K59037100,oxybenzone,DXGLGDHPHMLXJC,lipase inhibitor,LIPE,broad_id_20170327,Launched,,
5220,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5221,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5222,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5223,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5224,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5225,BRD-K59273480,propentofylline,RBQOQRRFDPXAGN,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,broad_id_20170327,Launched,,
5226,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5227,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5228,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5229,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5230,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5231,BRD-K59317601,MLN0128,GYLDXIAOMVERTK,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
5232,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5233,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5234,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5235,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5236,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5237,BRD-K59331299,voglibose,FZNCGRZWXLXZSZ,glucosidase inhibitor,MGAM,broad_id_20170327,Launched,,
5238,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5239,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5240,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5241,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5242,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5243,BRD-K59332007,linopirdine,YEJCDKJIEMIWRQ,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,broad_id_20170327,Phase 3,,
5244,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5245,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5246,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5247,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5248,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5249,BRD-K59369769,tozasertib,GCIKSSRWRFVXBI,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,broad_id_20170327,Phase 2,,
5250,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5251,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5252,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5253,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5254,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5255,BRD-K59433843,ICI-192605,WHUIENZXNGAHQI,thromboxane receptor antagonist,TBXA2R,broad_id_20170327,Phase 2,,
5256,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5257,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5258,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5259,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5260,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5261,BRD-K59436580,tedizolid,XFALPSLJIHVRKE,bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
5262,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5263,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5264,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5265,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5266,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5267,BRD-K59632282,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
5268,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5269,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5270,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5271,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5272,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5273,BRD-K59715032,pasireotide,VMZMNAABQBOLAK,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,broad_id_20170327,Launched,,
5274,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5275,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5276,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5277,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5278,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5279,BRD-K59875992,FPL-62064,WKLGNFJHVJIZPK,cyclooxygenase inhibitor|lipoxygenase inhibitor,,broad_id_20170327,Phase 2,,
5280,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5281,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5282,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5283,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5284,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5285,BRD-K59929863,CB-10-277,GUAZPUYTLMUTMA,DNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5286,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5287,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5288,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5289,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5290,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5291,BRD-K60160658,tiagabine,PBJUNZJWGZTSKL,GABA uptake inhibitor,SLC6A1,broad_id_20170327,Launched,,
5292,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5293,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5294,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5295,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5296,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5297,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5298,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5299,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5300,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5301,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5302,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5303,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5304,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5305,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5306,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5307,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5308,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5309,BRD-K60237333,niacin,PVNIIMVLHYAWGP,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,broad_id_20170327,Launched,,
5310,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5311,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5312,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5313,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5314,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5315,BRD-K60240222,carglumic-acid,LCQLHJZYVOQKHU,carbamoyl phosphate synthase activator,CPS1,broad_id_20170327,Launched,,
5316,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5317,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5318,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5319,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5320,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5321,BRD-K61195623,combretastatin-A-4,HVXBOLULGPECHP,tubulin polymerization inhibitor,,broad_id_20170327,Phase 2,,
5322,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5323,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5324,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5325,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5326,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5327,BRD-K61250553,loperamide,RDOIQAHITMMDAJ,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,broad_id_20170327,Launched,,
5328,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5329,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5330,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5331,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5332,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5333,BRD-K61397605,romidepsin,OHRURASPPZQGQM,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,broad_id_20170327,Launched,,
5334,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5335,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5336,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5337,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5338,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5339,BRD-K61452026,emtricitabine,XQSPYNMVSIKCOC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
5340,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5341,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5342,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5343,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5344,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5345,BRD-K61567297,resatorvid,LEEIJTHMHDMWLJ,toll-like receptor inhibitor,TLR4,broad_id_20170327,Phase 3,,
5346,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5347,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5348,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5349,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5350,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5351,BRD-K77987382,mebendazole,OPXLLQIJSORQAM,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
5352,,,,,,,,,
5353,,,,,,,,,
5354,,,,,,,,,
5355,,,,,,,,,
5356,,,,,,,,,
5357,,,,,,,,,
5358,,,,,,,,,
5359,,,,,,,,,
5360,,,,,,,,,
5361,,,,,,,,,
5362,,,,,,,,,
5363,,,,,,,,,
5364,,,,,,,,,
5365,,,,,,,,,
5366,,,,,,,,,
5367,,,,,,,,,
5368,,,,,,,,,
5369,,,,,,,,,
5370,,,,,,,,,
5371,,,,,,,,,
5372,,,,,,,,,
5373,,,,,,,,,
5374,,,,,,,,,
5375,,,,,,,,,
5376,BRD-A43331270,,,,,,,,
5377,BRD-A43331270,,,,,,,,
5378,BRD-A43331270,,,,,,,,
5379,BRD-A43331270,,,,,,,,
5380,BRD-A43331270,,,,,,,,
5381,BRD-A43331270,,,,,,,,
5382,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5383,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5384,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5385,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5386,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5387,BRD-A51714012,venlafaxine,PNVNVHUZROJLTJ,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,broad_id_20170327,Launched,,
5388,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5389,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5390,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5391,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5392,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5393,BRD-A51820102,econazole,LEZWWPYKPKIXLL,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,broad_id_20170327,Launched,,
5394,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5395,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5396,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5397,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5398,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5399,BRD-A52252998,clindamycin,KDLRVYVGXIQJDK,protein synthesis inhibitor,,broad_id_20170327,Launched,,
5400,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5401,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5402,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5403,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5404,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5405,BRD-A52660433,tetrindole,AUXCHYJDVJZEPG,monoamine oxidase inhibitor,MAOA,broad_id_20170327,Phase 3,,
5406,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5407,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5408,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5409,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5410,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5411,BRD-A53176877,methylprednisolone,VHRSUDSXCMQTMA,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
5412,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5413,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5414,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5415,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5416,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5417,BRD-A53566267,anecortave-acetate,YUWPMEXLKGOSBF,angiogenesis inhibitor,,broad_id_20170327,Launched,,
5418,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5419,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5420,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5421,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5422,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5423,BRD-A53576514,orphenadrine,QVYRGXJJSLMXQH,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
5424,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5425,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5426,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5427,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5428,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5429,BRD-A54880345,etomidate,NPUKDXXFDDZOKR,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
5430,BRD-A58280226,,,,,,,,
5431,BRD-A58280226,,,,,,,,
5432,BRD-A58280226,,,,,,,,
5433,BRD-A58280226,,,,,,,,
5434,BRD-A58280226,,,,,,,,
5435,BRD-A58280226,,,,,,,,
5436,BRD-A69951442,,,,,,,,
5437,BRD-A69951442,,,,,,,,
5438,BRD-A69951442,,,,,,,,
5439,BRD-A69951442,,,,,,,,
5440,BRD-A69951442,,,,,,,,
5441,BRD-A69951442,,,,,,,,
5442,BRD-A77216878,,,,,,,,
5443,BRD-A77216878,,,,,,,,
5444,BRD-A77216878,,,,,,,,
5445,BRD-A77216878,,,,,,,,
5446,BRD-A77216878,,,,,,,,
5447,BRD-A77216878,,,,,,,,
5448,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5449,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5450,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5451,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5452,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5453,BRD-K07572174,curcumin,ZIUSSTSXXLLKKK,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,broad_id_20200324,Launched,,
5454,BRD-K23875128,,,,,,,,
5455,BRD-K23875128,,,,,,,,
5456,BRD-K23875128,,,,,,,,
5457,BRD-K23875128,,,,,,,,
5458,BRD-K23875128,,,,,,,,
5459,BRD-K23875128,,,,,,,,
5460,BRD-K36324071,,,,,,,,
5461,BRD-K36324071,,,,,,,,
5462,BRD-K36324071,,,,,,,,
5463,BRD-K36324071,,,,,,,,
5464,BRD-K36324071,,,,,,,,
5465,BRD-K36324071,,,,,,,,
5466,BRD-K41895714,,,,,,,,
5467,BRD-K41895714,,,,,,,,
5468,BRD-K41895714,,,,,,,,
5469,BRD-K41895714,,,,,,,,
5470,BRD-K41895714,,,,,,,,
5471,BRD-K41895714,,,,,,,,
5472,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5473,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5474,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5475,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5476,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5477,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5478,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5479,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5480,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5481,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5482,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5483,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5484,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5485,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5486,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5487,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5488,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5489,BRD-K51087630,tirasemtiv,RSQGZEAXODVTOL,troponin activator,,broad_id_20170327,Phase 2,,
5490,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5491,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5492,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5493,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5494,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5495,BRD-K51143828,lurasidone,PQXKDMSYBGKCJA,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,broad_id_20170327,Launched,,
5496,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5497,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5498,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5499,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5500,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5501,BRD-K51263939,sarcosine,FSYKKLYZXJSNPZ,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 2,,
5502,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5503,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5504,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5505,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5506,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5507,BRD-K51313569,palbociclib,AHJRHEGDXFFMBM,CDK inhibitor,CDK4|CDK6,broad_id_20170327,Launched,,
5508,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5509,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5510,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5511,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5512,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5513,BRD-K51324732,meglitinide,SWLAMJPTOQZTAE,potassium channel blocker,CCR2,broad_id_20170327,Phase 2,,
5514,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5515,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5516,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5517,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5518,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5519,BRD-K51544265,cabozantinib,ONIQOQHATWINJY,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,broad_id_20170327,Launched,,
5520,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5521,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5522,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5523,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5524,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5525,BRD-K51662849,ilomastat,NITYDPDXAAFEIT,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,broad_id_20170327,Phase 3,,
5526,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5527,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5528,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5529,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5530,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5531,BRD-K51677086,erythromycin-ethylsuccinate,NSYZCCDSJNWWJL,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,broad_id_20170327,Launched,,
5532,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5533,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5534,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5535,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5536,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5537,BRD-K51747290,hydroxyurea,VSNHCAURESNICA,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
5538,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5539,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5540,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5541,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5542,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5543,BRD-K51967704,BIIB021,QULDDKSCVCJTPV,HSP inhibitor,HSP90AA1,broad_id_20170327,Phase 2,,
5544,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5545,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5546,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5547,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5548,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5549,BRD-K52233191,R547,JRNJNYBQQYBCLE,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,broad_id_20170327,Phase 1,,
5550,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5551,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5552,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5553,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5554,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5555,BRD-K52313696,tacedinaline,VAZAPHZUAVEOMC,HDAC inhibitor,HDAC1,broad_id_20170327,Phase 3,,
5556,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5557,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5558,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5559,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5560,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5561,BRD-K52618540,inositol,CDAISMWEOUEBRE,insulin sensitizer,CDIPT,broad_id_20170327,Launched,,
5562,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5563,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5564,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5565,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5566,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5567,BRD-K52662033,lidocaine,NNJVILVZKWQKPM,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,broad_id_20170327,Launched,,
5568,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5569,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5570,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5571,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5572,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5573,BRD-K52751261,TAK-715,HEKAIDKUDLCBRU,p38 MAPK inhibitor,MAPK14,broad_id_20170327,Phase 2,,
5574,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5575,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5576,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5577,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5578,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5579,BRD-K52818472,ivacaftor,PURKAOJPTOLRMP,CFTR channel potentiator,CFTR,broad_id_20170327,Launched,,
5580,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5581,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5582,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5583,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5584,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5585,BRD-K53061490,ozagrel,SHZKQBHERIJWAO,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Launched,,
5586,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5587,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5588,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5589,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5590,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5591,BRD-K53318339,vinpocetine,DDNCQMVWWZOMLN,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,broad_id_20170327,Launched,,
5592,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5593,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5594,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5595,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5596,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5597,BRD-K53414658,tivozanib,SPMVMDHWKHCIDT,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
5598,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5599,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5600,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5601,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5602,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5603,BRD-K53417444,OTS167,DKZYXHCYPUVGAF,maternal embryonic leucine zipper kinase inhibitor,MELK,broad_id_20170327,Phase 1/Phase 2,,
5604,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5605,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5606,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5607,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5608,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5609,BRD-K53517854,fluvoxamine,CJOFXWAVKWHTFT,selective serotonin reuptake inhibitor (SSRI),SLC6A4,broad_id_20170327,Launched,,
5610,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5611,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5612,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5613,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5614,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5615,BRD-K53814070,ripasudil,QSKQVZWVLOIIEV,rho associated kinase inhibitor,ROCK1|ROCK2,broad_id_20170327,Launched,,
5616,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5617,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5618,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5619,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5620,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5621,BRD-K53857191,risperidone,RAPZEAPATHNIPO,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
5622,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5623,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5624,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5625,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5626,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5627,BRD-K53963539,vortioxetine,YQNWZWMKLDQSAC,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,broad_id_20170327,Launched,,
5628,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5629,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5630,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5631,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5632,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5633,BRD-K53979406,ALX-5407,FDORQEIHOKEJNX,glycine transporter inhibitor,SLC6A9,broad_id_20170327,Phase 1,,
5634,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5635,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5636,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5637,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5638,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5639,BRD-K54006094,formoterol,BPZSYCZIITTYBL,adrenergic receptor agonist,ADRB2,broad_id_20170327,Launched,,
5640,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5641,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5642,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5643,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5644,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5645,BRD-K54028654,cabaletta,HDTRYLNUVZCQOY,pharmacological chaperone,,broad_id_20170327,Phase 2,,
5646,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5647,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5648,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5649,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5650,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5651,BRD-K54256913,MK-1775,BKWJAKQVGHWELA,WEE1 kinase inhibitor,WEE1,broad_id_20170327,Phase 2,,
5652,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5653,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5654,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5655,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5656,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5657,BRD-K54416256,methimazole,PMRYVIKBURPHAH,antithyroid agent,TPO,broad_id_20170327,Launched,,
5658,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5659,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5660,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5661,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5662,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5663,BRD-K54770957,etoricoxib,MNJVRJDLRVPLFE,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
5664,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5665,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5666,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5667,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5668,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5669,BRD-K54847683,equol,ADFCQWZHKCXPAJ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Launched,,
5670,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5671,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5672,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5673,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5674,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5675,BRD-K54936858,DMP-777,ZSDCIRYNTCVTMF,elastase inhibitor,MPO,broad_id_20170327,Phase 2,,
5676,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5677,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5678,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5679,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5680,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5681,BRD-K55013654,,XTTZERNUQAFMOF,,,broad_id_20170327,,,
5682,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5683,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5684,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5685,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5686,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5687,BRD-K55026842,azacitidine,NMUSYJAQQFHJEW,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
5688,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5689,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5690,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5691,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5692,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5693,BRD-K55127134,fluphenazine,PLDUPXSUYLZYBN,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,broad_id_20170327,Launched,,
5694,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5695,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5696,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5697,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5698,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5699,BRD-K55191674,benzylpenicillin,JGSARLDLIJGVTE,penicillin binding protein inhibitor,,broad_id_20170327,Launched,,
5700,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5701,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5702,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5703,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5704,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5705,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5706,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5707,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5708,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5709,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5710,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5711,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5712,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5713,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5714,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5715,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5716,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5717,BRD-K64990520,apocynin,DFYRUELUNQRZTB,NADPH oxidase inhibitor,NOX4,broad_id_20170327,Phase 1,,
5718,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5719,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5720,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5721,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5722,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5723,BRD-K81672972,dinoprost,PXGPLTODNUVGFL,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,broad_id_20170327,Launched,,
5724,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5725,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5726,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5727,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5728,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5729,BRD-K85140930,aphidicolin,NOFOAYPPHIUXJR,RNA synthesis inhibitor,,broad_id_20170327,Phase 1,,
5730,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5731,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5732,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5733,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5734,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5735,BRD-K86301799,dipyridamole,IZEKFCXSFNUWAM,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,broad_id_20170327,Launched,,
5736,,,,,,,,,
5737,,,,,,,,,
5738,,,,,,,,,
5739,,,,,,,,,
5740,,,,,,,,,
5741,,,,,,,,,
5742,,,,,,,,,
5743,,,,,,,,,
5744,,,,,,,,,
5745,,,,,,,,,
5746,,,,,,,,,
5747,,,,,,,,,
5748,,,,,,,,,
5749,,,,,,,,,
5750,,,,,,,,,
5751,,,,,,,,,
5752,,,,,,,,,
5753,,,,,,,,,
5754,,,,,,,,,
5755,,,,,,,,,
5756,,,,,,,,,
5757,,,,,,,,,
5758,,,,,,,,,
5759,,,,,,,,,
5760,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5761,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5762,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5763,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5764,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5765,BRD-A47598013,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
5766,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5767,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5768,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5769,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5770,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5771,BRD-A48430263,pioglitazone,HYAFETHFCAUJAY,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,broad_id_20170327,Launched,,
5772,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5773,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5774,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5775,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5776,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5777,BRD-A50311610,meclizine,OCJYIGYOJCODJL,constitutive androstane receptor (CAR) agonist,NR1I3,broad_id_20170327,Launched,,
5778,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5779,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5780,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5781,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5782,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5783,BRD-A50764878,MDL-73005EF,BVMYCHKQPGEOSI,serotonin receptor antagonist,HTR1A,broad_id_20170327,Phase 1,,
5784,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5785,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5786,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5787,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5788,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5789,BRD-A50998626,palomid-529,YEAHTLOYHVWAKW,AKT inhibitor|mTOR inhibitor,MTOR,broad_id_20170327,Phase 1,,
5790,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5791,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5792,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5793,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5794,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5795,BRD-A61767428,ursolic-acid,WCGUUGGRBIKTOS,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,deprecated_broad_id_20180907,Phase 2/Phase 3,,
5796,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5797,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5798,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5799,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5800,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5801,BRD-A61793559,metolazone,AQCHWTWZEMGIFD,carbonic anhydrase inhibitor,SLC12A3,broad_id_20170327,Launched,,
5802,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5803,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5804,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5805,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5806,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5807,BRD-A62879835,rifaximin,NZCRJKRKKOLAOJ,RNA synthesis inhibitor,,broad_id_20170327,Launched,,
5808,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5809,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5810,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5811,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5812,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5813,BRD-A63236097,andrographolide,BOJKULTULYSRAS,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,broad_id_20170327,Phase 2,,
5814,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5815,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5816,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5817,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5818,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5819,BRD-A63675168,brivudine,ODZBBRURCPAEIQ,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
5820,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5821,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5822,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5823,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5824,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5825,BRD-A64485570,trifluridine,VSQQQLOSPVPRAZ,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
5826,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5827,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5828,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5829,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5830,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5831,BRD-A64553394,DPI-201106,BYBYHCOEAFHGJL,sodium channel activator,ADRB2,broad_id_20170327,Phase 2,,
5832,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5833,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5834,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5835,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5836,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5837,BRD-A64977602,mirtazapine,RONZAEMNMFQXRA,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,broad_id_20170327,Launched,,
5838,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5839,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5840,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5841,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5842,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5843,BRD-A65013509,oxybutynin,XIQVNETUBQGFHX,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
5844,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5845,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5846,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5847,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5848,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5849,BRD-A65280694,molindone,KLPWJLBORRMFGK,dopamine receptor antagonist,DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
5850,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5851,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5852,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5853,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5854,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5855,BRD-A66155091,trilostane,RLQVKDVIBJCQGE,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,broad_id_20170327,Launched,,
5856,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5857,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5858,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5859,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5860,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5861,BRD-A67616246,levomequitazine,HOKDBMAJZXIPGC,histamine receptor antagonist,HRH1,broad_id_20170327,Phase 2,,
5862,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5863,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5864,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5865,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5866,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5867,BRD-K44771174,ibutamoren,UMUPQWIGCOZEOY,growth hormone secretagogue receptor agonist,GHR|GHSR,broad_id_20170327,Phase 2,,
5868,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5869,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5870,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5871,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5872,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5873,BRD-K44827188,vismodegib,BPQMGSKTAYIVFO,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,broad_id_20170327,Launched,,
5874,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5875,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5876,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5877,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5878,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5879,BRD-K45542189,diethylcarbamazine,RCKMWOKWVGPNJF,lipoxygenase inhibitor,ALOX5|PTGS1,broad_id_20170327,Launched,,
5880,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5881,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5882,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5883,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5884,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5885,BRD-K46386702,ARRY-334543,UWXSAYUXVSFDBQ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 2/Phase 3,,
5886,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5887,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5888,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5889,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5890,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5891,BRD-K49111258,prazosin,IENZQIKPVFGBNW,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,broad_id_20170327,Launched,,
5892,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5893,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5894,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5895,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5896,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5897,BRD-K50163129,acrivastine,PWACSDKDOHSSQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
5898,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5899,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5900,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5901,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5902,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5903,BRD-K50168500,canertinib,OMZCMEYTWSXEPZ,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,broad_id_20170327,Phase 3,,
5904,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5905,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5906,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5907,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5908,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5909,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5910,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5911,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5912,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5913,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5914,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5915,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
5916,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5917,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5918,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5919,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5920,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5921,BRD-K50859149,sulfafurazole,NHUHCSRWZMLRLA,bacterial antifolate,,broad_id_20170327,Launched,,
5922,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5923,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5924,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5925,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5926,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5927,BRD-K50938287,sumatriptan,KQKPFRSPSRPDEB,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
5928,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5929,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5930,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5931,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5932,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5933,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5934,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5935,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5936,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5937,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5938,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5939,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
5940,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5941,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5942,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5943,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5944,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5945,BRD-K61691541,PF-03084014,VFCRKLWBYMDAED,gamma secretase inhibitor,,broad_id_20170327,Phase 3,,
5946,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5947,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5948,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5949,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5950,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5951,BRD-K61693562,pyrazinoylguanidine,WNBSDCKJFDZMHT,diuretic,,broad_id_20170327,Phase 1,,
5952,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5953,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5954,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5955,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5956,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5957,BRD-K61988078,moxidectin,YZBLFMPOMVTDJY,chloride channel antagonist,,broad_id_20170327,Launched,,
5958,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5959,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5960,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5961,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5962,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5963,BRD-K62363391,dapsone,MQJKPEGWNLWLTK,bacterial antifolate,DHFR,broad_id_20170327,Launched,,
5964,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5965,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5966,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5967,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5968,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5969,BRD-K62387885,basimglurant,UPZWINBEAHDTLA,glutamate receptor antagonist,GRM5,broad_id_20170327,Phase 2,,
5970,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5971,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5972,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5973,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5974,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5975,BRD-K62391742,venetoclax,LQBVNQSMGBZMKD,BCL inhibitor,BCL2,broad_id_20170327,Launched,,
5976,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5977,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5978,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5979,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5980,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5981,BRD-K62398570,lerisetron,PWWDCRQZITYKDV,serotonin receptor antagonist,HTR3A,broad_id_20170327,Phase 3,,
5982,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5983,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5984,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5985,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5986,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5987,BRD-K62737565,gabapentin,UGJMXCAKCUNAIE,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,broad_id_20170327,Launched,,
5988,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5989,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5990,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5991,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5992,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5993,BRD-K62858456,lomerizine,JQSAYKKFZOSZGJ,calcium channel blocker,CACNA1B|SCN5A,broad_id_20170327,Launched,,
5994,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
5995,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
5996,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
5997,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
5998,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
5999,BRD-K62965247,tipifarnib,PLHJCIYEEKOWNM,farnesyltransferase inhibitor,FNTA|FNTB,broad_id_20170327,Phase 3,,
6000,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6001,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6002,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6003,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6004,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6005,BRD-K62996583,lidoflazine,ZBIAKUMOEKILTF,calcium channel blocker,SCN1A|SCN3A|SLC29A1,broad_id_20170327,Launched,,
6006,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6007,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6008,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6009,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6010,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6011,BRD-K63550407,erythromycin,ULGZDMOVFRHVEP,NFkB pathway inhibitor,MLNR,broad_id_20170327,Launched,,
6012,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6013,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6014,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6015,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6016,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6017,BRD-K63630713,etacrynic-acid,AVOLMBLBETYQHX,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,broad_id_20170327,Launched,,
6018,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6019,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6020,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6021,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6022,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6023,BRD-K63675182,triflupromazine,XSCGXQMFQXDFCW,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,broad_id_20170327,Launched,,
6024,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6025,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6026,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6027,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6028,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6029,BRD-K63861289,molsidomine,XLFWDASMENKTKL,guanylate cyclase stimulant,GUCY1A3,broad_id_20170327,Launched,,
6030,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6031,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6032,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6033,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6034,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6035,BRD-K64504314,dienogest,AZFLJNIPTRTECV,progesterone receptor agonist,PGR,broad_id_20170327,Launched,,
6036,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6037,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6038,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6039,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6040,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6041,BRD-K64538373,Ro-4987655,FIMYFEGKMOCQKT,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 1,,
6042,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6043,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6044,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6045,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6046,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6047,BRD-K64874225,NSC-4644,FVWJYYTZTCVBKE,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,broad_id_20170327,Phase 2,,
6048,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6049,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6050,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6051,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6052,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6053,BRD-K64931368,aminocaproic-acid,SLXKOJJOQWFEFD,plasminogen activator inhibitor,LPA|PLAT|PLG,broad_id_20170327,Launched,,
6054,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6055,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6056,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6057,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6058,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6059,BRD-K65991129,SB-705498,JYILLRHXRVTRSH,TRPV antagonist,TRPV1,broad_id_20170327,Phase 2,,
6060,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6061,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6062,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6063,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6064,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6065,BRD-K65992024,pirenoxine,OKPNYGAWTYOBFZ,AGE inhibitor,,broad_id_20170327,Launched,,
6066,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6067,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6068,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6069,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6070,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6071,BRD-K66035042,mannitol-D,FBPFZTCFMRRESA,diuretic,,broad_id_20170327,Launched,mucolytic agent,
6072,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6073,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6074,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6075,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6076,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6077,BRD-K66937583,lodoxamide,RVGLGHVJXCETIO,histamine receptor antagonist,,broad_id_20170327,Launched,,
6078,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6079,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6080,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6081,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6082,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6083,BRD-K67017579,cilostazol,RRGUKTPIGVIEKM,phosphodiesterase inhibitor,PDE3A|PDE3B,broad_id_20170327,Launched,,
6084,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6085,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6086,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6087,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6088,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6089,BRD-K67043667,altretamine,UUVWYPNAQBNQJQ,DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6090,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6091,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6092,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6093,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6094,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6095,BRD-K67068943,ORE1001,NTCCRGGIJNDEAB,angiotensin converting enzyme inhibitor,ACE2,broad_id_20170327,Phase 1/Phase 2,,
6096,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6097,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6098,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6099,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6100,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6101,BRD-K67080878,milrinone,PZRHRDRVRGEVNW,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,broad_id_20170327,Launched,,
6102,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6103,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6104,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6105,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6106,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6107,BRD-K67525671,ZK-200775,WZMQMKNCWDCCMT,kainate receptor antagonist,,broad_id_20170327,Phase 2,,
6108,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6109,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6110,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6111,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6112,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6113,BRD-K67680372,CI-966,CMHQDSBIBSKHFP,GAT inhibitor,SLC6A1,broad_id_20170327,Phase 1,,
6114,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6115,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6116,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6117,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6118,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6119,BRD-K67783091,haloperidol,LNEPOXFFQSENCJ,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,broad_id_20170327,Launched,,
6120,,,,,,,,,
6121,,,,,,,,,
6122,,,,,,,,,
6123,,,,,,,,,
6124,,,,,,,,,
6125,,,,,,,,,
6126,,,,,,,,,
6127,,,,,,,,,
6128,,,,,,,,,
6129,,,,,,,,,
6130,,,,,,,,,
6131,,,,,,,,,
6132,,,,,,,,,
6133,,,,,,,,,
6134,,,,,,,,,
6135,,,,,,,,,
6136,,,,,,,,,
6137,,,,,,,,,
6138,,,,,,,,,
6139,,,,,,,,,
6140,,,,,,,,,
6141,,,,,,,,,
6142,,,,,,,,,
6143,,,,,,,,,
6144,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6145,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6146,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6147,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6148,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6149,BRD-A36057565,bruceantin,KMCZIPGKKBSLEX,protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
6150,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6151,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6152,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6153,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6154,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6155,BRD-A62035778,scopolamine,STECJAGHUSJQJN,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,broad_id_20170327,Launched,,
6156,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6157,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6158,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6159,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6160,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6161,BRD-A62071884,siguazodan,NUHPODZZKHQQET,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Phase 1,,
6162,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6163,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6164,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6165,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6166,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6167,BRD-A62525898,prednisone,XOFYZVNMUHMLCC,glucocorticoid receptor agonist,HSD11B1|NR3C1,broad_id_20170327,Launched,,
6168,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6169,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6170,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6171,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6172,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6173,BRD-A63310107,miglitol,IBAQFPQHRJAVAV,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,broad_id_20170327,Launched,,
6174,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6175,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6176,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6177,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6178,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6179,BRD-A63752151,fidarestat,WAAPEIZFCHNLKK,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
6180,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6181,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6182,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6183,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6184,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6185,BRD-A64406146,timofibrate,QSNOWCXXECLALL,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,broad_id_20170327,Phase 2,,
6186,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6187,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6188,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6189,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6190,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6191,BRD-A65248799,EMD-53998,IZLRMTJLQCLMKF,phosphodiesterase inhibitor,TNNC1,broad_id_20170327,Phase 1,,
6192,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6193,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6194,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6195,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6196,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6197,BRD-A66419424,ixazomib-citrate,YTXSYWAKVMZICI,proteasome inhibitor,,broad_id_20170327,Launched,,
6198,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6199,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6200,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6201,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6202,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6203,BRD-A67097164,ifosfamide,HOMGKSMUEGBAAB,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,broad_id_20170327,Launched,,
6204,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6205,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6206,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6207,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6208,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6209,BRD-A67479912,progesterone,RJKFOVLPORLFTN,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,broad_id_20170327,Launched,,
6210,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6211,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6212,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6213,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6214,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6215,BRD-A67516570,lafutidine,KMZQAVXSMUKBPD,histamine receptor antagonist,HRH2,broad_id_20170327,Launched,,
6216,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6217,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6218,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6219,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6220,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6221,BRD-K34328244,MF-101,FURUXTVZLHCCNA,estrogen receptor agonist,CYP19A1|XDH,broad_id_20170327,Phase 3,,
6222,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6223,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6224,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6225,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6226,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6227,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6228,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6229,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6230,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6231,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6232,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6233,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6234,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6235,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6236,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6237,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6238,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6239,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6240,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6241,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6242,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6243,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6244,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6245,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6246,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6247,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6248,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6249,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6250,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6251,BRD-K62196610,AVN-944,GYCPCOJTCINIFZ,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Phase 2,,
6252,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6253,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6254,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6255,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6256,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6257,BRD-K62200014,anagrelide,OTBXOEAOVRKTNQ,phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6258,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6259,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6260,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6261,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6262,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6263,BRD-K62277907,PYM50028,GMBQZIIUCVWOCD,neurotrophic agent,,broad_id_20170327,Phase 2,,
6264,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6265,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6266,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6267,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6268,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6269,BRD-K62310379,fluticasone-propionate,WMWTYOKRWGGJOA,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,broad_id_20170327,Launched,,
6270,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6271,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6272,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6273,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6274,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6275,BRD-K62562723,SR-2640,LMPZHLXYBWGGNT,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 2,,
6276,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6277,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6278,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6279,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6280,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6281,BRD-K62627508,idasanutlin,TVTXCJFHQKSQQM,MDM inhibitor,MDM2|TP53,broad_id_20170327,Phase 3,,
6282,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6283,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6284,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6285,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6286,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6287,BRD-K62676709,guanethidine,ACGDKVXYNVEAGU,adrenergic inhibitor,SLC6A2,broad_id_20170327,Launched,,
6288,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6289,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6290,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6291,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6292,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6293,BRD-K62685538,triptorelin,VXKHXGOKWPXYNA,gonadotropin releasing factor hormone receptor agonist,GNRHR,broad_id_20170327,Launched,,
6294,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6295,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6296,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6297,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6298,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6299,BRD-K62734952,arglabin,UVJYAKBJSGRTHA,farnesyltransferase inhibitor,FNTA|NFKB1,broad_id_20170327,Launched,,
6300,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6301,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6302,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6303,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6304,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6305,BRD-K62762455,RU-58841,ARBYGDBJECGMGA,androgen receptor antagonist,AR,broad_id_20170327,Phase 2,,
6306,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6307,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6308,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6309,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6310,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6311,BRD-K63126190,epinephrine,UCTWMZQNUQWSLP,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,broad_id_20170327,Launched,,
6312,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6313,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6314,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6315,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6316,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6317,BRD-K63150726,JTE-907,GRAJFFFXJYFVOC,cannabinoid receptor inverse agonist,CNR2,broad_id_20170327,Phase 1,,
6318,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6319,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6320,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6321,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6322,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6323,BRD-K63178091,telotristat,NCLGDOBQAWBXRA,tryptophan hydroxylase inhibitor,TPH1,broad_id_20170327,Launched,,
6324,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6325,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6326,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6327,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6328,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6329,BRD-K63343048,orlistat,AHLBNYSZXLDEJQ,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,broad_id_20170327,Launched,,
6330,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6331,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6332,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6333,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6334,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6335,BRD-K63430059,methoxsalen,QXKHYNVANLEOEG,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,broad_id_20170327,Launched,,
6336,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6337,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6338,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6339,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6340,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6341,BRD-K63504947,semaxanib,WUWDLXZGHZSWQZ,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
6342,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6343,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6344,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6345,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6346,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6347,BRD-K63736853,acipimox,DJQOOSBJCLSSEY,cholesterol inhibitor,HCAR2,broad_id_20170327,Launched,,
6348,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6349,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6350,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6351,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6352,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6353,BRD-K63828191,raloxifene,GZUITABIAKMVPG,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
6354,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6355,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6356,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6357,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6358,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6359,BRD-K64052750,gefitinib,XGALLCVXEZPNRQ,EGFR inhibitor,EGFR,broad_id_20170327,Launched,,
6360,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6361,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6362,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6363,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6364,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6365,BRD-K64338723,milacemide,GJNNXIYZWIZFRH,monoamine oxidase inhibitor,MAOB,broad_id_20170327,Phase 3,,
6366,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6367,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6368,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6369,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6370,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6371,BRD-K64622987,torcetrapib,CMSGWTNRGKRWGS,cholesteryl ester transfer protein inhibitor,CETP,broad_id_20170327,Phase 3,,
6372,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6373,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6374,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6375,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6376,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6377,BRD-K64755930,etazolate,OPQRBXUBWHDHPQ,phosphodiesterase inhibitor,GABRB3|PDE4A,broad_id_20170327,Phase 2,,
6378,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6379,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6380,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6381,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6382,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6383,BRD-K64785675,TG100-115,UJIAQDJKSXQLIT,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,broad_id_20170327,Phase 1/Phase 2,,
6384,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6385,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6386,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6387,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6388,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6389,BRD-K64800655,PHA-793887,HUXYBQXJVXOMKX,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,broad_id_20170327,Phase 1,,
6390,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6391,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6392,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6393,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6394,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6395,BRD-K64838454,dipraglurant,LZXMUJCJAWVHPZ,glutamate receptor negative allosteric modulator,GRM5,broad_id_20170327,Phase 2,,
6396,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6397,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6398,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6399,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6400,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6401,BRD-K64890080,BI-2536,XQVVPGYIWAGRNI,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
6402,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6403,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6404,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6405,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6406,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6407,BRD-K64925568,AMG-232,DRLCSJFKKILATL,MDM inhibitor,MDM2,broad_id_20170327,Phase 2,,
6408,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6409,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6410,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6411,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6412,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6413,BRD-K65170927,aprepitant,ATALOFNDEOCMKK,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
6414,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6415,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6416,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6417,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6418,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6419,BRD-K65428967,cordycepin,OFEZSBMBBKLLBJ,DNA inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
6420,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6421,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6422,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6423,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6424,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6425,BRD-K65678996,nefiracetam,NGHTXZCKLWZPGK,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,broad_id_20170327,Phase 3,,
6426,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6427,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6428,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6429,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6430,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6431,BRD-K65781196,avanafil,WEAJZXNPAWBCOA,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
6432,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6433,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6434,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6435,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6436,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6437,BRD-K65820248,SDZ-NKT-343,PCVSIMQAFWRUEC,tachykinin antagonist,TACR1,broad_id_20170327,Phase 1,,
6438,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6439,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6440,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6441,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6442,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6443,BRD-K65928735,AZD1480,PDOQBOJDRPLBQU,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 1,,
6444,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6445,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6446,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6447,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6448,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6449,BRD-K66175015,afatinib,ULXXDDBFHOBEHA,EGFR inhibitor,EGFR|ERBB2|ERBB4,broad_id_20170327,Launched,,
6450,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6451,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6452,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6453,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6454,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6455,BRD-K66404838,nalbuphine,NETZHAKZCGBWSS,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
6456,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6457,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6458,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6459,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6460,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6461,BRD-K66412701,pazufloxacin,XAGMUUZPGZWTRP,topoisomerase inhibitor,,broad_id_20170327,Launched,,
6462,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6463,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6464,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6465,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6466,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6467,BRD-K66538826,amuvatinib,FOFDIMHVKGYHRU,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,broad_id_20170327,Phase 2,,
6468,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6469,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6470,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6471,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6472,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6473,BRD-K66615216,moxifloxacin,FABPRXSRWADJSP,bacterial DNA gyrase inhibitor,TOP2A,broad_id_20170327,Launched,,
6474,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6475,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6476,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6477,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6478,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6479,BRD-K66876909,linezolid,TYZROVQLWOKYKF,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,broad_id_20170327,Launched,,
6480,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6481,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6482,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6483,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6484,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6485,BRD-K66911501,MK-3207,AZAANWYREOQRFB,calcitonin antagonist,CALCA,broad_id_20170327,Phase 2,,
6486,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6487,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6488,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6489,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6490,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6491,BRD-K67121414,apixaban,QNZCBYKSOIHPEH,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6492,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6493,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6494,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6495,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6496,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6497,BRD-K67174965,acetylcysteine,PWKSKIMOESPYIA,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,broad_id_20170327,Launched,,
6498,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6499,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6500,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6501,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6502,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6503,BRD-K67277431,picotamide,KYWCWBXGRWWINE,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,broad_id_20170327,Launched,,
6504,,,,,,,,,
6505,,,,,,,,,
6506,,,,,,,,,
6507,,,,,,,,,
6508,,,,,,,,,
6509,,,,,,,,,
6510,,,,,,,,,
6511,,,,,,,,,
6512,,,,,,,,,
6513,,,,,,,,,
6514,,,,,,,,,
6515,,,,,,,,,
6516,,,,,,,,,
6517,,,,,,,,,
6518,,,,,,,,,
6519,,,,,,,,,
6520,,,,,,,,,
6521,,,,,,,,,
6522,,,,,,,,,
6523,,,,,,,,,
6524,,,,,,,,,
6525,,,,,,,,,
6526,,,,,,,,,
6527,,,,,,,,,
6528,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6529,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6530,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6531,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6532,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6533,BRD-A44863528,proglumide,DGMKFQYCZXERLX,CCK receptor antagonist,CCKAR|CCKBR,broad_id_20170327,Withdrawn,,
6534,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6535,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6536,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6537,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6538,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6539,BRD-A46179541,doxapram,XFDJYSQDBULQSI,potassium channel blocker,,broad_id_20170327,Launched,,
6540,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6541,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6542,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6543,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6544,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6545,BRD-A47364545,SK&F-10047-(+),LGQCVMYAEFTEFN,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 1,,
6546,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6547,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6548,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6549,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6550,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6551,BRD-A48237631,mitomycin-C,NWIBSHFKIJFRCO,DNA alkylating agent|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
6552,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6553,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6554,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6555,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6556,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6557,BRD-A48570745,ivermectin,AZSNMRSAGSSBNP,benzodiazepine receptor agonist,CHRNA7|P2RX7,broad_id_20170327,Launched,,
6558,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6559,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6560,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6561,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6562,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6563,BRD-A49160188,donepezil,ADEBPBSSDYVVLD,acetylcholinesterase inhibitor,ACHE,broad_id_20170327,Launched,,
6564,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6565,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6566,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6567,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6568,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6569,BRD-A49399758,desmopressin-acetate,NFLWUMRGJYTJIN,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Launched,,
6570,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6571,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6572,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6573,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6574,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6575,BRD-A49622760,faropenem,HGGAKXAHAYOLDJ,lactamase inhibitor,,broad_id_20170327,Launched,,
6576,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6577,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6578,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6579,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6580,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6581,BRD-A49765801,fludroxycortide,POPFMWWJOGLOIF,glucocorticoid receptor agonist,NR3C1|SERPINA6,broad_id_20170327,Launched,,
6582,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6583,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6584,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6585,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6586,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6587,BRD-A50675702,fipronil,ZOCSXAVNDGMNBV,chloride channel blocker|GABA gated chloride channel blocker,,broad_id_20170327,Launched,,
6588,BRD-K04887706,,,,,,,,
6589,BRD-K04887706,,,,,,,,
6590,BRD-K04887706,,,,,,,,
6591,BRD-K04887706,,,,,,,,
6592,BRD-K04887706,,,,,,,,
6593,BRD-K04887706,,,,,,,,
6594,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6595,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6596,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6597,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6598,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6599,BRD-K44844162,taselisib,BEUQXVWXFDOSAQ,PI3K inhibitor,PIK3CA,broad_id_20170327,Phase 3,,
6600,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6601,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6602,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6603,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6604,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6605,BRD-K44876623,,ZAFYATHCZYHLPB,,,broad_id_20170327,,,
6606,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6607,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6608,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6609,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6610,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6611,BRD-K44942188,fomocaine,CVHGCWVMTZWGAY,voltage-gated sodium channel modulator,,broad_id_20170327,Launched,,
6612,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6613,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6614,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6615,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6616,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6617,BRD-K44974079,ticagrelor,OEKWJQXRCDYSHL,purinergic receptor antagonist,P2RY12,broad_id_20170327,Launched,,
6618,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6619,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6620,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6621,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6622,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6623,BRD-K45033733,famciclovir,GGXKWVWZWMLJEH,DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6624,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6625,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6626,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6627,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6628,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6629,BRD-K45158365,valsartan,ACWBQPMHZXGDFX,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
6630,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6631,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6632,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6633,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6634,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6635,BRD-K45168550,SB-756050,GJUFPAZNBPFNRI,G protein-coupled receptor agonist,GPBAR1,broad_id_20170327,Phase 1,,
6636,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6637,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6638,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6639,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6640,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6641,BRD-K45245728,ursodeoxycholyltaurine,BHTRKEVKTKCXOH,cholesterol inhibitor,,broad_id_20170327,Phase 3,,
6642,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6643,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6644,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6645,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6646,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6647,BRD-K45252063,clofibrate,KNHUKKLJHYUCFP,PPAR receptor agonist,LPL|PPARA,broad_id_20170327,Launched,,
6648,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6649,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6650,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6651,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6652,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6653,BRD-K45330754,diethylstilbestrol,RGLYKWWBQGJZGM,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,broad_id_20170327,Withdrawn,,
6654,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6655,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6656,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6657,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6658,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6659,BRD-K45503887,delivert,CZGUSIXMZVURDU,angiotensin receptor agonist,AGTR1|AGTR2,broad_id_20170327,Launched,,
6660,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6661,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6662,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6663,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6664,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6665,BRD-K45746021,CC-401,XDJCLCLBSGGNKS,JNK inhibitor,MAPK8,broad_id_20170327,Phase 1,,
6666,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6667,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6668,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6669,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6670,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6671,BRD-K46133855,NXY-059,OVTCHWSLKGENKP,free radical scavenger,,broad_id_20170327,Phase 3,,
6672,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6673,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6674,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6675,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6676,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6677,BRD-K46290096,preladenant,DTYWJKSSUANMHD,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Phase 3,,
6678,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6679,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6680,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6681,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6682,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6683,BRD-K46424862,hymecromone,HSHNITRMYYLLCV,monoamine oxidase inhibitor,MAOA|MAOB,broad_id_20170327,Phase 2,,
6684,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6685,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6686,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6687,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6688,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6689,BRD-K46604138,dapagliflozin,JVHXJTBJCFBINQ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
6690,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6691,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6692,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6693,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6694,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6695,BRD-K46654563,zofenopril-calcium,IAIDUHCBNLFXEF,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6696,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6697,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6698,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6699,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6700,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6701,BRD-K46692793,umeclidinium,FVTWTVQXNAJTQP,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,broad_id_20170327,Launched,,
6702,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6703,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6704,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6705,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6706,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6707,BRD-K47095176,talnetant,BIAVGWDGIJKWRM,tachykinin antagonist,TACR2|TACR3,broad_id_20170327,Phase 2,,
6708,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6709,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6710,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6711,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6712,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6713,BRD-K47554101,eperezolid,SIMWTRCFFSTNMG,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Phase 1,,
6714,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6715,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6716,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6717,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6718,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6719,BRD-K47639036,flavoxate,SPIUTQOUKAMGCX,acetylcholine receptor antagonist,CHRM1|CHRM2,broad_id_20170327,Launched,,
6720,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6721,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6722,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6723,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6724,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6725,BRD-K47642186,piclamilast,RRRUXBQSQLKHEL,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Phase 2,,
6726,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6727,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6728,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6729,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6730,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6731,BRD-K47780086,penciclovir,JNTOCHDNEULJHD,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
6732,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6733,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6734,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6735,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6736,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6737,BRD-K48195801,tecastemizole,SFOVDSLXFUGAIV,histamine receptor antagonist,KCNH2,broad_id_20170327,Phase 3,,
6738,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6739,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6740,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6741,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6742,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6743,BRD-K48213016,CC-930,IBGLGMOPHJQDJB,JNK inhibitor,,broad_id_20170327,Phase 2,,
6744,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6745,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6746,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6747,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6748,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6749,BRD-K48300629,zonisamide,UBQNRHZMVUUOMG,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6750,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6751,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6752,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6753,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6754,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6755,BRD-K48367671,febuxostat,BQSJTQLCZDPROO,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
6756,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6757,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6758,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6759,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6760,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6761,BRD-K48461310,fosfomycin,YMDXZJFXQJVXBF,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
6762,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6763,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6764,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6765,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6766,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6767,BRD-K48894757,laropiprant,NXFFJDQHYLNEJK,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,broad_id_20170327,Launched,,
6768,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6769,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6770,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6771,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6772,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6773,BRD-K49075727,nintedanib,XZXHXSATPCNXJR,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
6774,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6775,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6776,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6777,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6778,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6779,BRD-K49215523,GSK2636771,XTKLTGBKIDQGQL,PI3K inhibitor,PIK3CB,broad_id_20170327,Phase 2,,
6780,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6781,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6782,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6783,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6784,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6785,BRD-K49328571,dasatinib,ZBNZXTGUTAYRHI,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,broad_id_20170327,Launched,,
6786,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6787,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6788,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6789,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6790,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6791,BRD-K49350383,thioguanine,WYWHKKSPHMUBEB,purine antagonist,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
6792,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6793,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6794,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6795,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6796,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6797,BRD-K49671696,ketanserin,FPCCSQOGAWCVBH,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,broad_id_20170327,Launched,,
6798,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6799,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6800,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6801,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6802,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6803,BRD-K49685476,TTNPB,FOIVPCKZDPCJJY,retinoid receptor agonist,RARA|RARB|RARG,broad_id_20170327,Phase 1,,
6804,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6805,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6806,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6807,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6808,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6809,BRD-K49807096,benazepril,XPCFTKFZXHTYIP,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
6810,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6811,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6812,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6813,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6814,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6815,BRD-K49840922,etofylline-clofibrate,KYAKGJDISSNVPZ,platelet aggregation inhibitor,PPARA,broad_id_20170327,Launched,,
6816,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6817,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6818,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6819,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6820,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6821,BRD-K49865102,PD-0325901,SUDAHWBOROXANE,MEK inhibitor,MAP2K1,broad_id_20170327,Phase 2,,
6822,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6823,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6824,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6825,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6826,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6827,BRD-K50031829,PF-04447943,IWXUVYOOUMLUTQ,phosphodiesterase inhibitor,PDE9A,broad_id_20170327,Phase 2,,
6828,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6829,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6830,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6831,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6832,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6833,BRD-K50398167,meclofenamic-acid,SBDNJUWAMKYJOX,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,broad_id_20170327,Launched,,
6834,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6835,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6836,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6837,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6838,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6839,BRD-K50422030,clomethiazole,PCLITLDOTJTVDJ,GABA receptor antagonist|GABA receptor modulator,GABRA1,broad_id_20170327,Launched,,
6840,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6841,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6842,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6843,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6844,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6845,BRD-K50498985,taladegib,SZBGQDXLNMELTB,smoothened receptor antagonist,DHH|IHH|SMO,broad_id_20170327,Phase 2,,
6846,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6847,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6848,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6849,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6850,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6851,BRD-K50564936,E-2012,PUOAETJYKQITMO,gamma secretase modulator,APH1A|APH1B|PSENEN,broad_id_20170327,Phase 1,,
6852,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6853,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6854,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6855,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6856,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6857,BRD-K50590187,capsaicin,YKPUWZUDDOIDPM,TRPV agonist,CFTR|TRPV1,broad_id_20170327,Launched,,
6858,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6859,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6860,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6861,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6862,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6863,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6864,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6865,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6866,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6867,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6868,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6869,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
6870,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6871,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6872,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6873,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6874,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6875,BRD-K53508936,CTS-1027,ROSNVSQTEGHUKU,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,broad_id_20170327,Phase 2,,
6876,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6877,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6878,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6879,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6880,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6881,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6882,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6883,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6884,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6885,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6886,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6887,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
6888,,,,,,,,,
6889,,,,,,,,,
6890,,,,,,,,,
6891,,,,,,,,,
6892,,,,,,,,,
6893,,,,,,,,,
6894,,,,,,,,,
6895,,,,,,,,,
6896,,,,,,,,,
6897,,,,,,,,,
6898,,,,,,,,,
6899,,,,,,,,,
6900,,,,,,,,,
6901,,,,,,,,,
6902,,,,,,,,,
6903,,,,,,,,,
6904,,,,,,,,,
6905,,,,,,,,,
6906,,,,,,,,,
6907,,,,,,,,,
6908,,,,,,,,,
6909,,,,,,,,,
6910,,,,,,,,,
6911,,,,,,,,,
6912,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6913,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6914,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6915,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6916,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6917,BRD-A45153512,bimatoprost,AQOKCDNYWBIDND,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,broad_id_20170327,Launched,,
6918,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6919,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6920,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6921,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6922,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6923,BRD-A45889380,mepacrine,GPKJTRJOBQGKQK,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,broad_id_20170327,Launched,,
6924,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6925,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6926,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6927,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6928,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6929,BRD-A50033377,rivaroxaban,KGFYHTZWPPHNLQ,coagulation factor inhibitor,F10,broad_id_20170327,Launched,,
6930,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6931,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6932,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6933,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6934,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6935,BRD-A80151636,bromocriptine,OZVBMTJYIDMWIL,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,broad_id_20170327,Launched,,
6936,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6937,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6938,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6939,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6940,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6941,BRD-A83081521,finasteride,DBEPLOCGEIEOCV,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,broad_id_20170327,Launched,,
6942,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6943,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6944,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6945,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6946,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6947,BRD-A84174393,,ZAHQBPYQBHTECE,,,broad_id_20170327,,,
6948,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6949,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6950,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6951,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6952,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6953,BRD-A84481105,thioridazine,KLBQZWRITKRQQV,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,broad_id_20170327,Withdrawn,,
6954,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6955,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6956,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6957,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6958,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6959,BRD-A84575140,pimobendan,GLBJJMFZWDBELO,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,broad_id_20170327,Launched,,
6960,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6961,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6962,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6963,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6964,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6965,BRD-A86216746,varenicline,JQSHBVHOMNKWFT,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,broad_id_20170327,Launched,,
6966,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6967,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6968,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6969,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6970,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6971,BRD-A87130939,masoprocol,HCZKYJDFEPMADG,lipoxygenase inhibitor,ALOX5,broad_id_20170327,Launched,,
6972,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6973,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6974,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6975,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6976,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6977,BRD-K45071273,tetracaine,GKCBAIGFKIBETG,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
6978,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6979,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6980,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6981,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6982,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6983,BRD-K45117373,Y-26763,IWTCFIIOUXJOOV,potassium channel activator,KCNJ8,broad_id_20170327,Phase 1,,
6984,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6985,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6986,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6987,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6988,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6989,BRD-K45152786,merbarone,GFYRZTLCYQQVHZ,topoisomerase inhibitor,TOP2A,broad_id_20200324,Phase 2,,
6990,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6991,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6992,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6993,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6994,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6995,BRD-K45875383,XBD173,NBMBIEOUVBHEBM,benzodiazepine receptor ligand,TSPO,broad_id_20170327,Phase 2,,
6996,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
6997,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
6998,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
6999,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
7000,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
7001,BRD-K45924332,amrinone,RNLQIBCLLYYYFJ,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,broad_id_20170327,Launched,,
7002,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7003,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7004,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7005,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7006,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7007,BRD-K46018455,bezafibrate,IIBYAHWJQTYFKB,PPAR receptor agonist,PPARA|PPARD|PPARG,broad_id_20170327,Launched,,
7008,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7009,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7010,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7011,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7012,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7013,BRD-K46839850,cinepazide,RCUDFXMNPQNBDU,calcium channel activator,,broad_id_20170327,Withdrawn,,
7014,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7015,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7016,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7017,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7018,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7019,BRD-K46937689,phenazone,VEQOALNAAJBPNY,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7020,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7021,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7022,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7023,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7024,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7025,BRD-K46970505,cefozopran,QDUIJCOKQCCXQY,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
7026,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7027,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7028,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7029,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7030,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7031,BRD-K47000838,cytochalasin-B,GBOGMAARMMDZGR,microtubule inhibitor,ACTB,broad_id_20170327,Phase 2,,
7032,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7033,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7034,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7035,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7036,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7037,BRD-K47869605,podophyllotoxin,YJGVMLPVUAXIQN,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,broad_id_20170327,Launched,,
7038,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7039,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7040,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7041,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7042,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7043,BRD-K47936004,piribedil,OQDPVLVUJFGPGQ,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,broad_id_20170327,Launched,,
7044,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7045,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7046,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7047,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7048,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7049,BRD-K47976015,balapiravir,VKXWOLCNTHXCLF,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
7050,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7051,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7052,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7053,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7054,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7055,BRD-K48068743,teneligliptin,WGRQANOPCQRCME,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7056,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7057,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7058,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7059,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7060,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7061,BRD-K48578705,methyldopa,CJCSPKMFHVPWAR,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,broad_id_20170327,Launched,,
7062,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7063,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7064,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7065,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7066,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7067,BRD-K48722258,dilazep,QVZCXCJXTMIDME,adenosine reuptake inhibitor,SLC29A1,broad_id_20170327,Launched,,
7068,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7069,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7070,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7071,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7072,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7073,BRD-K48812570,macitentan,JGCMEBMXRHSZKX,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
7074,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7075,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7076,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7077,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7078,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7079,BRD-K48892307,sasapyrine,WVYADZUPLLSGPU,NFkB pathway inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
7080,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7081,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7082,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7083,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7084,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7085,BRD-K49404994,levetiracetam,HPHUVLMMVZITSG,calcium channel blocker,CACNA1B|SCN1A|SV2A,broad_id_20170327,Launched,,
7086,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7087,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7088,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7089,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7090,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7091,BRD-K49456274,pilaralisib,QINPEPAQOBZPOF,PI3K inhibitor,,broad_id_20170327,Phase 2,,
7092,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7093,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7094,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7095,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7096,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7097,BRD-K49504902,SEP-227900,MMAIBGHDBYQYDI,D-amino acid oxidase Inhibitor,DAO,broad_id_20170327,Phase 1,,
7098,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7099,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7100,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7101,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7102,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7103,BRD-K49555808,BMS-707035,VNIWZCGZPBJWBI,HIV integrase inhibitor,,broad_id_20170327,Phase 2,,
7104,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7105,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7106,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7107,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7108,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7109,BRD-K50133271,tolfenamic-acid,YEZNLOUZAIOMLT,cyclooxygenase inhibitor|prostanoid receptor antagonist,,broad_id_20170327,Launched,,
7110,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7111,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7112,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7113,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7114,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7115,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7116,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7117,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7118,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7119,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7120,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7121,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7122,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7123,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7124,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7125,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7126,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7127,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7128,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7129,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7130,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7131,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7132,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7133,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7134,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7135,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7136,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7137,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7138,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7139,BRD-K80082640,otamixaban,PFGVNLZDWRZPJW,coagulation factor inhibitor,F10,broad_id_20170327,Phase 3,,
7140,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7141,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7142,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7143,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7144,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7145,BRD-K81795818,exherin,FQVLRGLGWNWPSS,cadherin antagonist,CDH2,broad_id_20170327,Phase 2,,
7146,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7147,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7148,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7149,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7150,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7151,BRD-K82236179,dicoumarol,DOBMPNYZJYQDGZ,NADPH inhibitor,CRYZ|NQO1|VKORC1,broad_id_20170327,Launched,,
7152,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7153,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7154,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7155,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7156,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7157,BRD-K82522873,N6022,YVPGZQLRPAGKLA,alcohol dehydrogenase inhibitor,ADH5,broad_id_20170327,Phase 1/Phase 2,,
7158,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7159,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7160,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7161,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7162,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7163,BRD-K82603084,ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC,PKC inhibitor,,broad_id_20170327,Launched,,
7164,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7165,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7166,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7167,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7168,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7169,BRD-K82928847,ACY-1215,QGZYDVAGYRLSKP,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,broad_id_20170327,Phase 1/Phase 2,,
7170,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7171,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7172,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7173,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7174,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7175,BRD-K83186168,AZD1981,JWYIGNODXSRKGP,CRTH receptor antagonist,PTGDR2,broad_id_20170327,Phase 2,,
7176,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7177,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7178,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7179,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7180,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7181,BRD-K83405785,pimavanserin,RKEWSXXUOLRFBX,serotonin receptor inverse agonist,DRD2|HTR2A,broad_id_20170327,Launched,,
7182,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7183,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7184,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7185,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7186,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7187,BRD-K83508485,FK-888,BFNKQTIJVFGCKQ,tachykinin antagonist,TACR1|TACR2,broad_id_20170327,Phase 2,,
7188,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7189,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7190,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7191,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7192,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7193,BRD-K84011460,nizofenone,WZGBZLHGOVJDET,ion channel antagonist,,broad_id_20170327,Launched,,
7194,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7195,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7196,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7197,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7198,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7199,BRD-K84466663,nelarabine,IXOXBSCIXZEQEQ,DNA synthesis inhibitor|T cell inhibitor,POLA1,broad_id_20170327,Launched,,
7200,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7201,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7202,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7203,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7204,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7205,BRD-K84564571,telatinib,QFCXANHHBCGMAS,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
7206,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7207,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7208,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7209,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7210,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7211,BRD-K84748119,vicriviroc,CNPVJJQCETWNEU,CC chemokine receptor antagonist,CCR5,broad_id_20170327,Phase 3,,
7212,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7213,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7214,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7215,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7216,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7217,BRD-K84925803,T-5224,DALCQQSLNPLQFZ,AP inhibitor,JUN,broad_id_20170327,Phase 2,,
7218,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7219,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7220,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7221,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7222,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7223,BRD-K84986517,darunavir,CJBJHOAVZSMMDJ,HIV protease inhibitor,CYP3A4,broad_id_20170327,Launched,,
7224,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7225,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7226,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7227,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7228,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7229,BRD-K84996356,AZD3514,JMEYDSHPKCSIJC,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
7230,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7231,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7232,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7233,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7234,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7235,BRD-K85090592,pilocarpine,QCHFTSOMWOSFHM,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7236,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7237,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7238,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7239,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7240,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7241,BRD-K85751432,refametinib,RDSACQWTXKSHJT,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Phase 2,,
7242,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7243,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7244,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7245,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7246,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7247,BRD-K85833139,dehydroepiandrosterone,FMGSKLZLMKYGDP,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,broad_id_20170327,Launched,,
7248,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7249,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7250,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7251,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7252,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7253,BRD-K85925969,zalcitabine,WREGKURFCTUGRC,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
7254,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7255,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7256,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7257,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7258,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7259,BRD-K86118762,linsitinib,PKCDDUHJAFVJJB,IGF-1 inhibitor,IGF1R|INSR|INSRR,broad_id_20170327,Phase 3,,
7260,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7261,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7262,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7263,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7264,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7265,BRD-K86892782,edoxudine,XACKNLSZYYIACO,DNA directed DNA polymerase inhibitor,,broad_id_20170327,Launched,,
7266,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7267,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7268,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7269,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7270,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7271,BRD-K86930074,cediranib,XXJWYDDUDKYVKI,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,broad_id_20170327,Phase 3,,
7272,,,,,,,,,
7273,,,,,,,,,
7274,,,,,,,,,
7275,,,,,,,,,
7276,,,,,,,,,
7277,,,,,,,,,
7278,,,,,,,,,
7279,,,,,,,,,
7280,,,,,,,,,
7281,,,,,,,,,
7282,,,,,,,,,
7283,,,,,,,,,
7284,,,,,,,,,
7285,,,,,,,,,
7286,,,,,,,,,
7287,,,,,,,,,
7288,,,,,,,,,
7289,,,,,,,,,
7290,,,,,,,,,
7291,,,,,,,,,
7292,,,,,,,,,
7293,,,,,,,,,
7294,,,,,,,,,
7295,,,,,,,,,
7296,BRD-A62025033,,,,,,,,
7297,BRD-A62025033,,,,,,,,
7298,BRD-A62025033,,,,,,,,
7299,BRD-A62025033,,,,,,,,
7300,BRD-A62025033,,,,,,,,
7301,BRD-A62025033,,,,,,,,
7302,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7303,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7304,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7305,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7306,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7307,BRD-A82395837,ginkgolide-B,SQOJOAFXDQDRGF,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,broad_id_20170327,Phase 3,,
7308,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7309,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7310,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7311,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7312,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7313,BRD-A82396632,miconazole,BYBLEWFAAKGYCD,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,broad_id_20170327,Launched,,
7314,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7315,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7316,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7317,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7318,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7319,BRD-A82772293,mepazine,CBHCDHNUZWWAPP,MALT1 inhibitor (JH),MALT1,broad_id_20170327,Phase 2,,
7320,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7321,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7322,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7323,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7324,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7325,BRD-A85439007,idoxuridine,XQFRJNBWHJMXHO,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,broad_id_20170327,Launched,,
7326,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7327,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7328,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7329,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7330,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7331,BRD-A85548292,piketoprofen,ASFKKFRSMGBFRO,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
7332,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7333,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7334,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7335,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7336,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7337,BRD-A86248581,tetrahydrouridine,UCKYOOZPSJFJIZ,cytidine deaminase inhibitor,CDA,broad_id_20170327,Phase 2,,
7338,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7339,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7340,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7341,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7342,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7343,BRD-A86871940,nicaraven,KTXBOOWDLPUROC,free radical scavenger,,broad_id_20170327,Phase 3,,
7344,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7345,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7346,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7347,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7348,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7349,BRD-K19111024,clofibric-acid,TXCGAZHTZHNUAI,PPAR receptor agonist,PPARA,broad_id_20170327,Launched,,
7350,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7351,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7352,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7353,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7354,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7355,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7356,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7357,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7358,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7359,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7360,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7361,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7362,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7363,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7364,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7365,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7366,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7367,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7368,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7369,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7370,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7371,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7372,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7373,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7374,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7375,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7376,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7377,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7378,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7379,BRD-K80267133,aminosalicylate,WUBBRNOQWQTFEX,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
7380,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7381,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7382,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7383,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7384,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7385,BRD-K80343549,TAK-285,ZYQXEVJIFYIBHZ,EGFR inhibitor,ERBB2,broad_id_20170327,Phase 1,,
7386,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7387,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7388,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7389,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7390,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7391,BRD-K80396088,gliquidone,LLJFMFZYVVLQKT,sulfonylurea,ABCC8|KCNJ10|KCNJ8,broad_id_20170327,Launched,,
7392,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7393,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7394,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7395,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7396,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7397,BRD-K80608265,erteberel,XIESSJVMWNJCGZ,estrogen receptor agonist,ESR1|ESR2,broad_id_20170327,Phase 2,,
7398,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7399,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7400,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7401,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7402,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7403,BRD-K81272440,dantrolene,OZOMQRBLCMDCEG,calcium channel blocker,RYR1|RYR3,broad_id_20170327,Launched,,
7404,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7405,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7406,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7407,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7408,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7409,BRD-K81332461,maxacalcitol,DTXXSJZBSTYZKE,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7410,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7411,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7412,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7413,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7414,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7415,BRD-K81458380,CX-4945,MUOKSQABCJCOPU,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,broad_id_20170327,Phase 1/Phase 2,,
7416,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7417,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7418,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7419,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7420,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7421,BRD-K81473089,tacrine,YLJREFDVOIBQDA,acetylcholinesterase inhibitor,ACHE|BCHE,broad_id_20170327,Launched,,
7422,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7423,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7424,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7425,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7426,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7427,BRD-K81528515,nilotinib,HHZIURLSWUIHRB,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,broad_id_20170327,Launched,,
7428,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7429,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7430,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7431,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7432,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7433,BRD-K81694556,VTP-27999,NXWASIVXQMMPLM,renin inhibitor,REN,broad_id_20170327,Phase 1,,
7434,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7435,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7436,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7437,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7438,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7439,BRD-K81916719,triclabendazole,NQPDXQQQCQDHHW,microtubule inhibitor,DNMT1,broad_id_20170327,Launched,,
7440,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7441,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7442,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7443,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7444,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7445,BRD-K82225283,isosorbide-mononitrate,YWXYYJSYQOXTPL,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7446,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7447,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7448,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7449,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7450,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7451,BRD-K82234479,tramiprosate,SNKZJIOFVMKAOJ,beta amyloid protein neurotoxicity inhibitor,APP,broad_id_20170327,Phase 3,,
7452,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7453,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7454,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7455,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7456,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7457,BRD-K82244583,binimetinib,ACWZRVQXLIRSDF,MEK inhibitor,MAP2K1|MAP2K2,broad_id_20170327,Launched,,
7458,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7459,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7460,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7461,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7462,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7463,BRD-K82467063,SB-271046,LOCQRDBFWSXQQI,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 1,,
7464,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7465,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7466,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7467,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7468,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7469,BRD-K82767007,dazoxiben,XQGZSYKGWHUSDH,thromboxane synthase inhibitor,TBXAS1,broad_id_20170327,Phase 2,,
7470,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7471,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7472,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7473,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7474,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7475,BRD-K82795137,loratadine,JCCNYMKQOSZNPW,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7476,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7477,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7478,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7479,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7480,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7481,BRD-K82846253,repaglinide,FAEKWTJYAYMJKF,insulin secretagogue,ABCC8|KCNJ11|PPARG,broad_id_20170327,Launched,,
7482,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7483,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7484,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7485,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7486,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7487,BRD-K82941592,rosuvastatin,BPRHUIZQVSMCRT,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7488,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7489,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7490,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7491,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7492,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7493,BRD-K82967685,mirodenafil,MIJFNYMSCFYZNY,phosphodiesterase inhibitor,PDE5A,broad_id_20170327,Launched,,
7494,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7495,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7496,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7497,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7498,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7499,BRD-K83057217,doxifluridine,ZWAOHEXOSAUJHY,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
7500,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7501,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7502,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7503,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7504,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7505,BRD-K83699324,NMS-1286937,QHLVBNKYJGBCQJ,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,broad_id_20170327,Phase 2,,
7506,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7507,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7508,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7509,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7510,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7511,BRD-K83720053,avagacestat,XEAOPVUAMONVLA,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 2,,
7512,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7513,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7514,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7515,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7516,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7517,BRD-K83794243,palovarotene,YTFHCXIPDIHOIA,retinoid receptor agonist,RARG,broad_id_20170327,Phase 3,,
7518,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7519,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7520,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7521,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7522,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7523,BRD-K83837640,JNJ-26481585,PAWIYAYFNXQGAP,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,broad_id_20170327,Phase 2,,
7524,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7525,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7526,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7527,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7528,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7529,BRD-K83963101,MLN8054,HHFBDROWDBDFBR,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 1,,
7530,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7531,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7532,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7533,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7534,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7535,BRD-K84091759,candesartan,HTQMVQVXFRQIKW,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
7536,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7537,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7538,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7539,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7540,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7541,BRD-K84163249,ercalcitriol,ZGLHBRQAEXKACO,vitamin D receptor agonist,VDR,broad_id_20170327,Phase 1,,
7542,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7543,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7544,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7545,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7546,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7547,BRD-K84683831,radezolid,BTTNOGHPGJANSW,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,broad_id_20170327,Phase 2,,
7548,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7549,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7550,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7551,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7552,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7553,BRD-K84698278,agomelatine,YJYPHIXNFHFHND,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,broad_id_20170327,Launched,,
7554,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7555,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7556,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7557,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7558,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7559,BRD-K84783599,riociguat,WXXSNCNJFUAIDG,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,broad_id_20170327,Launched,,
7560,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7561,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7562,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7563,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7564,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7565,BRD-K84794093,dideoxyadenosine,WVXRAFOPTSTNLL,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Phase 1,,
7566,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7567,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7568,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7569,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7570,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7571,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW,potassium channel activator,,broad_id_20170327,Phase 2,,
7572,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7573,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7574,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7575,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7576,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7577,BRD-K84810405,almorexant,DKMACHNQISHMDN,orexin receptor antagonist,HCRTR1|HCRTR2,broad_id_20170327,Phase 3,,
7578,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7579,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7580,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7581,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7582,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7583,BRD-K84892605,IOWH032,DSFNLJXHXBIKDS,CFTR channel antagonist,CFTR,broad_id_20170327,Phase 2,,
7584,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7585,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7586,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7587,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7588,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7589,BRD-K85119730,tolbutamide,JLRGJRBPOGGCBT,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,broad_id_20170327,Launched,,
7590,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7591,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7592,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7593,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7594,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7595,BRD-K85307935,novobiocin,YJQPYGGHQPGBLI,bacterial DNA gyrase inhibitor,,broad_id_20170327,Launched,,
7596,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7597,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7598,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7599,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7600,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7601,BRD-K85337334,otilonium,NQHNLNLJPDMBFN,acetylcholine receptor antagonist,CACNA1C,broad_id_20170327,Launched,,
7602,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7603,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7604,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7605,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7606,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7607,BRD-K85406984,sobetirome,QNAZTOHXCZPOSA,thyroid hormone receptor agonist,THRA|THRB,broad_id_20170327,Phase 1/Phase 2,,
7608,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7609,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7610,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7611,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7612,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7613,BRD-K85606544,neratinib,JWNPDZNEKVCWMY,EGFR inhibitor,EGFR|ERBB2|KDR,broad_id_20170327,Launched,,
7614,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7615,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7616,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7617,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7618,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7619,BRD-K85679373,sulbactam,FKENQMMABCRJMK,beta lactamase inhibitor,,broad_id_20170327,Launched,,
7620,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7621,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7622,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7623,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7624,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7625,BRD-K86307448,allopurinol,OFCNXPDARWKPPY,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
7626,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7627,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7628,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7629,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7630,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7631,BRD-K86525559,AZD7762,IAYGCINLNONXHY,CHK inhibitor,CHEK1|CHEK2,broad_id_20170327,Phase 1,,
7632,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7633,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7634,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7635,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7636,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7637,BRD-K86797399,SB-939,JHDKZFFAIZKUCU,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,broad_id_20170327,Phase 3,,
7638,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7639,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7640,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7641,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7642,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7643,BRD-K86816506,PF-04457845,BATCTBJIJJEPHM,FAAH inhibitor,FAAH,broad_id_20170327,Phase 2,,
7644,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7645,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7646,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7647,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7648,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7649,BRD-K86882815,cabergoline,KORNTPPJEAJQIU,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,broad_id_20170327,Launched,,
7650,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7651,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7652,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7653,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7654,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7655,BRD-M80207679,,QCYCDKUNJFKYEI,,,broad_id_20170327,,,
7656,,,,,,,,,
7657,,,,,,,,,
7658,,,,,,,,,
7659,,,,,,,,,
7660,,,,,,,,,
7661,,,,,,,,,
7662,,,,,,,,,
7663,,,,,,,,,
7664,,,,,,,,,
7665,,,,,,,,,
7666,,,,,,,,,
7667,,,,,,,,,
7668,,,,,,,,,
7669,,,,,,,,,
7670,,,,,,,,,
7671,,,,,,,,,
7672,,,,,,,,,
7673,,,,,,,,,
7674,,,,,,,,,
7675,,,,,,,,,
7676,,,,,,,,,
7677,,,,,,,,,
7678,,,,,,,,,
7679,,,,,,,,,
7680,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7681,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7682,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7683,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7684,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7685,BRD-A69275535,pinitol,DSCFFEYYQKSRSV,gamma secretase inhibitor,,broad_id_20170327,Phase 2,,
7686,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7687,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7688,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7689,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7690,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7691,BRD-A69636825,diltiazem,HSUGRBWQSSZJOP,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,broad_id_20170327,Launched,,
7692,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7693,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7694,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7695,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7696,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7697,BRD-A69815203,cyclosporin-A,PMATZTZNYRCHOR,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
7698,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7699,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7700,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7701,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7702,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7703,BRD-A70858459,estramustine,FRPJXPJMRWBBIH,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,broad_id_20170327,Launched,,
7704,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7705,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7706,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7707,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7708,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7709,BRD-A72309220,metergoline,WZHJKEUHNJHDLS,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
7710,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7711,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7712,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7713,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7714,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7715,BRD-A72390365,choline-alfoscerate,SUHOQUVVVLNYQR,acetylcholine precursor,,broad_id_20170327,Launched,,
7716,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7717,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7718,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7719,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7720,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7721,BRD-A73368467,fexofenadine,RWTNPBWLLIMQHL,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
7722,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7723,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7724,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7725,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7726,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7727,BRD-A74980173,gatifloxacin,XUBOMFCQGDBHNK,bacterial DNA gyrase inhibitor,,broad_id_20170327,Withdrawn,,
7728,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7729,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7730,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7731,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7732,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7733,BRD-A81233518,glycopyrrolate,ANGKOCUUWGHLCE,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7734,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7735,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7736,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7737,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7738,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7739,BRD-A82035391,tolvaptan,GYHCTFXIZSNGJT,vasopressin receptor antagonist,AVPR1A|AVPR2,broad_id_20170327,Launched,,
7740,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7741,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7742,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7743,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7744,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7745,BRD-A82156122,saxagliptin,QGJUIPDUBHWZPV,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Launched,,
7746,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7747,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7748,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7749,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7750,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7751,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7752,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7753,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7754,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7755,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7756,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7757,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
7758,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7759,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7760,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7761,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7762,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7763,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7764,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7765,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7766,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7767,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7768,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7769,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
7770,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7771,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7772,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7773,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7774,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7775,BRD-K67789209,adatanserin,HPFLVTSWRFCPCV,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,broad_id_20170327,Phase 2,,
7776,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7777,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7778,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7779,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7780,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7781,BRD-K67844266,pevonedistat,MPUQHZXIXSTTDU,nedd activating enzyme inhibitor,NAE1|UBA3,broad_id_20170327,Phase 3,,
7782,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7783,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7784,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7785,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7786,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7787,BRD-K68103045,CGS-20625,UBLXQFIFWUEVGJ,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20200324,Phase 1,,
7788,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7789,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7790,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7791,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7792,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7793,BRD-K68132782,terbinafine,DOMXUEMWDBAQBQ,fungal squalene epoxidase inhibitor,SQLE,broad_id_20170327,Launched,,
7794,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7795,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7796,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7797,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7798,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7799,BRD-K68164687,epothilone-B,QXRSDHAAWVKZLJ,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 3,,
7800,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7801,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7802,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7803,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7804,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7805,BRD-K68232413,etizolam,VMZUTJCNQWMAGF,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Launched,,
7806,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7807,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7808,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7809,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7810,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7811,BRD-K68488863,ENMD-2076,BLQYVHBZHAISJM,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,broad_id_20170327,Phase 2,,
7812,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7813,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7814,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7815,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7816,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7817,BRD-K68532323,SB-743921,PGXYIBJJCLWJST,kinesin-like spindle protein inhibitor,KIF11,broad_id_20170327,Phase 1/Phase 2,,
7818,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7819,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7820,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7821,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7822,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7823,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT,PKC activator,KCNT2|TRPV4,broad_id_20170327,Phase 2,,
7824,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7825,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7826,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7827,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7828,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7829,BRD-K68693535,lidamidine,RRHJHSBDJDZUGL,adrenergic receptor agonist,,broad_id_20170327,Launched,,
7830,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7831,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7832,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7833,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7834,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7835,BRD-K68747584,PF-03814735,RYYNGWLOYLRZLK,Aurora kinase inhibitor,AURKA|AURKB,broad_id_20170327,Phase 1,,
7836,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7837,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7838,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7839,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7840,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7841,BRD-K68938568,GDC-0152,WZRFLSDVFPIXOV,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,broad_id_20170327,Phase 1,,
7842,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7843,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7844,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7845,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7846,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7847,BRD-K69236721,lumacaftor,UFSKUSARDNFIRC,CFTR channel agonist,CFTR,broad_id_20170327,Launched,,
7848,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7849,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7850,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7851,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7852,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7853,BRD-K69247067,afloqualone,VDOSWXIDETXFET,acetylcholine receptor antagonist,,broad_id_20170327,Launched,,
7854,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7855,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7856,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7857,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7858,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7859,BRD-K70330367,amantadine,DKNWSYNQZKUICI,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,broad_id_20170327,Launched,,
7860,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7861,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7862,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7863,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7864,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7865,BRD-K70358946,aripiprazole,CEUORZQYGODEFX,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,broad_id_20170327,Launched,,
7866,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7867,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7868,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7869,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7870,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7871,BRD-K70401845,erlotinib,AAKJLRGGTJKAMG,EGFR inhibitor,EGFR|NR1I2,broad_id_20170327,Launched,,
7872,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7873,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7874,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7875,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7876,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7877,BRD-K70463136,BAY-87-2243,CDJNNOJINJAXPV,hypoxia inducible factor inhibitor,HIF1A,broad_id_20170327,Phase 1,,
7878,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7879,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7880,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7881,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7882,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7883,BRD-K70557564,zosuquidar,IHOVFYSQUDPMCN,P glycoprotein inhibitor,ABCB1|ABCB4,broad_id_20170327,Phase 3,,
7884,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7885,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7886,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7887,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7888,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7889,BRD-K70778732,trazodone,PHLBKPHSAVXXEF,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,broad_id_20170327,Launched,,
7890,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7891,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7892,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7893,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7894,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7895,BRD-K70912147,CO-102862,MHUUDVZSPFRUSK,sodium channel blocker,SCN4A|SCN9A,broad_id_20170327,Phase 1,,
7896,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7897,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7898,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7899,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7900,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7901,BRD-K70914287,BIBX-1382,FTFRZXFNZVCRSK,EGFR inhibitor,EGFR|ERBB2,broad_id_20170327,Phase 1,,
7902,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7903,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7904,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7905,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7906,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7907,BRD-K71035033,masitinib,WJEOLQLKVOPQFV,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,broad_id_20170327,Launched,,
7908,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7909,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7910,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7911,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7912,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7913,BRD-K71221037,birinapant,PKWRMUKBEYJEIX,XIAP inhibitor,BIRC2|XIAP,broad_id_20170327,Phase 2,,
7914,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7915,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7916,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7917,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7918,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7919,BRD-K71281111,SNX-2112,ZFVRYNYOPQZKDG,HSP inhibitor,,broad_id_20170327,Phase 1,,
7920,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7921,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7922,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7923,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7924,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7925,BRD-K71289571,zafirlukast,YEEZWCHGZNKEEK,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,broad_id_20170327,Launched,,
7926,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7927,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7928,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7929,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7930,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7931,BRD-K71480163,GDC-0068,GRZXWCHAXNAUHY,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,broad_id_20170327,Phase 3,,
7932,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7933,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7934,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7935,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7936,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7937,BRD-K72215350,acexamic-acid,WDSCBUNMANHPFH,5 alpha reductase inhibitor,GAST,broad_id_20170327,Launched,,
7938,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7939,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7940,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7941,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7942,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7943,BRD-K72222507,quinapril,JSDRRTOADPPCHY,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
7944,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7945,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7946,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7947,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7948,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7949,BRD-K72414522,AZD5438,WJRRGYBTGDJBFX,CDK inhibitor,KCNH2,broad_id_20170327,Phase 1,,
7950,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7951,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7952,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7953,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7954,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7955,BRD-K73196317,urapidil,ICMGLRUYEQNHPF,adrenergic receptor antagonist,HTR1A,broad_id_20170327,Launched,,
7956,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7957,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7958,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7959,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7960,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7961,BRD-K73237276,tacalcitol,BJYLYJCXYAMOFT,vitamin D receptor agonist,VDR,broad_id_20170327,Launched,,
7962,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7963,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7964,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7965,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7966,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7967,BRD-K73319509,PF-04217903,PDMUGYOXRHVNMO,c-Met inhibitor,MET,broad_id_20170327,Phase 1,,
7968,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7969,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7970,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7971,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7972,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7973,BRD-K74363950,aclidinium,ASMXXROZKSBQIH,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
7974,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7975,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7976,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7977,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7978,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7979,BRD-K75958547,pitavastatin,VGYFMXBACGZSIL,HMGCR inhibitor,HMGCR,broad_id_20170327,Launched,,
7980,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7981,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7982,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7983,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7984,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7985,BRD-K76908866,CP-724714,LLVZBTWPGQVVLW,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,broad_id_20170327,Phase 2,,
7986,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7987,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7988,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7989,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7990,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7991,BRD-K77908580,entinostat,INVTYAOGFAGBOE,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,broad_id_20170327,Phase 3,,
7992,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7993,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7994,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7995,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7996,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7997,BRD-K79254416,decitabine,XAUDJQYHKZQPEU,DNA methyltransferase inhibitor,DNMT1|DNMT3A,broad_id_20170327,Launched,,
7998,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
7999,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
8000,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
8001,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
8002,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
8003,BRD-K80700417,SGI-1776,MHXGEROHKGDZGO,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,broad_id_20170327,Phase 1,,
8004,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8005,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8006,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8007,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8008,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8009,BRD-K81144366,moxisylyte,VRYMTAVOXVTQEF,adrenergic receptor antagonist,,broad_id_20170327,Withdrawn,,
8010,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8011,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8012,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8013,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8014,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8015,BRD-K81258678,triptolide,DFBIRQPKNDILPW,RNA polymerase inhibitor,RELA,broad_id_20170327,Phase 3,,
8016,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8017,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8018,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8019,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8020,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8021,BRD-K81957469,semagacestat,PKXWXXPNHIWQHW,gamma secretase inhibitor,PSEN1,broad_id_20170327,Phase 3,,
8022,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8023,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8024,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8025,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8026,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8027,BRD-K82135108,elesclomol,BKJIXTWSNXCKJH,oxidative stress inducer,HSPA1A,broad_id_20170327,Phase 3,,
8028,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8029,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8030,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8031,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8032,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8033,BRD-K82677201,almitrine,OBDOVFRMEYHSQB,neurotransmitter agonist,ATP1A1,broad_id_20170327,Launched,,
8034,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8035,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8036,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8037,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8038,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8039,BRD-K82746043,navitoclax,JLYAXFNOILIKPP,BCL inhibitor,BCL2|BCL2L1|BCL2L2,broad_id_20170327,Phase 2,,
8040,,,,,,,,,
8041,,,,,,,,,
8042,,,,,,,,,
8043,,,,,,,,,
8044,,,,,,,,,
8045,,,,,,,,,
8046,,,,,,,,,
8047,,,,,,,,,
8048,,,,,,,,,
8049,,,,,,,,,
8050,,,,,,,,,
8051,,,,,,,,,
8052,,,,,,,,,
8053,,,,,,,,,
8054,,,,,,,,,
8055,,,,,,,,,
8056,,,,,,,,,
8057,,,,,,,,,
8058,,,,,,,,,
8059,,,,,,,,,
8060,,,,,,,,,
8061,,,,,,,,,
8062,,,,,,,,,
8063,,,,,,,,,
8064,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8065,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8066,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8067,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8068,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8069,BRD-A67862938,naftidrofuryl,KBAFPSLPKGSANY,adrenergic receptor antagonist,,broad_id_20170327,Launched,,
8070,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8071,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8072,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8073,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8074,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8075,BRD-A68281735,REV-5901,JRLOEMCOOZSCQP,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,broad_id_20170327,Phase 2,,
8076,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8077,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8078,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8079,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8080,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8081,BRD-A68304895,BTS-54505,WQSACWZKKZPCHN,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Withdrawn,,
8082,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8083,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8084,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8085,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8086,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8087,BRD-A68464583,,ZPXSCAKFGYXMGA,,,broad_id_20170327,,,
8088,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8089,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8090,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8091,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8092,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8093,BRD-A68493689,simeprevir,JTZZSQYMACOLNN,HCV inhibitor,CYP1A2|CYP3A4,broad_id_20170327,Launched,,
8094,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8095,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8096,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8097,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8098,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8099,BRD-A68888262,azelastine,MBUVEWMHONZEQD,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
8100,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8101,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8102,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8103,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8104,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8105,BRD-A68942014,amitifadine,BSMNRYCSBFHEMQ,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 3,,
8106,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8107,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8108,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8109,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8110,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8111,BRD-A70083328,secnidazole,KPQZUUQMTUIKBP,acetylcholinesterase inhibitor|microtubule inhibitor,,broad_id_20170327,Launched,,
8112,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8113,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8114,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8115,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8116,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8117,BRD-A70998768,pinaverium,DDHUTBKXLWCZCO,T-type calcium channel blocker,CACNA1C,broad_id_20170327,Launched,,
8118,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8119,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8120,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8121,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8122,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8123,BRD-A72066420,mifobate,VQHUQHAPWMNBLP,PPAR receptor antagonist,PPARG,broad_id_20170327,Phase 2,,
8124,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8125,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8126,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8127,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8128,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8129,BRD-A72711497,lasalocid,BBMULGJBVDDDNI,bacterial permeability inducer,,broad_id_20170327,Launched,,
8130,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8131,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8132,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8133,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8134,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8135,BRD-K35189033,levonorgestrel,WWYNJERNGUHSAO,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,broad_id_20170327,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1
8136,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8137,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8138,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8139,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8140,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8141,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8142,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8143,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8144,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8145,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8146,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8147,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8148,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8149,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8150,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8151,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8152,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8153,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8154,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8155,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8156,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8157,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8158,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8159,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8160,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8161,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8162,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8163,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8164,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8165,BRD-K67102207,phenylbutyrate,OBKXEAXTFZPCHS,HDAC inhibitor,HDAC1,broad_id_20170327,Launched,,
8166,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8167,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8168,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8169,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8170,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8171,BRD-K67901620,avasimibe,PTQXTEKSNBVPQJ,ACAT inhibitor,CES1,broad_id_20170327,Phase 3,,
8172,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8173,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8174,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8175,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8176,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8177,BRD-K67966701,lisinopril,RLAWWYSOJDYHDC,angiotensin converting enzyme inhibitor,ACE|ACE2,broad_id_20170327,Launched,,
8178,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8179,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8180,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8181,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8182,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8183,BRD-K68065987,MK-2206,ULDXWLCXEDXJGE,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 2,,
8184,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8185,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8186,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8187,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8188,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8189,BRD-K68095457,palmitoylethanolamide,HXYVTAGFYLMHSO,cannabinoid receptor agonist,CNR2|GPR119|GPR55,broad_id_20170327,Launched,,
8190,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8191,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8192,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8193,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8194,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8195,BRD-K68232650,,VPPJLAIAVCUEMN,,,broad_id_20170327,,,
8196,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8197,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8198,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8199,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8200,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8201,BRD-K68346641,amsacrine,XCPGHVQEEXUHNC,topoisomerase inhibitor,KCNH2|TOP2A,broad_id_20170327,Launched,,
8202,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8203,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8204,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8205,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8206,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8207,BRD-K68392338,ZK-93426,VMDUABMKBUKKPG,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,broad_id_20170327,Phase 1,,
8208,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8209,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8210,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8211,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8212,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8213,BRD-K68867920,quetiapine,URKOMYMAXPYINW,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,broad_id_20170327,Launched,,
8214,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8215,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8216,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8217,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8218,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8219,BRD-K68870568,flumatinib,BJCJYEYYYGBROF,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,broad_id_20170327,Phase 3,,
8220,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8221,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8222,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8223,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8224,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8225,BRD-K69001009,golvatinib,UQRCJCNVNUFYDX,VEGFR inhibitor,KDR|MET,broad_id_20170327,Phase 2,,
8226,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8227,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8228,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8229,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8230,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8231,BRD-K69116396,sertindole,GZKLJWGUPQBVJQ,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,broad_id_20170327,Withdrawn,,
8232,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8233,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8234,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8235,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8236,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8237,BRD-K69122748,diacerein,TYNLGDBUJLVSMA,interleukin inhibitor,IL1B,broad_id_20170327,Launched,,
8238,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8239,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8240,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8241,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8242,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8243,BRD-K69726342,atorvastatin,XUKUURHRXDUEBC,HMGCR inhibitor,AHR|DPP4|HMGCR,broad_id_20170327,Launched,,
8244,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8245,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8246,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8247,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8248,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8249,BRD-K69726595,mericitabine,MLESJYFEMSJZLZ,HCV inhibitor,,broad_id_20170327,Phase 2,,
8250,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8251,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8252,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8253,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8254,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8255,BRD-K69776681,volasertib,SXNJFOWDRLKDSF,PLK inhibitor,PLK1,broad_id_20170327,Phase 3,,
8256,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8257,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8258,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8259,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8260,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8261,BRD-K70301465,ibrutinib,XYFPWWZEPKGCCK,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,broad_id_20170327,Launched,,
8262,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8263,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8264,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8265,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8266,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8267,BRD-K70301876,citalopram,WSEQXVZVJXJVFP,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4
8268,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8269,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8270,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8271,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8272,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8273,BRD-K70464547,sertraline,VGKDLMBJGBXTGI,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8274,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8275,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8276,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8277,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8278,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8279,BRD-K70490179,rimcazole,GUDVQJXODNJRIJ,sigma receptor antagonist,SIGMAR1,broad_id_20170327,Phase 1,,
8280,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8281,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8282,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8283,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8284,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8285,BRD-K70505054,,VMXUWOKSQNHOCA,,,broad_id_20170327,,,
8286,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8287,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8288,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8289,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8290,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8291,BRD-K70507123,doxofylline,HWXIGFIVGWUZAO,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
8292,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8293,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8294,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8295,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8296,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8297,BRD-K70511574,HMN-214,OCKHRKSTDPOHEN,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
8298,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8299,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8300,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8301,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8302,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8303,BRD-K70592483,phenylacetylglutamine,JFLIEFSWGNOPJJ,DNA methylase inhibitor|protein synthesis inhibitor,,broad_id_20170327,Phase 2,,
8304,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8305,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8306,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8307,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8308,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8309,BRD-K70610771,VX-222,WPMJNLCLKAKMLA,HCV inhibitor,,broad_id_20170327,Phase 2,,
8310,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8311,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8312,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8313,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8314,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8315,BRD-K70924353,amtolmetin-guacil,CWJNMKKMGIAGDK,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8316,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8317,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8318,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8319,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8320,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8321,BRD-K71058253,luliconazole,YTAOBBFIOAEMLL,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
8322,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8323,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8324,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8325,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8326,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8327,BRD-K71075609,dorzolamide,IAVUPMFITXYVAF,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,broad_id_20170327,Launched,,
8328,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8329,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8330,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8331,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8332,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8333,BRD-K71103788,duloxetine,ZEUITGRIYCTCEM,norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
8334,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8335,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8336,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8337,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8338,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8339,BRD-K71106091,fludarabine-phosphate,GIUYCYHIANZCFB,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
8340,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8341,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8342,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8343,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8344,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8345,BRD-K71164191,KD-023,CZRCFAOMWRAFIC,ACAT inhibitor,ACACA|ACACB,broad_id_20170327,Phase 2,,
8346,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8347,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8348,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8349,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8350,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8351,BRD-K71603915,EVP-6124,SSRDSYXGYPJKRR,acetylcholine receptor agonist,CHRNA7,broad_id_20170327,Phase 3,,
8352,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8353,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8354,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8355,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8356,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8357,BRD-K71799949,carbamazepine,FFGPTBGBLSHEPO,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
8358,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8359,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8360,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8361,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8362,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8363,BRD-K71822263,D-serine,MTCFGRXMJLQNBG,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,broad_id_20170327,Launched,,
8364,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8365,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8366,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8367,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8368,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8369,BRD-K72005722,VT-464,ZBRAJOQFSNYJMF,cytochrome P450 inhibitor,CYP17A1,broad_id_20170327,Phase 2,,
8370,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8371,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8372,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8373,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8374,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8375,BRD-K72029282,probucol,FYPMFJGVHOHGLL,atherogenesis inhibitor,ABCA1|ABCB11|CES1,broad_id_20170327,Launched,,
8376,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8377,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8378,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8379,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8380,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8381,BRD-K72093121,adenosine,OIRDTQYFTABQOQ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,broad_id_20170327,Launched,antiviral,ADA
8382,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8383,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8384,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8385,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8386,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8387,BRD-K72166146,dihydroergotamine,LUZRJRNZXALNLM,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,broad_id_20170327,Launched,,
8388,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8389,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8390,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8391,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8392,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8393,BRD-K72827473,CEP-37440,BCSHRERPHLTPEE,ALK tyrosine kinase receptor inhibitor,ALK,broad_id_20170327,Phase 1,,
8394,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8395,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8396,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8397,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8398,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8399,BRD-K72922393,linsidomine,XZYRDNUZENBYFI,nitric oxide donor,,deprecated_broad_id_20180907,Launched,,
8400,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8401,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8402,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8403,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8404,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8405,BRD-K72951360,valrubicin,ZOCKGBMQLCSHFP,DNA inhibitor|topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8406,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8407,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8408,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8409,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8410,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8411,BRD-K73088654,floxuridine,ODKNJVUHOIMIIZ,DNA synthesis inhibitor,TYMS,broad_id_20170327,Launched,,
8412,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8413,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8414,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8415,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8416,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8417,BRD-K73107279,levamisole,HLFSDGLLUJUHTE,acetylcholine receptor agonist,ALPL,broad_id_20170327,Withdrawn,immunostimulant,ALPPL2|CHRNA3
8418,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8419,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8420,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8421,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8422,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8423,BRD-K73109821,diazoxide,GDLBFKVLRPITMI,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,broad_id_20170327,Launched,,
8424,,,,,,,,,
8425,,,,,,,,,
8426,,,,,,,,,
8427,,,,,,,,,
8428,,,,,,,,,
8429,,,,,,,,,
8430,,,,,,,,,
8431,,,,,,,,,
8432,,,,,,,,,
8433,,,,,,,,,
8434,,,,,,,,,
8435,,,,,,,,,
8436,,,,,,,,,
8437,,,,,,,,,
8438,,,,,,,,,
8439,,,,,,,,,
8440,,,,,,,,,
8441,,,,,,,,,
8442,,,,,,,,,
8443,,,,,,,,,
8444,,,,,,,,,
8445,,,,,,,,,
8446,,,,,,,,,
8447,,,,,,,,,
8448,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8449,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8450,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8451,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8452,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8453,BRD-A20239487,atenolol-(+),METKIMKYRPQLGS,adrenergic receptor antagonist,,broad_id_20170327,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E
8454,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8455,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8456,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8457,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8458,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8459,BRD-A73556557,tagatose,BJHIKXHVCXFQLS,phosphorylase inhibitor,PYGL,broad_id_20170327,Launched,,
8460,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8461,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8462,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8463,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8464,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8465,BRD-A73741725,exemestane,BFYIZQONLCFLEV,aromatase inhibitor,CYP19A1,broad_id_20170327,Launched,,
8466,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8467,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8468,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8469,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8470,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8471,BRD-A74914197,pralatrexate,OGSBUKJUDHAQEA,dihydrofolate reductase inhibitor,DHFR,broad_id_20170327,Launched,,
8472,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8473,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8474,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8475,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8476,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8477,BRD-A75172220,hydrocortisone,JYGXADMDTFJGBT,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,broad_id_20170327,Launched,,
8478,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8479,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8480,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8481,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8482,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8483,BRD-A75726477,clenbuterol,STJMRWALKKWQGH,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,broad_id_20170327,Launched,,
8484,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8485,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8486,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8487,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8488,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8489,BRD-A76747559,rutin,IKGXIBQEEMLURG,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,broad_id_20170327,Launched,,
8490,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8491,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8492,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8493,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8494,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8495,BRD-A78341343,regadenoson,LZPZPHGJDAGEJZ,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,broad_id_20170327,Launched,,
8496,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8497,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8498,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8499,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8500,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8501,BRD-A78723049,cefotetan,SRZNHPXWXCNNDU,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Launched,,
8502,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8503,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8504,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8505,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8506,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8507,BRD-A79431551,3-deazaadenosine,DBZQFUNLCALWDY,adenosylhomocysteinase inhibitor,AHCY,broad_id_20170327,Phase 2,,
8508,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8509,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8510,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8511,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8512,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8513,BRD-A79768653,sirolimus,QFJCIRLUMZQUOT,mTOR inhibitor,FKBP1A|MTOR,broad_id_20170327,Launched,,
8514,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8515,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8516,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8517,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8518,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8519,BRD-K45275534,betrixaban,XHOLNRLADUSQLD,coagulation factor inhibitor,KCNH2,broad_id_20170327,Launched,,
8520,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8521,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8522,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8523,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8524,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8525,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8526,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8527,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8528,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8529,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8530,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8531,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8532,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8533,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8534,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8535,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8536,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8537,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8538,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8539,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8540,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8541,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8542,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8543,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8544,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8545,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8546,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8547,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8548,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8549,BRD-K73524797,ST-1859,ZPANWZBSGMDWON,antiamyloidogenic agent,,broad_id_20170327,Phase 1,,
8550,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8551,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8552,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8553,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8554,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8555,BRD-K73541271,etofenamate,XILVEPYQJIOVNB,cyclooxygenase inhibitor,PTGS1|PTGS2,broad_id_20170327,Launched,,
8556,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8557,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8558,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8559,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8560,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8561,BRD-K73794685,azithromycin,MQTOSJVFKKJCRP,bacterial 50S ribosomal subunit inhibitor,MLNR,broad_id_20170327,Launched,,
8562,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8563,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8564,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8565,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8566,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8567,BRD-K74065929,doramapimod,MVCOAUNKQVWQHZ,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,broad_id_20170327,Phase 2,,
8568,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8569,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8570,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8571,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8572,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8573,BRD-K74141488,naftifine,OZGNYLLQHRPOBR,fungal squalene epoxidase inhibitor,,broad_id_20170327,Launched,,
8574,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8575,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8576,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8577,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8578,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8579,BRD-K74190368,resorcinol,GHMLBKRAJCXXBS,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,broad_id_20170327,Launched,,
8580,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8581,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8582,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8583,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8584,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8585,BRD-K74195153,irsogladine,ATCGGEJZONJOCL,phosphodiesterase inhibitor,PDE4A,broad_id_20170327,Launched,,
8586,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8587,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8588,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8589,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8590,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8591,BRD-K74305673,IKK-2-inhibitor-V,CHILCFMQWMQVAL,IKK inhibitor|NFkB pathway inhibitor,IKBKB,broad_id_20170327,Phase 1,,
8592,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8593,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8594,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8595,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8596,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8597,BRD-K74339692,tamsulosin,DRHKJLXJIQTDTD,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8598,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8599,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8600,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8601,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8602,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8603,BRD-K74371986,NSI-189,DYTOQURYRYYNOR,neurotrophic agent,,broad_id_20170327,Phase 2,,
8604,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8605,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8606,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8607,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8608,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8609,BRD-K74763371,bosentan,GJPICJJJRGTNOD,endothelin receptor antagonist,EDNRA|EDNRB,broad_id_20170327,Launched,,
8610,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8611,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8612,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8613,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8614,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8615,BRD-K74765201,tomelukast,MWYHLEQJTQJHSS,leukotriene receptor antagonist,CYSLTR1,broad_id_20170327,Phase 3,,
8616,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8617,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8618,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8619,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8620,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8621,BRD-K75037734,carbachol,VPJXQGSRWJZDOB,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,broad_id_20170327,Launched,,
8622,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8623,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8624,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8625,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8626,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8627,BRD-K75089421,procainamide,REQCZEXYDRLIBE,sodium channel blocker,DNMT1|SCN5A,broad_id_20170327,Launched,,
8628,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8629,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8630,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8631,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8632,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8633,BRD-K75295174,alisertib,ZLHFILGSQDJULK,Aurora kinase inhibitor,AURKA,broad_id_20170327,Phase 3,,
8634,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8635,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8636,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8637,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8638,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8639,BRD-K75699339,rizatriptan,ULFRLSNUDGIQQP,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,broad_id_20170327,Launched,,
8640,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8641,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8642,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8643,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8644,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8645,BRD-K75844781,mCPP,VHFVKMTVMIZMIK,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,broad_id_20170327,Phase 2,,
8646,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8647,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8648,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8649,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8650,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8651,BRD-K75911534,SU014813,CTNPALGJUAXMMC,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,broad_id_20170327,Phase 2,,
8652,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8653,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8654,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8655,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8656,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8657,BRD-K76022557,(R)-(-)-apomorphine,VMWNQDUVQKEIOC,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,broad_id_20170327,Launched,,
8658,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8659,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8660,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8661,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8662,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8663,BRD-K76197012,ulipristal,OOLLAFOLCSJHRE,progesterone receptor antagonist,PGR,broad_id_20170327,Launched,,
8664,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8665,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8666,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8667,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8668,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8669,BRD-K76205745,losartan,PSIFNNKUMBGKDQ,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8670,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8671,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8672,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8673,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8674,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8675,BRD-K76775527,nimesulide,HYWYRSMBCFDLJT,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,broad_id_20170327,Launched,,
8676,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8677,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8678,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8679,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8680,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8681,BRD-K76810206,nicergoline,YSEXMKHXIOCEJA,adrenergic receptor antagonist,ADRA1A,broad_id_20170327,Launched,,
8682,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8683,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8684,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8685,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8686,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8687,BRD-K76812510,metamizole,LVWZTYCIRDMTEY,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,broad_id_20170327,Withdrawn,,
8688,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8689,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8690,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8691,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8692,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8693,BRD-K76841105,tazarotene,OGQICQVSFDPSEI,retinoid receptor agonist,RARA|RARB|RARG|RXRB,broad_id_20170327,Launched,,
8694,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8695,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8696,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8697,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8698,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8699,BRD-K76953762,indoramin,JXZZEXZZKAWDSP,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
8700,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8701,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8702,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8703,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8704,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8705,BRD-K77396579,NVP-DPP728,VFFZWMWTUSXDCB,dipeptidyl peptidase inhibitor,DPP4,broad_id_20170327,Phase 2,,
8706,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8707,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8708,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8709,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8710,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8711,BRD-K77695569,tiabendazole,WJCNZQLZVWNLKY,angiogenesis inhibitor,,broad_id_20170327,Launched,,
8712,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8713,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8714,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8715,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8716,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8717,BRD-K77947974,fluspirilene,QOYHHIBFXOOADH,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
8718,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8719,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8720,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8721,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8722,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8723,BRD-K78010432,furosemide,ZZUFCTLCJUWOSV,diuretic,CA2|GPR35|SLC12A1|SLC12A2,broad_id_20170327,Launched,,
8724,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8725,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8726,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8727,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8728,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8729,BRD-K78055238,LY2090314,HRJWTAWVFDCTGO,glycogen synthase kinase inhibitor,GSK3B,broad_id_20170327,Phase 2,,
8730,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8731,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8732,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8733,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8734,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8735,BRD-K78096648,oxiperomide,NVDBBGBUTKLRSN,dopamine receptor antagonist,,broad_id_20170327,Phase 2,,
8736,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8737,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8738,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8739,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8740,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8741,BRD-K78113049,enoxacin,IDYZIJYBMGIQMJ,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,,
8742,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8743,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8744,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8745,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8746,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8747,BRD-K78431006,crizotinib,KTEIFNKAUNYNJU,ALK tyrosine kinase receptor inhibitor,ALK|MET,broad_id_20170327,Launched,MTH1 inhibitor,NUDT1
8748,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8749,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8750,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8751,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8752,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8753,BRD-K78485176,olmesartan-medoxomil,UQGKUQLKSCSZGY,angiotensin receptor antagonist,AGTR1,broad_id_20170327,Launched,,
8754,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8755,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8756,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8757,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8758,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8759,BRD-K78513633,lonidamine,WDRYRZXSPDWGEB,glucokinase inhibitor,GCK,broad_id_20170327,Launched,,
8760,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8761,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8762,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8763,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8764,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8765,BRD-K78567475,dolastatin-10,OFDNQWIFNXBECV,tubulin polymerization inhibitor,TUBB,broad_id_20170327,Phase 2,,
8766,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8767,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8768,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8769,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8770,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8771,BRD-K78659596,ixazomib,MXAYKZJJDUDWDS,proteasome inhibitor,,broad_id_20170327,Launched,,
8772,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8773,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8774,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8775,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8776,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8777,BRD-K78692225,leflunomide,VHOGYURTWQBHIL,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,broad_id_20170327,Launched,,
8778,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8779,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8780,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8781,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8782,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8783,BRD-K79404599,enzastaurin,AXRCEOKUDYDWLF,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,broad_id_20170327,Phase 3,,
8784,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8785,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8786,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8787,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8788,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8789,BRD-K79501723,cyclizine,UVKZSORBKUEBAZ,histamine receptor modulator,HRH1|SULT1E1,broad_id_20170327,Launched,,
8790,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8791,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8792,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8793,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8794,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8795,BRD-K79595931,bavisant,BGBVSGSIXIIREO,histamine receptor antagonist,HRH3,broad_id_20170327,Phase 2,,
8796,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8797,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8798,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8799,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8800,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8801,BRD-K79602928,metformin,XZWYZXLIPXDOLR,insulin sensitizer,ACACB|PRKAB1,broad_id_20170327,Launched,,
8802,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8803,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8804,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8805,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8806,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8807,BRD-K79759585,sildenafil,BNRNXUUZRGQAQC,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,broad_id_20170327,Launched,,
8808,,,,,,,,,
8809,,,,,,,,,
8810,,,,,,,,,
8811,,,,,,,,,
8812,,,,,,,,,
8813,,,,,,,,,
8814,,,,,,,,,
8815,,,,,,,,,
8816,,,,,,,,,
8817,,,,,,,,,
8818,,,,,,,,,
8819,,,,,,,,,
8820,,,,,,,,,
8821,,,,,,,,,
8822,,,,,,,,,
8823,,,,,,,,,
8824,,,,,,,,,
8825,,,,,,,,,
8826,,,,,,,,,
8827,,,,,,,,,
8828,,,,,,,,,
8829,,,,,,,,,
8830,,,,,,,,,
8831,,,,,,,,,
8832,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8833,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8834,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8835,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8836,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8837,BRD-A73908300,EX-527,FUZYTVDVLBBXDL,SIRT inhibitor,SIRT1,broad_id_20170327,Phase 2,,
8838,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8839,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8840,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8841,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8842,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8843,BRD-A74391928,ibutilide,ALOBUEHUHMBRLE,potassium channel blocker,CACNA1C|KCNH2,broad_id_20170327,Launched,,
8844,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8845,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8846,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8847,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8848,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8849,BRD-A74667430,etodolac,NNYBQONXHNTVIJ,cyclooxygenase inhibitor,PTGS2,broad_id_20170327,Launched,,
8850,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8851,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8852,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8853,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8854,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8855,BRD-A75305484,anidulafungin,JHVAMHSQVVQIOT,"fungal 1,3-beta-D-glucan synthase inhibitor",,broad_id_20170327,Launched,,
8856,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8857,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8858,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8859,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8860,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8861,BRD-A75479906,rimantadine,UBCHPRBFMUDMNC,antiviral|RNA synthesis inhibitor,,broad_id_20170327,Launched,,
8862,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8863,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8864,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8865,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8866,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8867,BRD-A78195072,imexon,BIXBBIPTYBJTRY,apoptosis stimulant|ribonucleotide reductase inhibitor,,broad_id_20170327,Phase 2,,
8868,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8869,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8870,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8871,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8872,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8873,BRD-A78877355,nefopam,RGPDEAGGEXEMMM,cyclooxygenase inhibitor,,broad_id_20170327,Launched,,
8874,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8875,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8876,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8877,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8878,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8879,BRD-A79981887,midodrine,PTKSEFOSCHHMPD,adrenergic receptor agonist,,broad_id_20170327,Launched,,
8880,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8881,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8882,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8883,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8884,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8885,BRD-A80017228,bendroflumethiazide,HDWIHXWEUNVBIY,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,broad_id_20170327,Launched,,
8886,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8887,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8888,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8889,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8890,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8891,BRD-A82522119,tibolone,WZDGZWOAQTVYBX,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,broad_id_20170327,Launched,,
8892,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8893,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8894,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8895,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8896,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8897,BRD-A89175223,bisoprolol,VHYCDWMUTMEGQY,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
8898,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8899,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8900,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8901,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8902,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8903,BRD-A90799790,isradipine,HMJIYCCIJYRONP,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,broad_id_20170327,Launched,,
8904,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8905,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8906,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8907,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8908,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8909,BRD-A97701745,pindolol,JZQKKSLKJUAGIC,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,broad_id_20170327,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A
8910,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8911,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8912,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8913,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8914,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8915,BRD-A98702003,carbenoxolone,OBZHEBDUNPOCJG,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,broad_id_20170327,Launched,,
8916,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8917,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8918,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8919,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8920,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8921,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8922,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8923,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8924,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8925,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8926,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8927,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
8928,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8929,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8930,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8931,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8932,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8933,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8934,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8935,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8936,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8937,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8938,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8939,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
8940,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8941,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8942,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8943,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8944,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8945,BRD-K73381542,phenylephrine,SONNWYBIRXJNDC,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,broad_id_20170327,Launched,,
8946,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8947,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8948,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8949,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8950,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8951,BRD-K73440166,cinaciguat,WPYWMXNXEZFMAK,guanylate cyclase activator,GUCY1A3|GUCY1B3,broad_id_20170327,Phase 2,,
8952,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8953,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8954,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8955,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8956,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8957,BRD-K73815512,HC-030031,HEQDZPHDVAOBLN,TRPA1 channel blocker,TRPA1,broad_id_20170327,Phase 1,,
8958,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8959,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8960,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8961,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8962,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8963,BRD-K73999723,telmisartan,RMMXLENWKUUMAY,angiotensin receptor antagonist,AGTR1|PPARG,broad_id_20170327,Launched,,
8964,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8965,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8966,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8967,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8968,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8969,BRD-K74057757,indibulin,SOLIIYNRSAWTSQ,tubulin polymerization inhibitor,,broad_id_20170327,Phase 1/Phase 2,,
8970,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8971,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8972,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8973,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8974,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8975,BRD-K74514084,pazopanib,CUIHSIWYWATEQL,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,broad_id_20170327,Launched,,
8976,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8977,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8978,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8979,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8980,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8981,BRD-K74717603,etravirine,PYGWGZALEOIKDF,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,broad_id_20170327,Launched,,
8982,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8983,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8984,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8985,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8986,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8987,BRD-K75641298,metoclopramide,TTWJBBZEZQICBI,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,broad_id_20170327,Launched,,
8988,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8989,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8990,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8991,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8992,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8993,BRD-K75649340,tioguanine,OTDJAMXESTUWLO,purine antagonist,,broad_id_20170327,Launched,,
8994,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
8995,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
8996,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
8997,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
8998,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
8999,BRD-K76210423,resiquimod,BXNMTOQRYBFHNZ,toll-like receptor agonist,TLR7|TLR8,broad_id_20170327,Phase 3,,
9000,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9001,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9002,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9003,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9004,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9005,BRD-K76617868,fasudil,NGOGFTYYXHNFQH,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,broad_id_20170327,Launched,,
9006,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9007,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9008,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9009,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9010,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9011,BRD-K76674262,homoharringtonine,HYFHYPWGAURHIV,protein synthesis inhibitor,RPL3,broad_id_20170327,Launched,,
9012,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9013,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9014,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9015,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9016,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9017,BRD-K77561571,topiroxostat,UBVZQGOVTLIHLH,xanthine oxidase inhibitor,XDH,broad_id_20170327,Launched,,
9018,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9019,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9020,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9021,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9022,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9023,BRD-K77625799,vandetanib,UHTHHESEBZOYNR,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,broad_id_20170327,Launched,,
9024,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9025,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9026,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9027,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9028,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9029,BRD-K77641333,naphazoline,CNIIGCLFLJGOGP,adrenergic receptor agonist,ADRA1A|ADRA2A,broad_id_20170327,Launched,,
9030,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9031,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9032,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9033,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9034,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9035,BRD-K77685957,dequalinium,PCSWXVJAIHCTMO,PKC inhibitor,KCNN1|KCNN3,broad_id_20170327,Launched,,
9036,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9037,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9038,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9039,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9040,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9041,BRD-K78118466,LY2157299,IVRXNBXKWIJUQB,TGF beta receptor inhibitor,TGFBR1,broad_id_20170327,Phase 2/Phase 3,,
9042,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9043,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9044,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9045,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9046,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9047,BRD-K78126613,menadione,MJVAVZPDRWSRRC,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,broad_id_20170327,Launched,,
9048,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9049,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9050,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9051,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9052,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9053,BRD-K78303961,glycitein,DXYUAIFZCFRPTH,tumor necrosis factor release inhibitor,TNF,broad_id_20170327,Phase 3,,
9054,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9055,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9056,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9057,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9058,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9059,BRD-K79095980,broxuridine,WOVKYSAHUYNSMH,antimetabolite,,broad_id_20170327,Phase 2,,
9060,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9061,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9062,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9063,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9064,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9065,BRD-K79102359,idalopirdine,YBAWYTYNMZWMMJ,serotonin receptor antagonist,HTR6,broad_id_20170327,Phase 3,,
9066,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9067,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9068,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9069,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9070,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9071,BRD-K79131256,albendazole,HXHWSAZORRCQMX,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,broad_id_20170327,Launched,,
9072,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9073,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9074,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9075,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9076,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9077,BRD-K79989959,nesbuvir,WTDWVLJJJOTABN,RNA polymerase inhibitor,,broad_id_20170327,Phase 2,,
9078,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9079,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9080,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9081,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9082,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9083,BRD-K80043866,sodium-gualenate,VIZXMHCBZLGUET,antacid,,broad_id_20170327,Launched,,
9084,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9085,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9086,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9087,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9088,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9089,BRD-K88544581,CI-976,WAFNZAURAWBNDZ,ACAT inhibitor,ACAT1|CES1,broad_id_20170327,Phase 1,,
9090,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9091,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9092,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9093,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9094,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9095,BRD-K90333595,phentolamine,MRBDMNSDAVCSSF,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9096,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9097,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9098,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9099,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9100,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9101,BRD-K91301684,noscapine,AKNNEGZIBPJZJG,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,broad_id_20170327,Launched,,
9102,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9103,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9104,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9105,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9106,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9107,BRD-K91336023,mesulergine,JLVHTNZNKOSCNB,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,broad_id_20170327,Phase 2,,
9108,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9109,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9110,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9111,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9112,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9113,BRD-K91456750,sacubitril,PYNXFZCZUAOOQC,neprilysin inhibitor,MME,broad_id_20170327,Launched,,
9114,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9115,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9116,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9117,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9118,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9119,BRD-K91822704,torcitabine,CKTSBUTUHBMZGZ,DNA polymerase inhibitor,DCK|TK2,broad_id_20170327,Phase 2,,
9120,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9121,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9122,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9123,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9124,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9125,BRD-K92213669,lomitapide,MBBCVAKAJPKAKM,microsomal trigylceride transfer protein inhibitor,MTTP,broad_id_20170327,Launched,,
9126,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9127,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9128,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9129,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9130,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9131,BRD-K92241597,tosedostat,FWFGIHPGRQZWIW,peptidase inhibitor,ANPEP|LAP3|NPEPPS,broad_id_20170327,Phase 2,,
9132,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9133,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9134,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9135,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9136,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9137,BRD-K96194081,cepharanthine,YVPXVXANRNDGTA,NFkB pathway inhibitor,,broad_id_20170327,Phase 2,,
9138,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9139,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9140,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9141,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9142,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9143,BRD-K97729603,pimecrolimus,KASDHRXLYQOAKZ,calcineurin inhibitor,,broad_id_20170327,Launched,,
9144,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9145,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9146,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9147,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9148,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9149,BRD-K97746869,chlorpropamide,RKWGIWYCVPQPMF,ATP channel blocker,ABCC8|KCNJ10,broad_id_20170327,Launched,,
9150,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9151,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9152,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9153,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9154,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9155,BRD-K97799481,aminophylline,ZFXYFBGIUFBOJW,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,broad_id_20170327,Launched,,
9156,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9157,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9158,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9159,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9160,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9161,BRD-K98493452,honokiol,FVYXIJYOAGAUQK,AKT inhibitor,ALOX5|PTGS1|PTGS2,broad_id_20170327,Phase 3,,
9162,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9163,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9164,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9165,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9166,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9167,BRD-K98530306,clonidine,GJSURZIOUXUGAL,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,broad_id_20170327,Launched,,
9168,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9169,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9170,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9171,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9172,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9173,BRD-K98624455,bepotastine,YWGDOWXRIALTES,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9174,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9175,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9176,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9177,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9178,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9179,BRD-K98733875,baicalin,DAIGSUHCWOZEQG,beta glucuronidase inhibitor,PREP,deprecated_broad_id_20200324,Launched,,
9180,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9181,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9182,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9183,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9184,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9185,BRD-K99113996,AZD2014,JUSFANSTBFGBAF,mTOR inhibitor,MTOR,broad_id_20170327,Phase 2,,
9186,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9187,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9188,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9189,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9190,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9191,BRD-K99475619,genz-644282,BAORCAMWLWRZQG,topoisomerase inhibitor,TOP1,broad_id_20170327,Phase 1,,
9192,,,,,,,,,
9193,,,,,,,,,
9194,,,,,,,,,
9195,,,,,,,,,
9196,,,,,,,,,
9197,,,,,,,,,
9198,,,,,,,,,
9199,,,,,,,,,
9200,,,,,,,,,
9201,,,,,,,,,
9202,,,,,,,,,
9203,,,,,,,,,
9204,,,,,,,,,
9205,,,,,,,,,
9206,,,,,,,,,
9207,,,,,,,,,
9208,,,,,,,,,
9209,,,,,,,,,
9210,,,,,,,,,
9211,,,,,,,,,
9212,,,,,,,,,
9213,,,,,,,,,
9214,,,,,,,,,
9215,,,,,,,,,
9216,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9217,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9218,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9219,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9220,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9221,BRD-A05457250,BAY-K-8644-(+/-),ZFLWDHHVRRZMEI,L-type calcium channel blocker,,broad_id_20170327,Preclinical,L-type calcium channel activator,CACNA1C
9222,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9223,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9224,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9225,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9226,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9227,BRD-A15931911,bucladesine,CJGYSWNGNKCJSB,adenosine receptor agonist|cAMP stimulant,PRKACA,broad_id_20170327,Launched,,
9228,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9229,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9230,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9231,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9232,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9233,BRD-A20348246,chlormezanone,WEQAYVWKMWHEJO,GABA receptor modulator,GABRA1,broad_id_20170327,Withdrawn,,
9234,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9235,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9236,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9237,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9238,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9239,BRD-A65051990,acenocoumarol,VABCILAOYCMVPS,vitamin K antagonist,VKORC1,broad_id_20170327,Launched,,
9240,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9241,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9242,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9243,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9244,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9245,BRD-A87435144,AZD7545,DTDZLJHKVNTQGZ,pyruvate dehydrogenase kinase inhibitor,PDK1,broad_id_20170327,Phase 1,,
9246,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9247,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9248,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9249,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9250,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9251,BRD-A87479750,tenidap,IGPDWKCUDHIIRL,cyclooxygenase inhibitor,KCNJ4|PTGS1,broad_id_20170327,Phase 3,,
9252,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9253,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9254,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9255,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9256,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9257,BRD-A88138582,halcinonide,MUQNGPZZQDCDFT,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,,
9258,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9259,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9260,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9261,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9262,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9263,BRD-A89164055,sorbinil,LXANPKRCLVQAOG,aldose reductase inhibitor,AKR1B1,broad_id_20170327,Phase 3,,
9264,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9265,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9266,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9267,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9268,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9269,BRD-A90547603,eptifibatide,CZKPOZZJODAYPZ,platelet aggregation inhibitor,ITGA2B|ITGB3,broad_id_20170327,Launched,,
9270,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9271,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9272,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9273,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9274,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9275,BRD-A90625545,clinofibrate,BMOVQUBVGICXQN,lipase clearing factor inhibitor,LPL,broad_id_20170327,Launched,,
9276,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9277,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9278,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9279,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9280,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9281,BRD-A91699651,chloroquine,WHTVZRBIWZFKQO,antimalarial agent,MRGPRX1,broad_id_20170327,Launched,,
9282,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9283,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9284,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9285,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9286,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9287,BRD-A91877226,capecitabine,GAGWJHPBXLXJQN,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9288,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9289,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9290,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9291,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9292,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9293,BRD-A98845662,desvenlafaxine,KYYIDSXMWOZKMP,serotoninânorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Launched,,
9294,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9295,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9296,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9297,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9298,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9299,BRD-A98990573,epinastine,WHWZLSFABNNENI,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9300,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9301,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9302,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9303,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9304,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9305,BRD-A99939097,,OFZCIYFFPZCNJE,,,broad_id_20170327,,,
9306,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9307,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9308,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9309,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9310,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9311,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9312,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9313,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9314,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9315,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9316,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9317,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9318,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9319,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9320,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9321,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9322,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9323,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9324,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9325,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9326,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9327,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9328,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9329,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9330,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9331,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9332,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9333,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9334,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9335,BRD-K87156652,carbimazole,CFOYWRHIYXMDOT,antithyroid agent,TPO,broad_id_20170327,Launched,,
9336,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9337,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9338,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9339,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9340,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9341,BRD-K87300616,chenodeoxycholic-acid,RUDATBOHQWOJDD,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,broad_id_20170327,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4
9342,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9343,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9344,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9345,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9346,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9347,BRD-K87737963,cyt387,ZVHNDZWQTBEVRY,JAK inhibitor,JAK1|JAK2|JAK3,broad_id_20170327,Phase 3,,
9348,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9349,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9350,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9351,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9352,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9353,BRD-K87782578,AVL-292,KXBDTLQSDKGAEB,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,broad_id_20170327,Phase 2,,
9354,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9355,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9356,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9357,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9358,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9359,BRD-K87909389,alvocidib,BIIVYFLTOXDAOV,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,broad_id_20170327,Phase 2,,
9360,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9361,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9362,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9363,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9364,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9365,BRD-K88358234,xaliproden,WJJYZXPHLSLMGE,serotonin receptor agonist,HTR1A,broad_id_20170327,Phase 3,,
9366,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9367,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9368,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9369,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9370,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9371,BRD-K88366685,trimetazidine,UHWVSEOVJBQKBE,3-ketoacyl CoA thiolase inhibitor,ACAA2,broad_id_20170327,Launched,,
9372,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9373,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9374,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9375,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9376,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9377,BRD-K88429204,pyrimethamine,WKSAUQYGYAYLPV,dihydrofolate reductase inhibitor,DHFR|SLC47A1,broad_id_20170327,Launched,,
9378,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9379,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9380,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9381,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9382,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9383,BRD-K88506063,KD025,GKHIVNAUVKXIIY,rho associated kinase inhibitor,ROCK2,broad_id_20170327,Phase 2,,
9384,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9385,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9386,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9387,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9388,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9389,BRD-K88510285,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,broad_id_20170327,Launched,,
9390,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9391,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9392,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9393,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9394,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9395,BRD-K88611939,aniracetam,ZXNRTKGTQJPIJK,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,broad_id_20170327,Launched,,
9396,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9397,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9398,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9399,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9400,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9401,BRD-K89162000,tandutinib,UXXQOJXBIDBUAC,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,broad_id_20170327,Phase 2,,
9402,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9403,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9404,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9405,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9406,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9407,BRD-K89208535,indacaterol,QZZUEBNBZAPZLX,adrenergic receptor agonist,ADRB1|ADRB2,broad_id_20170327,Launched,,
9408,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9409,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9410,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9411,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9412,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9413,BRD-K89274813,DMP-543,MUJBUUDUXGDXLW,acetylcholine release enhancer,,broad_id_20170327,Phase 2,,
9414,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9415,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9416,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9417,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9418,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9419,BRD-K89348303,ramipril,HDACQVRGBOVJII,angiotensin converting enzyme inhibitor,ACE,broad_id_20170327,Launched,,
9420,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9421,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9422,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9423,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9424,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9425,BRD-K89375097,pirenzepine,RMHMFHUVIITRHF,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9426,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9427,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9428,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9429,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9430,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9431,BRD-K89917372,,PCOBBVZJEWWZFR,,,broad_id_20170327,,,
9432,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9433,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9434,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9435,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9436,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9437,BRD-K89997465,chlorpromazine,ZPEIMTDSQAKGNT,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,broad_id_20170327,Launched,,
9438,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9439,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9440,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9441,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9442,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9443,BRD-K90195324,bazedoxifene,UCJGJABZCDBEDK,selective estrogen receptor modulator (SERM),ESR1|ESR2,broad_id_20170327,Launched,,
9444,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9445,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9446,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9447,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9448,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9449,BRD-K90777969,cutamesine,UVSWWUWQVAQPJR,sigma receptor agonist,SIGMAR1,broad_id_20170327,Phase 2,,
9450,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9451,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9452,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9453,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9454,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9455,BRD-K90948141,indiplon,CBIAWPMZSFFRGN,benzodiazepine receptor agonist,GABRA1,broad_id_20170327,Phase 3,,
9456,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9457,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9458,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9459,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9460,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9461,BRD-K91111634,rotigotine,KFQYTPMOWPVWEJ,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,broad_id_20170327,Launched,,
9462,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9463,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9464,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9465,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9466,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9467,BRD-K91159026,telcagepant,CGDZXLJGHVKVIE,calcitonin antagonist,CALCRL|RAMP1,broad_id_20170327,Phase 3,,
9468,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9469,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9470,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9471,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9472,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9473,BRD-K91263825,nortriptyline,PHVGLTMQBUFIQQ,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,broad_id_20170327,Launched,,
9474,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9475,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9476,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9477,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9478,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9479,BRD-K91308639,apalutamide,HJBWBFZLDZWPHF,androgen receptor antagonist,,broad_id_20170327,Launched,,
9480,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9481,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9482,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9483,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9484,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9485,BRD-K91315211,betahistine,UUQMNUMQCIQDMZ,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,broad_id_20170327,Launched,,
9486,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9487,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9488,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9489,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9490,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9491,BRD-K91601245,mercaptopurine,GLVAUDGFNGKCSF,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,broad_id_20170327,Launched,,
9492,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9493,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9494,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9495,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9496,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9497,BRD-K91740057,felbinac,QRZAKQDHEVVFRX,cyclooxygenase inhibitor,CTSL,broad_id_20170327,Launched,,
9498,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9499,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9500,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9501,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9502,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9503,BRD-K91825936,ZK-811752,XQYASZNUFDVMFH,CC chemokine receptor antagonist,CCR1,broad_id_20170327,Phase 2,,
9504,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9505,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9506,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9507,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9508,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9509,BRD-K92041145,O6-benzylguanine,KRWMERLEINMZFT,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,broad_id_20170327,Phase 3,,
9510,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9511,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9512,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9513,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9514,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9515,BRD-K92049597,triamterene,FNYLWPVRPXGIIP,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,broad_id_20170327,Launched,,
9516,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9517,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9518,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9519,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9520,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9521,BRD-K92093830,doxorubicin,AOJJSUZBOXZQNB,topoisomerase inhibitor,TOP2A,broad_id_20170327,Launched,topoisomerase inhibitor,CHD1|TOP2A
9522,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9523,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9524,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9525,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9526,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9527,BRD-K98769987,flumazenil,OFBIFZUFASYYRE,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,broad_id_20170327,Launched,,
9528,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9529,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9530,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9531,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9532,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9533,BRD-K99023089,AZD5363,JDUBGYFRJFOXQC,AKT inhibitor,AKT1|AKT2|AKT3,broad_id_20170327,Phase 3,,
9534,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9535,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9536,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9537,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9538,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9539,BRD-K99092662,PS178990,KEJORAMIZFOODM,androgen receptor modulator,AR,broad_id_20170327,Phase 1,,
9540,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9541,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9542,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9543,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9544,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9545,BRD-K99257182,quinidine,LOUPRKONTZGTKE,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,broad_id_20170327,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4
9546,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9547,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9548,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9549,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9550,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9551,BRD-K99383816,ftorafur,WFWLQNSHRPWKFK,thymidylate synthase inhibitor,TYMS,broad_id_20170327,Launched,,
9552,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9553,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9554,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9555,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9556,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9557,BRD-K99451608,lopinavir,KJHKTHWMRKYKJE,HIV protease inhibitor,,broad_id_20170327,Launched,,
9558,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9559,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9560,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9561,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9562,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9563,BRD-K99749624,linifanib,MPVGZUGXCQEXTM,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,broad_id_20170327,Phase 3,,
9564,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9565,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9566,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9567,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9568,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9569,BRD-K99792991,hexachlorophene,ACGUYXCXAPNIKK,potassium channel activator,GLUD1|SDHD,broad_id_20170327,Launched,,
9570,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9571,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9572,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9573,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9574,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9575,BRD-M89827113,cromakalim,BVMDRSUIADWFLV,,KCNJ8,broad_id_20170327,Phase 2,,
9576,,,,,,,,,
9577,,,,,,,,,
9578,,,,,,,,,
9579,,,,,,,,,
9580,,,,,,,,,
9581,,,,,,,,,
9582,,,,,,,,,
9583,,,,,,,,,
9584,,,,,,,,,
9585,,,,,,,,,
9586,,,,,,,,,
9587,,,,,,,,,
9588,,,,,,,,,
9589,,,,,,,,,
9590,,,,,,,,,
9591,,,,,,,,,
9592,,,,,,,,,
9593,,,,,,,,,
9594,,,,,,,,,
9595,,,,,,,,,
9596,,,,,,,,,
9597,,,,,,,,,
9598,,,,,,,,,
9599,,,,,,,,,
9600,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9601,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9602,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9603,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9604,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9605,BRD-A38592941,timonacic,DZLNHFMRPBPULJ,antioxidant,,broad_id_20170327,Launched,,
9606,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9607,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9608,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9609,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9610,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9611,BRD-A92630576,trimebutine,LORDFXWUHHSAQU,opioid receptor agonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9612,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9613,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9614,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9615,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9616,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9617,BRD-A93255169,thalidomide,UEJJHQNACJXSKW,tumor necrosis factor production inhibitor,TNF,broad_id_20170327,Launched,,
9618,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9619,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9620,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9621,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9622,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9623,BRD-A94543220,bifonazole,OCAPBUJLXMYKEJ,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9624,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9625,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9626,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9627,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9628,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9629,BRD-A94756469,digoxin,LTMHDMANZUZIPE,ATPase inhibitor,ATP1A1,broad_id_20170327,Launched,,
9630,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9631,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9632,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9633,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9634,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9635,BRD-A95869247,indapamide,NDDAHWYSQHTHNT,thiazide diuretic,CA2|HTR3A|KCNQ1,broad_id_20170327,Launched,,
9636,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9637,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9638,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9639,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9640,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9641,BRD-A95939040,sertaconazole,JLGKQTAYUIMGRK,sterol demethylase inhibitor,,broad_id_20170327,Launched,,
9642,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9643,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9644,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9645,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9646,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9647,BRD-A96456596,FPL-55712,LMQBMWHHGVZWMR,leukotriene receptor antagonist,,broad_id_20170327,Phase 1,,
9648,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9649,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9650,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9651,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9652,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9653,BRD-A97104540,fenoterol,LSLYOANBFKQKPT,adrenergic receptor agonist,ADRB2,broad_id_20170327,Withdrawn,,
9654,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9655,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9656,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9657,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9658,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9659,BRD-A97674275,ranolazine,XKLMZUWKNUAPSZ,sodium channel blocker,SCN10A|SCN9A,broad_id_20170327,Launched,,
9660,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9661,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9662,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9663,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9664,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9665,BRD-A97739905,ketoprofen,DKYWVDODHFEZIM,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,broad_id_20170327,Launched,,
9666,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9667,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9668,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9669,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9670,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9671,BRD-A97808748,spironolactone,LXMSZDCAJNLERA,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,broad_id_20170327,Launched,,
9672,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9673,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9674,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9675,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9676,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9677,BRD-K07857022,alvimopan,UPNUIXSCZBYVBB,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,broad_id_20170327,Launched,,
9678,BRD-K41996876,,,,,,,,
9679,BRD-K41996876,,,,,,,,
9680,BRD-K41996876,,,,,,,,
9681,BRD-K41996876,,,,,,,,
9682,BRD-K41996876,,,,,,,,
9683,BRD-K41996876,,,,,,,,
9684,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9685,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9686,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9687,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9688,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9689,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9690,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9691,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9692,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9693,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9694,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9695,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
9696,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9697,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9698,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9699,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9700,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9701,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9702,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9703,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9704,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9705,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9706,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9707,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
9708,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9709,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9710,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9711,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9712,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9713,BRD-K61443650,thiomersal,HXQVQGWHFRNKMS,other antibiotic,OXCT1,broad_id_20170327,Launched,,
9714,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9715,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9716,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9717,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9718,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9719,BRD-K90825648,RS-127445,ZZZQXCUPAJFVBN,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,broad_id_20170327,Phase 1,,
9720,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9721,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9722,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9723,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9724,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9725,BRD-K90868879,canagliflozin,XTNGUQKDFGDXSJ,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,broad_id_20170327,Launched,,
9726,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9727,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9728,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9729,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9730,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9731,BRD-K91495480,AGP-103,UKMSUNONTOPOIO,membrane permeability inhibitor,,broad_id_20170327,Launched,,
9732,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9733,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9734,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9735,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9736,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9737,BRD-K91544578,nikethamide,NCYVXEGFNDZQCU,immunostimulant,,broad_id_20170327,Withdrawn,,
9738,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9739,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9740,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9741,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9742,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9743,BRD-K92301463,"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU,prostanoid receptor agonist,HPGD,broad_id_20170327,Phase 2,,
9744,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9745,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9746,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9747,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9748,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9749,BRD-K92303087,oglemilast,OKFDRAHPFKMAJH,phosphodiesterase inhibitor,,broad_id_20170327,Phase 2,,
9750,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9751,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9752,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9753,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9754,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9755,BRD-K92657060,,HUNXMJYCHXQEGX,,,broad_id_20170327,,,
9756,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9757,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9758,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9759,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9760,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9761,BRD-K92723993,imatinib,KTUFNOKKBVMGRW,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,broad_id_20170327,Launched,,
9762,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9763,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9764,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9765,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9766,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9767,BRD-K93034159,cladribine,PTOAARAWEBMLNO,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,broad_id_20170327,Launched,,
9768,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9769,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9770,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9771,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9772,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9773,BRD-K93123848,RAF265,YABJJWZLRMPFSI,RAF inhibitor|VEGFR inhibitor,BRAF,broad_id_20170327,Phase 2,,
9774,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9775,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9776,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9777,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9778,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9779,BRD-K93208532,apremilast,IMOZEMNVLZVGJZ,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,broad_id_20170327,Launched,,
9780,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9781,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9782,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9783,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9784,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9785,BRD-K93255255,indoximod,ZADWXFSZEAPBJS,"indoleamine 2,3-dioxygenase inhibitor",IDO1,broad_id_20170327,Phase 2,,
9786,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9787,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9788,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9789,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9790,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9791,BRD-K93461745,buspirone,QWCRAEMEVRGPNT,serotonin receptor agonist,DRD2|HTR1A,broad_id_20170327,Launched,,
9792,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9793,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9794,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9795,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9796,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9797,BRD-K93767137,oseltamivir-carboxylate,NENPYTRHICXVCS,neuraminidase inhibitor,,broad_id_20170327,Launched,,
9798,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9799,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9800,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9801,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9802,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9803,BRD-K93779381,ingenol-mebutate,VDJHFHXMUKFKET,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,broad_id_20170327,Launched,,
9804,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9805,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9806,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9807,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9808,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9809,BRD-K93869735,taltirelin,LQZAIAZUDWIVPM,thyrotropin releasing hormone receptor agonist,TRHR,broad_id_20170327,Launched,,
9810,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9811,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9812,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9813,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9814,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9815,BRD-K93880783,stavudine,XNKLLVCARDGLGL,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
9816,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9817,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9818,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9819,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9820,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9821,BRD-K94288301,letermovir,FWYSMLBETOMXAG,CMV terminase inhibitor,,broad_id_20170327,Launched,,
9822,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9823,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9824,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9825,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9826,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9827,BRD-K94436377,diosmin,GZSOSUNBTXMUFQ,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,broad_id_20170327,Launched,,
9828,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9829,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9830,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9831,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9832,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9833,BRD-K94534639,LY2811376,MJQMRGWYPNIERM,beta-secretase inhibitor,BACE1,broad_id_20170327,Phase 1,,
9834,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9835,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9836,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9837,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9838,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9839,BRD-K95412502,istaroxime,MPYLDWFDPHRTEG,ATPase inhibitor,ATP1A1,broad_id_20170327,Phase 2,,
9840,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9841,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9842,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9843,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9844,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9845,BRD-K95763993,trapidil,GSNOZLZNQMLSKJ,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,broad_id_20170327,Launched,,
9846,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9847,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9848,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9849,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9850,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9851,BRD-K95773607,darifenacin,HXGBXQDTNZMWGS,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
9852,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9853,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9854,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9855,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9856,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9857,BRD-K95880107,PH-797804,KCAJXIDMCNPGHZ,p38 MAPK inhibitor,MAPK11|MAPK14,broad_id_20170327,Phase 2,,
9858,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9859,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9860,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9861,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9862,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9863,BRD-K96319534,,DHHVAGZRUROJKS,,,broad_id_20170327,,,
9864,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9865,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9866,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9867,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9868,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9869,BRD-K96342952,tobramycin,NLVFBUXFDBBNBW,bacterial 30S ribosomal subunit inhibitor,,broad_id_20170327,Launched,,
9870,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9871,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9872,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9873,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9874,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9875,BRD-K96615647,AV-608,NXLUTEDAEFXMQR,tachykinin antagonist,TACR1,broad_id_20170327,Phase 2,,
9876,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9877,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9878,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9879,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9880,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9881,BRD-K97101532,tezacaftor,MJUVRTYWUMPBTR,CFTR channel agonist,,broad_id_20170327,Launched,,
9882,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9883,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9884,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9885,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9886,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9887,BRD-K97158071,droperidol,RMEDXOLNCUSCGS,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,broad_id_20170327,Launched,,
9888,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9889,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9890,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9891,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9892,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9893,BRD-K97181089,amiloride,XSDQTOBWRPYKKA,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,broad_id_20170327,Launched,,
9894,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9895,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9896,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9897,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9898,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9899,BRD-K97309399,thiothixene,GFBKORZTTCHDGY,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,broad_id_20170327,Launched,,
9900,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9901,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9902,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9903,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9904,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9905,BRD-K97530723,melatonin,DRLFMBDRBRZALE,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,broad_id_20170327,Launched,,
9906,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9907,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9908,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9909,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9910,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9911,BRD-K97564742,mepyramine,YECBIJXISLIIDS,histamine receptor antagonist,HRH1,broad_id_20170327,Launched,,
9912,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9913,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9914,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9915,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9916,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9917,BRD-K97643133,amiprilose,YXBQLONCIPUQKO,CD antagonist,,broad_id_20170327,Phase 3,,
9918,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9919,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9920,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9921,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9922,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9923,BRD-K97884852,malotilate,YPIQVCUJEKAZCP,protein synthesis stimulant,,broad_id_20170327,Launched,,
9924,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9925,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9926,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9927,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9928,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9929,BRD-K97963946,EMD-1214063,AHYMHWXQRWRBKT,hepatocyte growth factor receptor inhibitor,MET,broad_id_20170327,Phase 2,,
9930,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9931,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9932,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9933,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9934,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9935,BRD-K98004573,rupatadine,WUZYKBABMWJHDL,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,broad_id_20170327,Launched,,
9936,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9937,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9938,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9939,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9940,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9941,BRD-K98572433,AZD8931,DFJSJLGUIXFDJP,EGFR inhibitor,EGFR|ERBB2|ERBB3,broad_id_20170327,Phase 2,,
9942,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9943,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9944,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9945,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9946,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9947,BRD-K99504665,goserelin-acetate,BLCLNMBMMGCOAS,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,broad_id_20170327,Launched,,
9948,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9949,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9950,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9951,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9952,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9953,BRD-K99545815,PF-562271,MZDKLVOWGIOKTN,focal adhesion kinase inhibitor,PTK2|PTK2B,broad_id_20170327,Phase 1,,
9954,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9955,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9956,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9957,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9958,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9959,BRD-K99604664,tanaproget,PYVFWTPEBMRKSR,progesterone receptor agonist,PGR,broad_id_20170327,Phase 2,,
9960,,,,,,,,,
9961,,,,,,,,,
9962,,,,,,,,,
9963,,,,,,,,,
9964,,,,,,,,,
9965,,,,,,,,,
9966,,,,,,,,,
9967,,,,,,,,,
9968,,,,,,,,,
9969,,,,,,,,,
9970,,,,,,,,,
9971,,,,,,,,,
9972,,,,,,,,,
9973,,,,,,,,,
9974,,,,,,,,,
9975,,,,,,,,,
9976,,,,,,,,,
9977,,,,,,,,,
9978,,,,,,,,,
9979,,,,,,,,,
9980,,,,,,,,,
9981,,,,,,,,,
9982,,,,,,,,,
9983,,,,,,,,,
9984,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9985,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9986,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9987,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9988,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9989,BRD-A92537424,danazol,POZRVZJJTULAOH,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,broad_id_20170327,Launched,,
9990,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9991,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9992,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9993,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9994,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9995,BRD-A92826379,lupanine,JYIJIIVLEOETIQ,sodium channel blocker,INS,broad_id_20170327,Phase 1,,
9996,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
9997,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
9998,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
9999,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
10000,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
10001,BRD-A93000692,ciglitazone,YZFWTZACSRHJQD,PPAR receptor agonist,PPARG,broad_id_20170327,Phase 2,,
10002,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10003,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10004,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10005,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10006,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10007,BRD-A93093700,,SEQDDYPDSLOBDC,,,broad_id_20170327,,,
10008,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10009,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10010,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10011,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10012,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10013,BRD-A93353767,isoconazole,MPIPASJGOJYODL,fungal lanosterol demethylase inhibitor,CYP17A1,broad_id_20170327,Launched,,
10014,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10015,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10016,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10017,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10018,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10019,BRD-A93424738,betamethasone-acetate,AKUJBENLRBOFTD,glucocorticoid receptor agonist,NR3C1,broad_id_20170327,Launched,glucocorticoid receptor agonist,
10020,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10021,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10022,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10023,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10024,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10025,BRD-A93964801,clinafloxacin,QGPKADBNRMWEQR,bacterial DNA gyrase inhibitor,,broad_id_20170327,Phase 3,,
10026,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10027,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10028,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10029,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10030,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10031,BRD-A94276798,talinolol,MXFWWQICDIZSOA,adrenergic receptor antagonist,ADRB1,broad_id_20170327,Launched,,
10032,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10033,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10034,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10035,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10036,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10037,BRD-A95032015,abacavir,MCGSCOLBFJQGHM,nucleoside reverse transcriptase inhibitor,,broad_id_20170327,Launched,,
10038,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10039,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10040,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10041,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10042,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10043,BRD-A95696066,nisoxetine,ITJNARMNRKSWTA,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,broad_id_20170327,Phase 1,,
10044,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10045,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10046,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10047,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10048,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10049,BRD-A96060515,ipratropium,OEXHQOGQTVQTAT,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,broad_id_20170327,Launched,,
10050,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10051,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10052,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10053,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10054,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10055,BRD-A96292436,eflornithine,VLCYCQAOQCDTCN,ornithine decarboxylase inhibitor,ARG2|ODC1,broad_id_20170327,Launched,,
10056,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10057,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10058,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10059,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10060,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10061,BRD-A96754982,tacrolimus,QJJXYPPXXYFBGM,calcineurin inhibitor,FKBP1A,broad_id_20170327,Launched,,
10062,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10063,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10064,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10065,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10066,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10067,BRD-A97437073,rosiglitazone,YASAKCUCGLMORW,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,broad_id_20170327,Withdrawn,,
10068,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10069,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10070,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10071,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10072,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10073,BRD-A97479839,piperidolate,KTHVBAZBLKXIHZ,acetylcholine receptor antagonist,CHRM1,broad_id_20170327,Launched,,
10074,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10075,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10076,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10077,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10078,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10079,BRD-A97502381,,FMCRMSOQAVOHRD,,,broad_id_20170327,,,
10080,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10081,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10082,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10083,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10084,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10085,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10086,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10087,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10088,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10089,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10090,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10091,BRD-K50691590,bortezomib,GXJABQQUPOEUTA,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,deprecated_broad_id_20180907,Launched,,
10092,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10093,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10094,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10095,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10096,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10097,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10098,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10099,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10100,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10101,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10102,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10103,BRD-K60230970,MG-132,TZYWCYJVHRLUCT,proteasome inhibitor,PSMB1,broad_id_20170327,Preclinical,,
10104,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10105,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10106,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10107,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10108,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10109,BRD-K63750851,mycophenolic-acid,HPNSFSBZBAHARI,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10110,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10111,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10112,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10113,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10114,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10115,BRD-K92428153,mycophenolate-mofetil,RTGDFNSFWBGLEC,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,broad_id_20170327,Launched,,
10116,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10117,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10118,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10119,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10120,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10121,BRD-K92428232,GSK461364,ZHJGWYRLJUCMRT,PLK inhibitor,PLK1,broad_id_20170327,Phase 1,,
10122,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10123,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10124,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10125,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10126,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10127,BRD-K92441787,bexarotene,NAVMQTYZDKMPEU,retinoid receptor agonist,RXRA|RXRB|RXRG,broad_id_20170327,Launched,,
10128,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10129,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10130,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10131,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10132,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10133,BRD-K92467929,,QSLJIVKCVHQPLV,,,broad_id_20170327,,,
10134,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10135,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10136,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10137,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10138,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10139,BRD-K92613113,safinamide,NEMGRZFTLSKBAP,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,broad_id_20170327,Launched,,
10140,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10141,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10142,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10143,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10144,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10145,BRD-K92758126,MD-920,IXORZMNAPKEEDV,NFkB pathway inhibitor,AADACL2,broad_id_20170327,Phase 1,,
10146,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10147,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10148,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10149,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10150,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10151,BRD-K92848252,diminazene-aceturate,XNYZHCFCZNMTFY,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,broad_id_20170327,Phase 3,,
10152,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10153,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10154,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10155,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10156,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10157,BRD-K92968657,tirapazamine,ORYDPOVDJJZGHQ,DNA inhibitor,,broad_id_20170327,Phase 3,,
10158,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10159,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10160,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10161,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10162,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10163,BRD-K92984783,melperone,DKMFBWQBDIGMHM,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,broad_id_20170327,Launched,,
10164,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10165,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10166,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10167,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10168,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10169,BRD-K93460210,lamotrigine,PYZRQGJRPPTADH,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,broad_id_20170327,Launched,,
10170,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10171,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10172,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10173,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10174,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10175,BRD-K93618743,ipriflavone,SFBODOKJTYAUCM,bone resorption inhibitor,,broad_id_20170327,Launched,,
10176,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10177,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10178,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10179,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10180,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10181,BRD-K93633846,hesperidin,QUQPHWDTPGMPEX,flavanone glycoside,AURKB|CACNA1B,broad_id_20170327,Launched,,
10182,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10183,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10184,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10185,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10186,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10187,BRD-K93645900,tadalafil,WOXKDUGGOYFFRN,phosphodiesterase inhibitor,PDE11A|PDE5A,broad_id_20170327,Launched,,
10188,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10189,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10190,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10191,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10192,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10193,BRD-K93754473,tamoxifen,NKANXQFJJICGDU,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,broad_id_20170327,Launched,,
10194,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10195,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10196,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10197,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10198,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10199,BRD-K93918653,quizartinib,CVWXJKQAOSCOAB,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,broad_id_20170327,Phase 3,,
10200,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10201,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10202,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10203,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10204,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10205,BRD-K93944989,safingol,OTKJDMGTUTTYMP,PKC inhibitor,TRPM3,broad_id_20170327,Phase 1,,
10206,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10207,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10208,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10209,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10210,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10211,BRD-K94293891,,JYTNQNCOQXFQPK,,,broad_id_20170327,,,
10212,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10213,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10214,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10215,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10216,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10217,BRD-K94397152,ribavirin,IWUCXVSUMQZMFG,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,broad_id_20170327,Launched,,
10218,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10219,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10220,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10221,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10222,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10223,BRD-K94420399,PF-04136309,ZNSVOHSYDRPBGI,CC chemokine receptor antagonist,,broad_id_20170327,Phase 2,,
10224,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10225,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10226,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10227,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10228,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10229,BRD-K94830329,ataluren,OOUGLTULBSNHNF,CFTR channel agonist|dystrophin stimulant,DMD,broad_id_20170327,Launched,,
10230,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10231,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10232,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10233,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10234,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10235,BRD-K95142244,talazoparib,HWGQMRYQVZSGDQ,PARP inhibitor,PARP2,broad_id_20170327,Launched,,
10236,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10237,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10238,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10239,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10240,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10241,BRD-K95237249,probenecid,DBABZHXKTCFAPX,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,broad_id_20170327,Launched,,
10242,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10243,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10244,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10245,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10246,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10247,BRD-K95260951,asenapine,VSWBSWWIRNCQIJ,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,broad_id_20170327,Launched,,
10248,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10249,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10250,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10251,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10252,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10253,BRD-K95739795,tetrabenazine,MKJIEFSOBYUXJB,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10254,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10255,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10256,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10257,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10258,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10259,BRD-K95901403,XL147,MQMKRQLTIWPEDM,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,broad_id_20170327,Phase 2,,
10260,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10261,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10262,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10263,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10264,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10265,BRD-K95921201,reserpine,QEVHRUUCFGRFIF,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,broad_id_20170327,Launched,,
10266,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10267,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10268,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10269,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10270,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10271,BRD-K96042922,etanidazole,WCDWBPCFGJXFJZ,bacterial cell wall synthesis inhibitor,,broad_id_20170327,Phase 3,,
10272,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10273,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10274,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10275,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10276,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10277,BRD-K96123349,brequinar,PHEZJEYUWHETKO,dihydroorotate dehydrogenase inhibitor,DHODH,broad_id_20170327,Phase 2,,
10278,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10279,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10280,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10281,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10282,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10283,BRD-K96671969,pretomanid,ZLHZLMOSPGACSZ,nitric oxide donor,FASN,broad_id_20170327,Launched,,
10284,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10285,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10286,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10287,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10288,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10289,BRD-K96720755,relcovaptan,CEBYCSRFKCEUSW,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,broad_id_20170327,Phase 2,,
10290,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10291,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10292,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10293,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10294,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10295,BRD-K96740444,itopride,QQQIECGTIMUVDS,dopamine receptor antagonist,CHRM3|DRD2,broad_id_20170327,Launched,,
10296,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10297,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10298,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10299,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10300,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10301,BRD-K96862998,pirfenidone,ISWRGOKTTBVCFA,TGF beta receptor inhibitor,FURIN|TNF,broad_id_20170327,Launched,,
10302,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10303,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10304,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10305,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10306,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10307,BRD-K96936751,bretazenil,LWUDDYHYYNNIQI,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,broad_id_20170327,Phase 2,,
10308,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10309,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10310,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10311,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10312,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10313,BRD-K97010173,deferasirox,BOFQWVMAQOTZIW,chelating agent,CYP3A4,broad_id_20170327,Launched,,
10314,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10315,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10316,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10317,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10318,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10319,BRD-K97045029,pranlukast,NBQKINXMPLXUET,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,broad_id_20170327,Launched,,
10320,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10321,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10322,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10323,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10324,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10325,BRD-K97399794,quercetin,REFJWTPEDVJJIY,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,broad_id_20170327,Launched,,
10326,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10327,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10328,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10329,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10330,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10331,BRD-K97428065,netupitant,WAXQNWCZJDTGBU,tachykinin antagonist,TACR1,broad_id_20170327,Launched,,
10332,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10333,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10334,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10335,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10336,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10337,BRD-K97440753,dihydroergocristine,DEQITUUQPICUMR,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,broad_id_20170327,Launched,,
10338,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10339,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10340,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10341,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10342,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10343,BRD-K97472745,gestrinone,BJJXHLWLUDYTGC,progesterone receptor antagonist,AR|ESR1|PGR,broad_id_20170327,Launched,,
10344,,,,,,,,,
10345,,,,,,,,,
10346,,,,,,,,,
10347,,,,,,,,,
10348,,,,,,,,,
10349,,,,,,,,,
10350,,,,,,,,,
10351,,,,,,,,,
10352,,,,,,,,,
10353,,,,,,,,,
10354,,,,,,,,,
10355,,,,,,,,,
10356,,,,,,,,,
10357,,,,,,,,,
10358,,,,,,,,,
10359,,,,,,,,,
10360,,,,,,,,,
10361,,,,,,,,,
10362,,,,,,,,,
10363,,,,,,,,,
10364,,,,,,,,,
10365,,,,,,,,,
10366,,,,,,,,,
10367,,,,,,,,,
